TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1280215	Cytokine Signaling in Immune system	6.75065298886099e-28	-62.5627433645372	756	111	0.223790322580645	496	10287	1848,64127,10148,2668,1440,29949,4940,3593,330,6364,4790,3162,3604,1850,3429,3659,960,115362,6352,50604,3553,3576,4938,8638,4982,4318,4067,2247,5743,5721,1839,2634,6363,3559,115361,3934,3557,2633,4312,3569,6351,3055,3455,6348,5292,3586,6708,3589,1844,3575,5699,9636,90865,1847,5698,970,3656,3552,943,26281,3669,2069,10125,3394,27177,3684,3627,11009,3561,23529,6288,941,11213,3976,84639,4939,4843,9235,3460,8503,3383,8809,27189,3601,5971,6347,2919,56300,1435,2537,1437,149233,2635,54739,2920,4791,3592,91543,3687,4233,51561,27179,8995,8767,4314,595,5008,23586,146433,7133,1326	DUSP6,NOD2,EBI3,GDNF,CSF3,IL19,OAS3,IL12B,BIRC3,CCL20,NFKB1,HMOX1,TNFRSF9,DUSP8,IFI27,IRF1,CD44,GBP5,CCL5,IL20,IL1B,CXCL8,OAS1,OASL,TNFRSF11B,MMP9,LYN,FGF2,PTGS2,PSME2,HBEGF,GBP2,CCL19,IL2RA,GBP4,LCN2,IL1RN,GBP1,MMP1,IL6,CCL4,HCK,IFNAR2,CCL3,PIM1,IL10,SPTA1,IL11,DUSP2,IL7R,PSMB10,ISG15,IL33,DUSP5,PSMB9,CD70,IRAK2,IL1A,TNFRSF8,FGF20,ISG20,EREG,RASGRP1,IRF8,IL36B,ITGAM,CXCL10,IL24,IL2RG,CLCF1,SAA1,CD80,IRAK3,LIF,IL1F10,OAS2,NOS2,IL32,IFNGR2,PIK3R3,ICAM1,IL18R1,IL17C,IL15RA,RELB,CCL2,CXCL1,IL36G,CSF1,IFI6,CSF2,IL23R,GBP3,XAF1,CXCL2,NFKB2,IL12A,RSAD2,ITGAX,MET,IL23A,IL36A,TNFSF18,RIPK2,MMP3,CCND1,OSM,DDX58,IL34,TNFRSF1B,MAP3K8
R-HSA-449147	Signaling by Interleukins	7.828658357475e-23	-50.901665989969	525	83	0.167338709677419	496	10287	5743,2247,4067,4318,3559,5721,1839,6363,3055,6351,3569,4312,3934,3557,6708,5292,3586,6348,29949,1440,10148,64127,2668,1848,6364,3593,1850,3162,4790,6352,3553,50604,3576,1435,2919,6347,56300,3601,27189,8503,3383,8809,3592,2920,4791,149233,1437,8767,51561,27179,3687,4233,1326,7133,146433,4314,595,5008,1844,3575,5699,90865,3589,10125,2069,26281,3552,5698,1847,3656,23529,3561,6288,3627,11009,3684,27177,9235,4843,3976,84639,941,11213	PTGS2,FGF2,LYN,MMP9,IL2RA,PSME2,HBEGF,CCL19,HCK,CCL4,IL6,MMP1,LCN2,IL1RN,SPTA1,PIM1,IL10,CCL3,IL19,CSF3,EBI3,NOD2,GDNF,DUSP6,CCL20,IL12B,DUSP8,HMOX1,NFKB1,CCL5,IL1B,IL20,CXCL8,CSF1,CXCL1,CCL2,IL36G,IL15RA,IL17C,PIK3R3,ICAM1,IL18R1,IL12A,CXCL2,NFKB2,IL23R,CSF2,RIPK2,IL23A,IL36A,ITGAX,MET,MAP3K8,TNFRSF1B,IL34,MMP3,CCND1,OSM,DUSP2,IL7R,PSMB10,IL33,IL11,RASGRP1,EREG,FGF20,IL1A,PSMB9,DUSP5,IRAK2,CLCF1,IL2RG,SAA1,CXCL10,IL24,ITGAM,IL36B,IL32,NOS2,LIF,IL1F10,CD80,IRAK3
R-HSA-6783783	Interleukin-10 signaling	1.43072828778242e-20	-45.6935182530988	49	25	0.0504032258064516	496	10287	3383,2919,6347,1440,5743,1435,1437,6363,3593,3552,6364,2920,3592,3557,3569,6351,3627,6348,941,3586,3976,6352,3553,3576,7133	ICAM1,CXCL1,CCL2,CSF3,PTGS2,CSF1,CSF2,CCL19,IL12B,IL1A,CCL20,CXCL2,IL12A,IL1RN,IL6,CCL4,CXCL10,CCL3,CD80,IL10,LIF,CCL5,IL1B,CXCL8,TNFRSF1B
R-HSA-168256	Immune System	8.39308585362293e-17	-37.0165383266567	2101	179	0.360887096774194	496	10287	3553,4982,8638,719,3659,115362,3604,3429,7498,1540,7130,3386,6364,2268,11119,10517,6279,3593,1440,5329,4586,2495,114770,1848,4688,2668,10148,64127,92369,53831,3055,4312,2633,6278,1839,3559,6317,29126,5317,3976,3460,4843,11213,54210,11009,3627,23308,3561,117157,3725,3669,26281,943,154664,2069,10584,3656,5698,3552,5266,23327,3575,1844,7097,3589,50617,1326,4314,8767,3937,8995,3687,2920,4794,4791,91543,1118,1437,8876,2635,149233,55521,2919,6347,6891,2537,7295,8503,5971,342510,3576,4938,6280,6352,50604,960,3162,1850,4790,330,84676,5005,10071,4940,29949,1604,3586,5292,6708,3455,6348,64135,6351,3557,3934,115361,285852,3569,4033,272,718,6363,2634,5721,2247,5743,5004,4318,644150,55008,4067,84639,4939,9235,941,3684,6288,7128,23529,3394,27177,26253,10125,2207,970,1847,9636,90865,5699,79930,245973,629,7133,6616,146433,255488,3710,127544,5008,23586,5068,595,5806,27179,57823,51561,6890,4233,3592,1520,54739,221687,56300,1435,8809,3383,4792,3601,27189	IL1B,TNFRSF11B,OASL,C3AR1,IRF1,GBP5,TNFRSF9,IFI27,XDH,CYLD,TNFAIP6,ICAM4,CCL20,FGR,BTN3A1,FBXW10,S100A8,IL12B,CSF3,PLAUR,MUC5AC,FTH1,PGLYRP2,DUSP6,NCF2,GDNF,EBI3,NOD2,SPSB4,GPR84,HCK,MMP1,GBP1,S100A7,HBEGF,IL2RA,SERPINB3,CD274,PKP1,LIF,IFNGR2,NOS2,IRAK3,TREM1,IL24,CXCL10,ICOSLG,IL2RG,SH2D1B,JUN,ISG20,FGF20,TNFRSF8,ABCA13,EREG,COLEC10,IRAK2,PSMB9,IL1A,PI3,NEDD4L,IL7R,DUSP2,TLR2,IL11,ATP6V0A4,MAP3K8,MMP3,RIPK2,LCP2,TNFSF18,ITGAX,CXCL2,NFKBIE,NFKB2,RSAD2,CHIT1,CSF2,VNN1,GBP3,IL23R,TRIM36,CXCL1,CCL2,TAP2,IFI6,TXN,PIK3R3,RELB,CD300E,CXCL8,OAS1,S100A9,CCL5,IL20,CD44,HMOX1,DUSP8,NFKB1,BIRC3,TRIM63,ORM2,MUC12,OAS3,IL19,CD55,IL10,PIM1,SPTA1,IFNAR2,CCL3,IFIH1,CCL4,IL1RN,LCN2,GBP4,TREML4,IL6,LRMP,AMPD3,C3,CCL19,GBP2,PSME2,FGF2,PTGS2,ORM1,MMP9,WIPF3,HERC6,LYN,IL1F10,OAS2,IL32,CD80,ITGAM,SAA1,TNFAIP3,CLCF1,IRF8,IL36B,CLEC4E,RASGRP1,FCER1G,CD70,DUSP5,ISG15,IL33,PSMB10,DOK3,ATP6V1C2,CFB,TNFRSF1B,SNAP25,IL34,RNF144B,ITPR3,RNF19B,OSM,DDX58,REG3A,CCND1,PTX3,IL36A,SLAMF7,IL23A,TAP1,MET,IL12A,CTSS,XAF1,RNF182,IL36G,CSF1,IL18R1,ICAM1,NFKBIA,IL15RA,IL17C
R-HSA-380108	Chemokine receptors bind chemokines	2.13946272718275e-13	-29.1730514734743	48	19	0.0383064516129032	496	10287	6346,6376,2919,643,6363,2921,6373,7852,6372,2920,57007,6364,4283,1236,9034,3627,6352,6374,3576	CCL1,CX3CL1,CXCL1,CXCR5,CCL19,CXCL3,CXCL11,CXCR4,CXCL6,CXCL2,ACKR3,CCL20,CXCL9,CCR7,CCRL2,CXCL10,CCL5,CXCL5,CXCL8
R-HSA-6785807	Interleukin-4 and 13 signaling	2.22879096465813e-13	-29.1321469387917	111	28	0.0564516129032258	496	10287	3569,4312,3687,3934,3561,6288,3162,51561,3684,595,4314,5008,4843,5292,3976,3586,3553,3576,7133,3383,4318,5743,2247,6347,3593,149233,3552,3592	IL6,MMP1,ITGAX,LCN2,IL2RG,SAA1,HMOX1,IL23A,ITGAM,CCND1,MMP3,OSM,NOS2,PIM1,LIF,IL10,IL1B,CXCL8,TNFRSF1B,ICAM1,MMP9,PTGS2,FGF2,CCL2,IL12B,IL23R,IL1A,IL12A
R-HSA-375276	Peptide ligand-binding receptors	5.8879842579223e-09	-18.95035212911	188	30	0.0604838709677419	496	10287	4283,6752,1236,1910,9034,9283,6288,3627,719,6352,6374,3576,6346,623,6376,2919,5021,2847,643,6363,10887,6373,718,7852,2921,6372,2151,57007,6364,2920	CXCL9,SSTR2,CCR7,EDNRB,CCRL2,GPR37L1,SAA1,CXCL10,C3AR1,CCL5,CXCL5,CXCL8,CCL1,BDKRB1,CX3CL1,CXCL1,OXTR,MCHR1,CXCR5,CCL19,PROKR1,CXCL11,C3,CXCR4,CXCL3,CXCL6,F2RL2,ACKR3,CCL20,CXCL2
R-HSA-418594	G alpha (i) signalling events	1.76611068405617e-06	-13.246730782743	242	30	0.0604838709677419	496	10287	5996,4283,6752,1236,5999,2918,6000,6288,3627,719,6352,6374,2914,3576,9628,623,2919,150,2847,643,6004,6363,2921,718,6373,7852,6372,2920,57007,6364	RGS1,CXCL9,SSTR2,CCR7,RGS4,GRM8,RGS7,SAA1,CXCL10,C3AR1,CCL5,CXCL5,GRM4,CXCL8,RGS6,BDKRB1,CXCL1,ADRA2A,MCHR1,CXCR5,RGS16,CCL19,CXCL3,C3,CXCL11,CXCR4,CXCL6,CXCL2,ACKR3,CCL20
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	1.9925543009754e-06	-13.1260931739681	322	36	0.0725806451612903	496	10287	147,1236,3627,6288,9034,719,3576,6352,8111,2847,150,6376,6364,6372,134864,7852,6373,1910,6752,4283,9283,2863,135,6374,6346,2919,5021,623,6363,10887,643,57007,2920,2151,2921,718	ADRA1B,CCR7,CXCL10,SAA1,CCRL2,C3AR1,CXCL8,CCL5,GPR68,MCHR1,ADRA2A,CX3CL1,CCL20,CXCL6,TAAR1,CXCR4,CXCL11,EDNRB,SSTR2,CXCL9,GPR37L1,GPR39,ADORA2A,CXCL5,CCL1,CXCL1,OXTR,BDKRB1,CCL19,PROKR1,CXCR5,ACKR3,CXCL2,F2RL2,CXCL3,C3
R-HSA-909733	Interferon alpha/beta signaling	4.09014292904466e-06	-12.4069306425435	69	14	0.0282258064516129	496	10287	9636,4940,2537,3429,3394,4939,4938,3669,91543,8638,2634,3455,3659,54739	ISG15,OAS3,IFI6,IFI27,IRF8,OAS2,OAS1,ISG20,RSAD2,OASL,GBP2,IFNAR2,IRF1,XAF1
R-HSA-500792	GPCR ligand binding	6.49542671348704e-06	-11.9444122112335	453	44	0.0887096774193548	496	10287	718,2921,57007,2920,2151,643,10887,6363,623,5021,2919,11211,6346,2914,135,6374,9283,2863,6752,4283,2918,1910,134864,6372,7852,6373,90226,6364,2847,150,6376,1604,8111,9340,3576,6352,719,6288,9034,3627,2642,7474,147,1236	C3,CXCL3,ACKR3,CXCL2,F2RL2,CXCR5,PROKR1,CCL19,BDKRB1,OXTR,CXCL1,FZD10,CCL1,GRM4,ADORA2A,CXCL5,GPR37L1,GPR39,SSTR2,CXCL9,GRM8,EDNRB,TAAR1,CXCL6,CXCR4,CXCL11,UCN2,CCL20,MCHR1,ADRA2A,CX3CL1,CD55,GPR68,GLP2R,CXCL8,CCL5,C3AR1,SAA1,CCRL2,CXCL10,GCGR,WNT5A,ADRA1B,CCR7
R-HSA-168249	Innate Immune System	4.69752933392128e-05	-9.96588876810281	1285	92	0.185483870967742	496	10287	4791,1520,1118,1437,8876,2919,7295,8503,4792,5971,6616,7133,1326,3710,23586,5068,5806,3937,8767,3687,4233,26281,10125,26253,2069,10584,154664,5698,1847,2207,3656,5266,79930,1844,5699,9636,629,7097,245973,50617,5317,4843,941,11213,54210,3684,3561,7128,6288,3725,6278,718,5721,1839,3559,2247,5004,6317,4318,4067,644150,6708,64135,53831,3055,3934,4033,272,2268,5005,330,6279,5329,2495,4586,10071,1848,4688,114770,64127,2668,1604,3553,6280,342510,3659,719,960,1850,1540,4790,7130	NFKB2,CTSS,CHIT1,CSF2,VNN1,CXCL1,TXN,PIK3R3,NFKBIA,RELB,SNAP25,TNFRSF1B,MAP3K8,ITPR3,DDX58,REG3A,PTX3,LCP2,RIPK2,ITGAX,MET,FGF20,RASGRP1,CLEC4E,EREG,COLEC10,ABCA13,PSMB9,DUSP5,FCER1G,IRAK2,PI3,DOK3,DUSP2,PSMB10,ISG15,CFB,TLR2,ATP6V1C2,ATP6V0A4,PKP1,NOS2,CD80,IRAK3,TREM1,ITGAM,IL2RG,TNFAIP3,SAA1,JUN,S100A7,C3,PSME2,HBEGF,IL2RA,FGF2,ORM1,SERPINB3,MMP9,LYN,WIPF3,SPTA1,IFIH1,GPR84,HCK,LCN2,LRMP,AMPD3,FGR,ORM2,BIRC3,S100A8,PLAUR,FTH1,MUC5AC,MUC12,DUSP6,NCF2,PGLYRP2,NOD2,GDNF,CD55,IL1B,S100A9,CD300E,IRF1,C3AR1,CD44,DUSP8,CYLD,NFKB1,TNFAIP6
R-HSA-6799990	Metal sequestration by antimicrobial proteins	7.41272468692856e-05	-9.50972738920985	6	4	0.00806451612903226	496	10287	3934,6279,6280,6278	LCN2,S100A8,S100A9,S100A7
R-HSA-109582	Hemostasis	9.54563744187571e-05	-9.25684122721718	632	52	0.104838709677419	496	10287	7273,2151,3559,5341,11343,6401,1437,6385,5004,9056,4067,5552,9162,9732,8503,3053,3710,2888,23764,490,8140,5152,5327,3937,4312,5197,83953,3687,3779,10125,857,5005,5055,55619,2207,5880,2268,5270,2886,5329,10938,150,23657,4602,4843,6547,2152,960,3659,3561,54210,3684	TTN,F2RL2,IL2RA,PLEK,MGLL,SELE,CSF2,SDC4,ORM1,SLC7A7,LYN,SRGN,DGKI,DOCK4,PIK3R3,SERPIND1,ITPR3,GRB14,MAFF,ATP2B1,SLC7A5,PDE9A,PLAT,LCP2,MMP1,PF4V1,FCAMR,ITGAX,KCNMB1,RASGRP1,CAV1,ORM2,SERPINB2,DOCK10,FCER1G,RAC2,FGR,SERPINE2,GRB7,PLAUR,EHD1,ADRA2A,SLC7A11,MYB,NOS2,SLC8A3,F3,CD44,IRF1,IL2RG,TREM1,ITGAM
R-HSA-877300	Interferon gamma signaling	0.000152337418468871	-8.78941263901545	94	14	0.0282258064516129	496	10287	3460,8638,4939,4938,960,115362,2635,2634,3659,4940,2633,115361,3383,3394	IFNGR2,OASL,OAS2,OAS1,CD44,GBP5,GBP3,GBP2,IRF1,OAS3,GBP1,GBP4,ICAM1,IRF8
R-HSA-448706	Interleukin-1 processing	0.000166364081791866	-8.70133190749332	7	4	0.00806451612903226	496	10287	3552,4790,4791,3553	IL1A,NFKB1,NFKB2,IL1B
R-HSA-6783589	Interleukin-6 family signaling	0.000221929463620597	-8.41315095801808	27	7	0.0141129032258065	496	10287	3976,23529,3592,3589,10148,5008,3569	LIF,CLCF1,IL12A,IL11,EBI3,OSM,IL6
R-HSA-71240	Tryptophan catabolism	0.000238046600340754	-8.343044103708	13	5	0.0100806451612903	496	10287	8140,8564,6999,8942,3620	SLC7A5,KMO,TDO2,KYNU,IDO1
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.000264723203572695	-8.23682579268383	20	6	0.0120967741935484	496	10287	3589,10148,5008,3976,23529,3592	IL11,EBI3,OSM,LIF,CLCF1,IL12A
R-HSA-913531	Interferon Signaling	0.000269856897237323	-8.21761874970311	201	22	0.0443548387096774	496	10287	4938,4939,8638,3460,3455,3659,23586,960,115362,3429,3394,115361,2633,3669,91543,2634,2635,54739,9636,2537,4940,3383	OAS1,OAS2,OASL,IFNGR2,IFNAR2,IRF1,DDX58,CD44,GBP5,IFI27,IRF8,GBP4,GBP1,ISG20,RSAD2,GBP2,GBP3,XAF1,ISG15,IFI6,OAS3,ICAM1
R-HSA-202733	Cell surface interactions at the vascular wall	0.000281264080227982	-8.17621654266593	136	17	0.0342741935483871	496	10287	857,6401,6385,2207,9056,4067,23657,2886,960,8140,2888,4312,5197,83953,3687,54210,3684	CAV1,SELE,SDC4,FCER1G,SLC7A7,LYN,SLC7A11,GRB7,CD44,SLC7A5,GRB14,MMP1,PF4V1,FCAMR,ITGAX,TREM1,ITGAM
R-HSA-446652	Interleukin-1 signaling	0.000292081524262682	-8.1384776019826	46	9	0.0181451612903226	496	10287	3552,11213,3656,1326,3553,4790,64127,3557,8767	IL1A,IRAK3,IRAK2,MAP3K8,IL1B,NFKB1,NOD2,IL1RN,RIPK2
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.000358683975640623	-7.93306884785402	29	7	0.0141129032258065	496	10287	4791,8767,6288,4792,3656,4790,64127	NFKB2,RIPK2,SAA1,NFKBIA,IRAK2,NFKB1,NOD2
R-HSA-1474244	Extracellular matrix organization	0.00049216092899977	-7.61670480349177	296	28	0.0564516129032258	496	10287	2247,3914,4316,4318,3383,375790,3386,1305,4321,1294,6385,3918,10516,1520,27302,56999,3684,4319,9507,63923,3687,9378,4312,169044,650,4322,4314,960	FGF2,LAMB3,MMP7,MMP9,ICAM1,AGRN,ICAM4,COL13A1,MMP12,COL7A1,SDC4,LAMC2,FBLN5,CTSS,BMP10,ADAMTS9,ITGAM,MMP10,ADAMTS4,TNN,ITGAX,NRXN1,MMP1,COL22A1,BMP2,MMP13,MMP3,CD44
R-HSA-1442490	Collagen degradation	0.000541548882106479	-7.52107722393269	40	8	0.0161290322580645	496	10287	4312,4316,4318,4319,4314,4321,4322,1305	MMP1,MMP7,MMP9,MMP10,MMP3,MMP12,MMP13,COL13A1
R-HSA-1474228	Degradation of the extracellular matrix	0.000868571956349116	-7.04866012442077	111	14	0.0282258064516129	496	10287	960,4314,3918,1520,4321,4322,1305,4312,4316,4318,9507,3914,56999,4319	CD44,MMP3,LAMC2,CTSS,MMP12,MMP13,COL13A1,MMP1,MMP7,MMP9,ADAMTS4,LAMB3,ADAMTS9,MMP10
R-HSA-933542	TRAF6 mediated NF-kB activation	0.000984753558225963	-6.92311914279055	25	6	0.0120967741935484	496	10287	4791,6288,4792,23586,4790,64135	NFKB2,SAA1,NFKBIA,DDX58,NFKB1,IFIH1
R-HSA-168898	Toll-Like Receptors Cascades	0.00110416731908635	-6.80866378546743	153	17	0.0342741935483871	496	10287	7097,64127,1848,4792,4791,330,6279,1520,3656,8767,6288,3684,4790,3725,1326,6280,11213	TLR2,NOD2,DUSP6,NFKBIA,NFKB2,BIRC3,S100A8,CTSS,IRAK2,RIPK2,SAA1,ITGAM,NFKB1,JUN,MAP3K8,S100A9,IRAK3
R-HSA-5689896	Ovarian tumor domain proteases	0.00169397027601884	-6.38068022953028	37	7	0.0141129032258065	496	10287	79931,8767,7128,23586,10318,64135,64127	TNIP3,RIPK2,TNFAIP3,DDX58,TNIP1,IFIH1,NOD2
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.00196621810224449	-6.23164332635809	95	12	0.0241935483870968	496	10287	3656,11213,4791,1326,1848,4792,3725,4790,64127,8767,7097,6288	IRAK2,IRAK3,NFKB2,MAP3K8,DUSP6,NFKBIA,JUN,NFKB1,NOD2,RIPK2,TLR2,SAA1
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.00196621810224449	-6.23164332635809	95	12	0.0241935483870968	496	10287	1848,4792,3725,64127,4790,8767,7097,6288,11213,3656,4791,1326	DUSP6,NFKBIA,JUN,NOD2,NFKB1,RIPK2,TLR2,SAA1,IRAK3,IRAK2,NFKB2,MAP3K8
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.00196621810224449	-6.23164332635809	95	12	0.0241935483870968	496	10287	8767,7097,6288,4790,64127,4792,1848,3725,1326,4791,11213,3656	RIPK2,TLR2,SAA1,NFKB1,NOD2,NFKBIA,DUSP6,JUN,MAP3K8,NFKB2,IRAK3,IRAK2
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.00196621810224449	-6.23164332635809	95	12	0.0241935483870968	496	10287	4790,64127,3725,4792,1848,6288,7097,8767,3656,11213,1326,4791	NFKB1,NOD2,JUN,NFKBIA,DUSP6,SAA1,TLR2,RIPK2,IRAK2,IRAK3,MAP3K8,NFKB2
R-HSA-5669034	TNFs bind their physiological receptors	0.00269071564693631	-5.91794808099742	30	6	0.0120967741935484	496	10287	970,4982,8995,7133,943,3604	CD70,TNFRSF11B,TNFSF18,TNFRSF1B,TNFRSF8,TNFRSF9
R-HSA-75205	Dissolution of Fibrin Clot	0.00269475521784823	-5.916447907003	13	4	0.00806451612903226	496	10287	5327,5055,5329,5270	PLAT,SERPINB2,PLAUR,SERPINE2
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00294772595170104	-5.82672126972887	126	14	0.0282258064516129	496	10287	3684,6288,7097,8767,3725,4792,1848,4790,64127,4791,1326,11213,3656,330	ITGAM,SAA1,TLR2,RIPK2,JUN,NFKBIA,DUSP6,NFKB1,NOD2,NFKB2,MAP3K8,IRAK3,IRAK2,BIRC3
R-HSA-425407	SLC-mediated transmembrane transport	0.00303197835886154	-5.79853994880613	287	25	0.0504032258064516	496	10287	8671,11182,51458,80736,124935,84102,8140,64116,11254,6506,3099,6513,6547,28231,6542,23657,64849,9056,28232,23382,6580,6534,64078,115019,51296	SLC4A4,SLC2A6,RHCG,SLC44A4,SLC43A2,SLC41A2,SLC7A5,SLC39A8,SLC6A14,SLC1A2,HK2,SLC2A1,SLC8A3,SLCO4A1,SLC7A2,SLC7A11,SLC13A3,SLC7A7,SLCO3A1,AHCYL2,SLC22A1,SLC6A7,SLC28A3,SLC26A9,SLC15A3
R-HSA-352230	Amino acid transport across the plasma membrane	0.0032031030700613	-5.74363522964673	31	6	0.0120967741935484	496	10287	124935,8140,11254,6542,23657,9056	SLC43A2,SLC7A5,SLC6A14,SLC7A2,SLC7A11,SLC7A7
R-HSA-5603029	IkBA variant leads to EDA-ID	0.00337107958965048	-5.69252223290793	7	3	0.00604838709677419	496	10287	4791,4792,4790	NFKB2,NFKBIA,NFKB1
R-HSA-166054	Activated TLR4 signalling	0.00352953969269633	-5.64658781520917	115	13	0.0262096774193548	496	10287	64127,4790,4792,1848,3725,8767,7097,6288,330,11213,3656,1326,4791	NOD2,NFKB1,NFKBIA,DUSP6,JUN,RIPK2,TLR2,SAA1,BIRC3,IRAK3,IRAK2,MAP3K8,NFKB2
R-HSA-168638	NOD1/2 Signaling Pathway	0.00378483850009972	-5.57675206140471	32	6	0.0120967741935484	496	10287	8767,7128,3656,1540,330,64127	RIPK2,TNFAIP3,IRAK2,CYLD,BIRC3,NOD2
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.00378483850009972	-5.57675206140471	32	6	0.0120967741935484	496	10287	4314,4312,4318,4316,4322,4319	MMP3,MMP1,MMP9,MMP7,MMP13,MMP10
R-HSA-114604	GPVI-mediated activation cascade	0.00405902812566331	-5.5068117119394	54	8	0.0161290322580645	496	10287	3559,5880,2207,1437,3937,3561,4067,8503	IL2RA,RAC2,FCER1G,CSF2,LCP2,IL2RG,LYN,PIK3R3
R-HSA-112409	RAF-independent MAPK1/3 activation	0.00417175178246959	-5.47941923966592	23	5	0.0100806451612903	496	10287	1850,1844,3569,1848,1847	DUSP8,DUSP2,IL6,DUSP6,DUSP5
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.00420764727684648	-5.47085162910218	104	12	0.0241935483870968	496	10287	3604,5699,8995,5971,943,4791,7133,4982,5721,5698,970,330	TNFRSF9,PSMB10,TNFSF18,RELB,TNFRSF8,NFKB2,TNFRSF1B,TNFRSF11B,PSME2,PSMB9,CD70,BIRC3
R-HSA-382551	Transmembrane transport of small molecules	0.00433665758942032	-5.44065136826707	677	48	0.0967741935483871	496	10287	55879,5698,338440,23327,6534,366,51296,6542,28231,1080,266675,64849,50617,23657,5699,28232,8714,2495,245973,64116,6513,3099,6547,6338,8671,124935,11182,80736,51458,3162,84102,6580,5721,23382,24,115019,64078,8989,6446,9056,4645,11254,8140,490,26154,6506,3934,4363	GABRQ,PSMB9,ANO9,NEDD4L,SLC6A7,AQP9,SLC15A3,SLC7A2,SLCO4A1,CFTR,BEST4,SLC13A3,ATP6V0A4,SLC7A11,PSMB10,SLCO3A1,ABCC3,FTH1,ATP6V1C2,SLC39A8,SLC2A1,HK2,SLC8A3,SCNN1B,SLC4A4,SLC43A2,SLC2A6,SLC44A4,RHCG,HMOX1,SLC41A2,SLC22A1,PSME2,AHCYL2,ABCA4,SLC26A9,SLC28A3,TRPA1,SGK1,SLC7A7,MYO5B,SLC6A14,SLC7A5,ATP2B1,ABCA12,SLC1A2,LCN2,ABCC1
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.00476414507949749	-5.34663717465775	15	4	0.00806451612903226	496	10287	9420,1581,1645,1646	CYP7B1,CYP7A1,AKR1C1,AKR1C2
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.00520169538771354	-5.25877067043422	8	3	0.00604838709677419	496	10287	4791,4792,4790	NFKB2,NFKBIA,NFKB1
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.00529879206867527	-5.24027639597055	107	12	0.0241935483870968	496	10287	6506,115019,51296,6547,11254,8140,23382,124935,6542,9056,23657,8671	SLC1A2,SLC26A9,SLC15A3,SLC8A3,SLC6A14,SLC7A5,AHCYL2,SLC43A2,SLC7A2,SLC7A7,SLC7A11,SLC4A4
R-HSA-351200	Interconversion of polyamines	0.00673812279887287	-4.99997390933855	3	2	0.00403225806451613	496	10287	54498,6303	SMOX,SAT1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.00694545539883639	-4.96966773273893	84	10	0.0201612903225806	496	10287	3656,4791,1326,4792,1848,3725,4790,64127,8767,6288	IRAK2,NFKB2,MAP3K8,NFKBIA,DUSP6,JUN,NFKB1,NOD2,RIPK2,SAA1
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.00694545539883639	-4.96966773273893	84	10	0.0201612903225806	496	10287	3656,1326,4791,4790,64127,1848,4792,3725,8767,6288	IRAK2,MAP3K8,NFKB2,NFKB1,NOD2,DUSP6,NFKBIA,JUN,RIPK2,SAA1
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.00694545539883639	-4.96966773273893	84	10	0.0201612903225806	496	10287	6288,8767,3725,4792,1848,64127,4790,4791,1326,3656	SAA1,RIPK2,JUN,NFKBIA,DUSP6,NOD2,NFKB1,NFKB2,MAP3K8,IRAK2
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.00694545539883639	-4.96966773273893	84	10	0.0201612903225806	496	10287	4790,4792,1540,6288,7128,9636,23586,64135,3659,4791	NFKB1,NFKBIA,CYLD,SAA1,TNFAIP3,ISG15,DDX58,IFIH1,IRF1,NFKB2
R-HSA-210991	Basigin interactions	0.00724036489623313	-4.92808367382235	26	5	0.0100806451612903	496	10287	8140,23657,857,9056,4312	SLC7A5,SLC7A11,CAV1,SLC7A7,MMP1
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.00752545012417867	-4.88946465296957	9	3	0.00604838709677419	496	10287	5366,637,27113	PMAIP1,BID,BBC3
R-HSA-2214320	Anchoring fibril formation	0.00752545012417867	-4.88946465296957	9	3	0.00604838709677419	496	10287	3914,1294,3918	LAMB3,COL7A1,LAMC2
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.00752545012417867	-4.88946465296957	9	3	0.00604838709677419	496	10287	50604,11009,29949	IL20,IL24,IL19
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.0076794301863058	-4.86920992906654	48	7	0.0141129032258065	496	10287	64127,330,1540,3656,7295,7128,8767	NOD2,BIRC3,CYLD,IRAK2,TXN,TNFAIP3,RIPK2
R-HSA-193639	p75NTR signals via NF-kB	0.00769462914072839	-4.86723270768982	17	4	0.00806451612903226	496	10287	4790,4792,8767,4803	NFKB1,NFKBIA,RIPK2,NGF
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.00776322538420858	-4.85835738884742	60	8	0.0161290322580645	496	10287	1294,3918,1520,4314,4322,4316,4318,3914	COL7A1,LAMC2,CTSS,MMP3,MMP13,MMP7,MMP9,LAMB3
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.00796718090261453	-4.8324245623506	99	11	0.0221774193548387	496	10287	3656,330,4791,1326,1848,4792,3725,4790,64127,8767,6288	IRAK2,BIRC3,NFKB2,MAP3K8,DUSP6,NFKBIA,JUN,NFKB1,NOD2,RIPK2,SAA1
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.00796718090261453	-4.8324245623506	99	11	0.0221774193548387	496	10287	4790,64127,4792,1848,3725,8767,6288,330,3656,1326,4791	NFKB1,NOD2,NFKBIA,DUSP6,JUN,RIPK2,SAA1,BIRC3,IRAK2,MAP3K8,NFKB2
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.00796718090261453	-4.8324245623506	99	11	0.0221774193548387	496	10287	3725,4792,1848,64127,4790,6288,8767,3656,330,4791,1326	JUN,NFKBIA,DUSP6,NOD2,NFKB1,SAA1,RIPK2,IRAK2,BIRC3,NFKB2,MAP3K8
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.00842602139634296	-4.77643057610466	443	33	0.0665322580645161	496	10287	9162,8503,5021,2247,623,1437,10887,1839,5721,3559,11343,2151,4233,1910,4314,6708,3710,1848,2668,8111,5699,2847,1844,1847,5698,26281,10125,2069,147,2642,6288,1850,3561	DGKI,PIK3R3,OXTR,FGF2,BDKRB1,CSF2,PROKR1,HBEGF,PSME2,IL2RA,MGLL,F2RL2,MET,EDNRB,MMP3,SPTA1,ITPR3,DUSP6,GDNF,GPR68,PSMB10,MCHR1,DUSP2,DUSP5,PSMB9,FGF20,RASGRP1,EREG,ADRA1B,GCGR,SAA1,DUSP8,IL2RG
R-HSA-5621481	C-type lectin receptors (CLRs)	0.00959636529375392	-4.64637086743516	144	14	0.0282258064516129	496	10287	4067,4790,5971,4792,10071,4586,5699,5698,5721,2207,26253,3710,3553,4791	LYN,NFKB1,RELB,NFKBIA,MUC12,MUC5AC,PSMB10,PSMB9,PSME2,FCER1G,CLEC4E,ITPR3,IL1B,NFKB2
R-HSA-5621480	Dectin-2 family	0.00999532317999166	-4.60563797738626	28	5	0.0100806451612903	496	10287	4586,10071,26253,4067,2207	MUC5AC,MUC12,CLEC4E,LYN,FCER1G
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0120021903636154	-4.42266611554948	91	10	0.0201612903225806	496	10287	4791,1326,3656,8767,6288,4792,1848,3725,4790,64127	NFKB2,MAP3K8,IRAK2,RIPK2,SAA1,NFKBIA,DUSP6,JUN,NFKB1,NOD2
R-HSA-913709	O-linked glycosylation of mucins	0.0124312247327181	-4.3875438479257	65	8	0.0161290322580645	496	10287	51301,50614,79623,6484,6482,10071,4586,10164	GCNT4,GALNT9,GALNT14,ST3GAL4,ST3GAL1,MUC12,MUC5AC,CHST4
R-HSA-447115	Interleukin-12 signaling	0.0130464795943914	-4.33923694448787	4	2	0.00403225806451613	496	10287	3593,3592	IL12B,IL12A
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.0130464795943914	-4.33923694448787	4	2	0.00403225806451613	496	10287	9353,6092	SLIT2,ROBO2
R-HSA-173736	Alternative complement activation	0.0130464795943914	-4.33923694448787	4	2	0.00403225806451613	496	10287	629,718	CFB,C3
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0138603016769703	-4.27872651944209	93	10	0.0201612903225806	496	10287	1326,4791,3656,8767,6288,64127,4790,4792,1848,3725	MAP3K8,NFKB2,IRAK2,RIPK2,SAA1,NOD2,NFKB1,NFKBIA,DUSP6,JUN
R-HSA-1474290	Collagen formation	0.0138603016769703	-4.27872651944209	93	10	0.0201612903225806	496	10287	3918,1294,1520,4314,169044,4322,1305,4318,4316,3914	LAMC2,COL7A1,CTSS,MMP3,COL22A1,MMP13,COL13A1,MMP9,MMP7,LAMB3
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0138603016769703	-4.27872651944209	93	10	0.0201612903225806	496	10287	8767,6288,1848,4792,3725,64127,4790,4791,1326,3656	RIPK2,SAA1,DUSP6,NFKBIA,JUN,NOD2,NFKB1,NFKB2,MAP3K8,IRAK2
R-HSA-162582	Signal Transduction	0.0148990174396598	-4.2064600118521	2548	144	0.290322580645161	496	10287	1236,1540,3624,719,650,4688,1848,2668,4629,2986,857,6364,83478,7852,6372,64321,5142,53831,10046,91010,343578,23767,26230,1839,24,3559,57007,2921,5999,3725,7474,3627,3561,113878,283365,375790,50617,6376,1844,84870,23002,5698,3918,23327,26281,2069,64108,2918,4283,8767,5327,1030,4314,6374,8503,5957,2919,3914,92737,1437,11343,6461,2151,2920,26575,4790,5996,1850,6658,6352,3576,9340,1080,8111,723790,1604,150,54567,2886,27121,330,6373,134864,3569,2863,9283,6708,4318,9162,4067,644150,11211,5021,2247,623,5721,6004,6363,6385,643,1645,718,147,9938,658,116984,2642,9034,6000,7128,4023,6288,8828,23286,941,10252,5699,2847,7185,245973,195814,1847,5880,6484,284654,8313,4803,10125,90226,1910,4233,6752,171177,64220,83595,595,2914,135,3710,9628,4792,6346,10887,51176	CCR7,CYLD,INHBA,C3AR1,BMP2,NCF2,DUSP6,GDNF,MYH11,GUCY2F,CAV1,CCL20,ARHGAP24,CXCR4,CXCL6,SOX17,PDE4B,GPR84,MAMLD1,FMNL3,ARHGAP40,FLRT3,TIAM2,HBEGF,ABCA4,IL2RA,ACKR3,CXCL3,RGS4,JUN,WNT5A,CXCL10,IL2RG,DTX2,OR6C6,AGRN,ATP6V0A4,CX3CL1,DUSP2,RSPO3,DAAM1,PSMB9,LAMC2,NEDD4L,FGF20,EREG,RTP4,GRM8,CXCL9,RIPK2,PLAT,CDKN2B,MMP3,CXCL5,PIK3R3,RCVRN,CXCL1,LAMB3,DNER,CSF2,MGLL,SHB,F2RL2,CXCL2,RGS17,NFKB1,RGS1,DUSP8,SOX3,CCL5,CXCL8,GLP2R,CFTR,GPR68,HIST2H2AA4,CD55,ADRA2A,DLL4,GRB7,DKK4,BIRC3,CXCL11,TAAR1,IL6,GPR39,GPR37L1,SPTA1,MMP9,DGKI,LYN,WIPF3,FZD10,OXTR,FGF2,BDKRB1,PSME2,RGS16,CCL19,SDC4,CXCR5,AKR1C1,C3,ADRA1B,ARHGAP25,BMPR1B,ARAP2,GCGR,CCRL2,RGS7,TNFAIP3,LPL,SAA1,NRP2,WWC1,CD80,SPRY1,PSMB10,MCHR1,TRAF1,ATP6V1C2,SDR16C5,DUSP5,RAC2,ST3GAL4,RSPO1,AXIN2,NGF,RASGRP1,UCN2,EDNRB,MET,SSTR2,RHOV,STRA6,SOX7,CCND1,GRM4,ADORA2A,ITPR3,RGS6,NFKBIA,CCL1,PROKR1,LEF1
R-HSA-372790	Signaling by GPCR	0.0159594837404993	-4.13770203457016	1299	79	0.159274193548387	496	10287	2863,9283,53831,5142,6708,623,26230,2247,5021,11211,9162,718,2921,57007,643,3559,1839,5721,6004,6363,1850,5996,26575,1236,9340,6352,3576,719,150,8111,1604,2668,1848,7852,6373,6372,134864,6364,4283,6752,64108,1910,2918,4233,3710,6374,2914,135,4314,2919,6346,8503,9628,2151,2920,11343,1437,10887,6000,9034,3561,6288,3627,2642,7474,147,5999,283365,1844,6376,5699,2847,10125,90226,2069,26281,5698,1847,5880	GPR39,GPR37L1,GPR84,PDE4B,SPTA1,BDKRB1,TIAM2,FGF2,OXTR,FZD10,DGKI,C3,CXCL3,ACKR3,CXCR5,IL2RA,HBEGF,PSME2,RGS16,CCL19,DUSP8,RGS1,RGS17,CCR7,GLP2R,CCL5,CXCL8,C3AR1,ADRA2A,GPR68,CD55,GDNF,DUSP6,CXCR4,CXCL11,CXCL6,TAAR1,CCL20,CXCL9,SSTR2,RTP4,EDNRB,GRM8,MET,ITPR3,CXCL5,GRM4,ADORA2A,MMP3,CXCL1,CCL1,PIK3R3,RGS6,F2RL2,CXCL2,MGLL,CSF2,PROKR1,RGS7,CCRL2,IL2RG,SAA1,CXCL10,GCGR,WNT5A,ADRA1B,RGS4,OR6C6,DUSP2,CX3CL1,PSMB10,MCHR1,RASGRP1,UCN2,EREG,FGF20,PSMB9,DUSP5,RAC2
R-HSA-194068	Bile acid and bile salt metabolism	0.0163103138178577	-4.1159576217092	43	6	0.0120967741935484	496	10287	1646,1581,1645,9023,9420,8714	AKR1C2,CYP7A1,AKR1C1,CH25H,CYP7B1,ABCC3
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.0166172142928505	-4.0973161153451	21	4	0.00806451612903226	496	10287	3484,4312,5069,60676	IGFBP1,MMP1,PAPPA,PAPPA2
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.0166172142928505	-4.0973161153451	21	4	0.00806451612903226	496	10287	4790,4792,6288,4791	NFKB1,NFKBIA,SAA1,NFKB2
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	0.0166172142928505	-4.0973161153451	21	4	0.00806451612903226	496	10287	5366,8626,637,27113	PMAIP1,TP63,BID,BBC3
R-HSA-2871796	FCERI mediated MAPK activation	0.0172970740662364	-4.05721792090163	265	21	0.0423387096774194	496	10287	6708,3561,3937,1850,3725,4233,26281,2069,10125,5721,5698,1839,1847,1437,3559,1844,2247,5699,1848,4067,2668	SPTA1,IL2RG,LCP2,DUSP8,JUN,MET,FGF20,EREG,RASGRP1,PSME2,PSMB9,HBEGF,DUSP5,CSF2,IL2RA,DUSP2,FGF2,PSMB10,DUSP6,LYN,GDNF
R-HSA-196071	Metabolism of steroid hormones	0.0174968915400451	-4.04573204011322	32	5	0.0100806451612903	496	10287	441282,6716,1586,3290,231	AKR1B15,SRD5A2,CYP17A1,HSD11B1,AKR1B1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.0181411420759944	-4.00957287729162	44	6	0.0120967741935484	496	10287	8140,8564,259307,6999,3620,8942	SLC7A5,KMO,IL4I1,TDO2,IDO1,KYNU
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0182117256404681	-4.00568962638982	97	10	0.0201612903225806	496	10287	6288,8767,3725,1848,4792,64127,4790,4791,1326,3656	SAA1,RIPK2,JUN,DUSP6,NFKBIA,NOD2,NFKB1,NFKB2,MAP3K8,IRAK2
R-HSA-6798695	Neutrophil degranulation	0.0187580492165111	-3.97613232713771	487	34	0.0685483870967742	496	10287	6317,4318,5004,2919,8876,1520,1118,718,6278,272,4033,3687,3934,53831,5806,6616,7133,1604,7097,5329,2495,79930,5005,6279,2268,2207,154664,4790,7130,3684,960,719,6280,5317	SERPINB3,MMP9,ORM1,CXCL1,VNN1,CTSS,CHIT1,C3,S100A7,AMPD3,LRMP,ITGAX,LCN2,GPR84,PTX3,SNAP25,TNFRSF1B,CD55,TLR2,PLAUR,FTH1,DOK3,ORM2,S100A8,FGR,FCER1G,ABCA13,NFKB1,TNFAIP6,ITGAM,CD44,C3AR1,S100A9,PKP1
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0201078810674657	-3.9066434478567	45	6	0.0120967741935484	496	10287	9378,3918,6385,375790,3914,2247	NRXN1,LAMC2,SDC4,AGRN,LAMB3,FGF2
R-HSA-196854	Metabolism of vitamins and cofactors	0.0208953651168869	-3.86822790934706	174	15	0.030241935483871	496	10287	4363,952,375790,1591,5743,4023,8875,8876,1594,54625,6385,10135,441024,1645,6513	ABCC1,CD38,AGRN,CYP24A1,PTGS2,LPL,VNN2,VNN1,CYP27B1,PARP14,SDC4,NAMPT,MTHFD2L,AKR1C1,SLC2A1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0210535468797157	-3.86068623519919	5	2	0.00403225806451613	496	10287	3038,3036	HAS3,HAS1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.0216250041353886	-3.83390503493237	271	21	0.0423387096774194	496	10287	5699,1844,2247,8503,1848,2668,4067,26281,2069,10125,1437,1847,5721,5698,1839,3559,1850,3561,3055,4233,6708	PSMB10,DUSP2,FGF2,PIK3R3,DUSP6,GDNF,LYN,FGF20,EREG,RASGRP1,CSF2,DUSP5,PSME2,PSMB9,HBEGF,IL2RA,DUSP8,IL2RG,HCK,MET,SPTA1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.0219867533274174	-3.81731512845279	372	27	0.0544354838709677	496	10287	1850,3561,3937,4233,3725,4790,3710,6708,941,5699,2247,1844,4792,1848,8503,2668,4067,26281,10125,2069,2207,1437,5698,1839,5721,1847,3559	DUSP8,IL2RG,LCP2,MET,JUN,NFKB1,ITPR3,SPTA1,CD80,PSMB10,FGF2,DUSP2,NFKBIA,DUSP6,PIK3R3,GDNF,LYN,FGF20,RASGRP1,EREG,FCER1G,CSF2,PSMB9,HBEGF,PSME2,DUSP5,IL2RA
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.0221929488859154	-3.80798065830666	13	3	0.00604838709677419	496	10287	6288,4791,4790	SAA1,NFKB2,NFKB1
R-HSA-2029481	FCGR activation	0.0221929488859154	-3.80798065830666	13	3	0.00604838709677419	496	10287	4067,2268,3055	LYN,FGR,HCK
R-HSA-192105	Synthesis of bile acids and bile salts	0.0223541152790494	-3.80074484605566	34	5	0.0100806451612903	496	10287	1646,1581,1645,9420,9023	AKR1C2,CYP7A1,AKR1C1,CYP7B1,CH25H
R-HSA-5260271	Diseases of Immune System	0.026339373646739	-3.63669036249648	24	4	0.00806451612903226	496	10287	4790,4792,7097,4791	NFKB1,NFKBIA,TLR2,NFKB2
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.026339373646739	-3.63669036249648	24	4	0.00806451612903226	496	10287	7097,4791,4790,4792	TLR2,NFKB2,NFKB1,NFKBIA
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.026339373646739	-3.63669036249648	24	4	0.00806451612903226	496	10287	1646,9420,1645,1581	AKR1C2,CYP7B1,AKR1C1,CYP7A1
R-HSA-209560	NF-kB is activated and signals survival	0.0272554676610475	-3.60250112988819	14	3	0.00604838709677419	496	10287	4803,4790,4792	NGF,NFKB1,NFKBIA
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.0280095708575436	-3.57520901087199	36	5	0.0100806451612903	496	10287	1540,23586,64135,9636,7128	CYLD,DDX58,IFIH1,ISG15,TNFAIP3
R-HSA-977068	Termination of O-glycan biosynthesis	0.0301974858271816	-3.49999660882243	25	4	0.00806451612903226	496	10287	6484,6482,10071,4586	ST3GAL4,ST3GAL1,MUC12,MUC5AC
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0301974858271816	-3.49999660882243	25	4	0.00806451612903226	496	10287	4791,6288,4792,4790	NFKB2,SAA1,NFKBIA,NFKB1
R-HSA-211916	Vitamins	0.0305815052764465	-3.48735985547927	6	2	0.00403225806451613	496	10287	1591,1594	CYP24A1,CYP27B1
R-HSA-5660668	CLEC7A/inflammasome pathway	0.0305815052764465	-3.48735985547927	6	2	0.00403225806451613	496	10287	4790,3553	NFKB1,IL1B
R-HSA-5336415	Uptake and function of diphtheria toxin	0.0305815052764465	-3.48735985547927	6	2	0.00403225806451613	496	10287	1839,7296	HBEGF,TXNRD1
R-HSA-187015	Activation of TRKA receptors	0.0305815052764465	-3.48735985547927	6	2	0.00403225806451613	496	10287	4803,135	NGF,ADORA2A
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.0305815052764465	-3.48735985547927	6	2	0.00403225806451613	496	10287	247,5743	ALOX15B,PTGS2
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.0315518770079463	-3.45612219864423	106	10	0.0201612903225806	496	10287	11182,80736,51458,84102,64849,6513,6580,11254,64116,6534	SLC2A6,SLC44A4,RHCG,SLC41A2,SLC13A3,SLC2A1,SLC22A1,SLC6A14,SLC39A8,SLC6A7
R-HSA-187706	Signalling to p38 via RIT and RIN	0.0320927897156071	-3.43912389352839	249	19	0.0383064516129032	496	10287	3559,1839,5721,5698,1847,1437,2069,10125,26281,4803,2668,1848,1844,2247,5699,6708,4233,3561,1850	IL2RA,HBEGF,PSME2,PSMB9,DUSP5,CSF2,EREG,RASGRP1,FGF20,NGF,GDNF,DUSP6,DUSP2,FGF2,PSMB10,SPTA1,MET,IL2RG,DUSP8
R-HSA-170984	ARMS-mediated activation	0.0320927897156071	-3.43912389352839	249	19	0.0383064516129032	496	10287	4233,3561,1850,6708,1848,2668,1844,2247,5699,1847,5721,1839,5698,1437,3559,4803,26281,10125,2069	MET,IL2RG,DUSP8,SPTA1,DUSP6,GDNF,DUSP2,FGF2,PSMB10,DUSP5,PSME2,HBEGF,PSMB9,CSF2,IL2RA,NGF,FGF20,RASGRP1,EREG
R-HSA-170968	Frs2-mediated activation	0.0332419969300183	-3.40394123468572	250	19	0.0383064516129032	496	10287	6708,3561,1850,4233,26281,4803,2069,10125,1847,5721,1839,5698,1437,3559,2247,1844,5699,1848,2668	SPTA1,IL2RG,DUSP8,MET,FGF20,NGF,EREG,RASGRP1,DUSP5,PSME2,HBEGF,PSMB9,CSF2,IL2RA,FGF2,DUSP2,PSMB10,DUSP6,GDNF
R-HSA-450294	MAP kinase activation in TLR cascade	0.033657750047793	-3.39151193595352	64	7	0.0141129032258065	496	10287	1326,8767,4790,64127,3725,3656,1848	MAP3K8,RIPK2,NFKB1,NOD2,JUN,IRAK2,DUSP6
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.0343715078145508	-3.37052731900553	26	4	0.00806451612903226	496	10287	7128,7185,330,1540	TNFAIP3,TRAF1,BIRC3,CYLD
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0344215142861104	-3.36907349479952	251	19	0.0383064516129032	496	10287	26281,2069,10125,5698,1839,5721,1847,1437,3559,1844,2247,5699,1848,2668,6708,3561,1850,4233,3569	FGF20,EREG,RASGRP1,PSMB9,HBEGF,PSME2,DUSP5,CSF2,IL2RA,DUSP2,FGF2,PSMB10,DUSP6,GDNF,SPTA1,IL2RG,DUSP8,MET,IL6
R-HSA-169893	Prolonged ERK activation events	0.0356317610916559	-3.33451787337128	252	19	0.0383064516129032	496	10287	10125,2069,26281,4803,3559,5721,1839,1847,5698,1437,2247,1844,5699,2668,1848,6708,3561,1850,4233	RASGRP1,EREG,FGF20,NGF,IL2RA,PSME2,HBEGF,DUSP5,PSMB9,CSF2,FGF2,DUSP2,PSMB10,GDNF,DUSP6,SPTA1,IL2RG,DUSP8,MET
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0362195720691007	-3.31815564136473	65	7	0.0141129032258065	496	10287	941,1839,8503,4233,2247,26281,2069	CD80,HBEGF,PIK3R3,MET,FGF2,FGF20,EREG
R-HSA-422475	Axon guidance	0.0365428269746293	-3.3092703644505	549	36	0.0725806451612903	496	10287	2048,27289,214,8828,1850,3561,4629,5880,1847,5698,6092,26281,10125,2069,1848,375790,2668,5699,1844,2886,1943,6708,4233,80031,1437,137970,1839,5721,3559,6461,4318,286,8503,4067,9353,2247	EPHB2,RND1,ALCAM,NRP2,DUSP8,IL2RG,MYH11,RAC2,DUSP5,PSMB9,ROBO2,FGF20,RASGRP1,EREG,DUSP6,AGRN,GDNF,PSMB10,DUSP2,GRB7,EFNA2,SPTA1,MET,SEMA6D,CSF2,UNC5D,HBEGF,PSME2,IL2RA,SHB,MMP9,ANK1,PIK3R3,LYN,SLIT2,FGF2
R-HSA-8853659	RET signaling	0.0371430841368834	-3.29297768566297	270	20	0.0403225806451613	496	10287	2886,5699,2247,1844,2668,1848,8503,2069,10125,26281,3559,1437,1847,1839,5721,5698,1850,3561,4233,6708	GRB7,PSMB10,FGF2,DUSP2,GDNF,DUSP6,PIK3R3,EREG,RASGRP1,FGF20,IL2RA,CSF2,DUSP5,HBEGF,PSME2,PSMB9,DUSP8,IL2RG,MET,SPTA1
R-HSA-400685	Sema4D in semaphorin signaling	0.0388637241876921	-3.24769400360598	27	4	0.00806451612903226	496	10287	27289,4629,4233,5880	RND1,MYH11,MET,RAC2
R-HSA-114508	Effects of PIP2 hydrolysis	0.0388637241876921	-3.24769400360598	27	4	0.00806451612903226	496	10287	9162,11343,10125,3710	DGKI,MGLL,RASGRP1,ITPR3
R-HSA-977606	Regulation of Complement cascade	0.0388637241876921	-3.24769400360598	27	4	0.00806451612903226	496	10287	1604,719,629,718	CD55,C3AR1,CFB,C3
R-HSA-380994	ATF4 activates genes	0.0388637241876921	-3.24769400360598	27	4	0.00806451612903226	496	10287	3484,3576,6347,467	IGFBP1,CXCL8,CCL2,ATF3
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0390547968775425	-3.24278957086689	16	3	0.00604838709677419	496	10287	6279,7097,6280	S100A8,TLR2,S100A9
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.0390547968775425	-3.24278957086689	16	3	0.00604838709677419	496	10287	3008,3159,8091	HIST1H1E,HMGA1,HMGA2
R-HSA-912526	Interleukin receptor SHC signaling	0.0394509873397088	-3.23269620438091	255	19	0.0383064516129032	496	10287	2668,8503,1848,1844,2247,5699,3559,1839,5698,5721,1847,1437,2069,10125,26281,4233,3561,1850,6708	GDNF,PIK3R3,DUSP6,DUSP2,FGF2,PSMB10,IL2RA,HBEGF,PSMB9,PSME2,DUSP5,CSF2,EREG,RASGRP1,FGF20,MET,IL2RG,DUSP8,SPTA1
R-HSA-167044	Signalling to RAS	0.0407882307630149	-3.19936170087591	256	19	0.0383064516129032	496	10287	4233,1850,3561,6708,2668,1848,5699,1844,2247,3559,1437,5721,1847,5698,1839,2069,10125,4803,26281	MET,DUSP8,IL2RG,SPTA1,GDNF,DUSP6,PSMB10,DUSP2,FGF2,IL2RA,CSF2,PSME2,DUSP5,PSMB9,HBEGF,EREG,RASGRP1,NGF,FGF20
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0411706000328761	-3.19003086878926	53	6	0.0120967741935484	496	10287	1591,4023,1645,1594,6385,375790	CYP24A1,LPL,AKR1C1,CYP27B1,SDC4,AGRN
R-HSA-196791	Vitamin D (calciferol) metabolism	0.0414656755520139	-3.18288928910958	7	2	0.00403225806451613	496	10287	1591,1594	CYP24A1,CYP27B1
R-HSA-174577	Activation of C3 and C5	0.0414656755520139	-3.18288928910958	7	2	0.00403225806451613	496	10287	718,629	C3,CFB
R-HSA-447038	NrCAM interactions	0.0414656755520139	-3.18288928910958	7	2	0.00403225806451613	496	10287	8828,286	NRP2,ANK1
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.0414656755520139	-3.18288928910958	7	2	0.00403225806451613	496	10287	51176,8313	LEF1,AXIN2
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0435613113453701	-3.13358587702316	258	19	0.0383064516129032	496	10287	1848,2668,2247,1844,5699,5698,1847,5721,1839,1437,3559,26281,2069,10125,4233,3561,1850,6708,3710	DUSP6,GDNF,FGF2,DUSP2,PSMB10,PSMB9,DUSP5,PSME2,HBEGF,CSF2,IL2RA,FGF20,EREG,RASGRP1,MET,IL2RG,DUSP8,SPTA1,ITPR3
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.0436751243548743	-3.1309765756879	28	4	0.00806451612903226	496	10287	2182,51703,79993,2181	ACSL4,ACSL5,ELOVL7,ACSL3
R-HSA-416476	G alpha (q) signalling events	0.0445342403788776	-3.11149693896595	192	15	0.030241935483871	496	10287	11343,10887,3710,10125,2151,2642,8111,9162,8503,147,1910,6288,623,2847,5021	MGLL,PROKR1,ITPR3,RASGRP1,F2RL2,GCGR,GPR68,DGKI,PIK3R3,ADRA1B,EDNRB,SAA1,BDKRB1,MCHR1,OXTR
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.0446651090497023	-3.10856264032897	68	7	0.0141129032258065	496	10287	1551,1586,1594,9420,1577,1581,1591	CYP3A7,CYP17A1,CYP27B1,CYP7B1,CYP3A5,CYP7A1,CYP24A1
R-HSA-216083	Integrin cell surface interactions	0.0446651090497023	-3.10856264032897	68	7	0.0141129032258065	496	10287	3386,3684,1305,960,3687,3383,375790	ICAM4,ITGAM,COL13A1,CD44,ITGAX,ICAM1,AGRN
R-HSA-2142845	Hyaluronan metabolism	0.0457748328226333	-3.08402084058261	17	3	0.00604838709677419	496	10287	960,3038,3036	CD44,HAS3,HAS1
R-HSA-5173105	O-linked glycosylation	0.0481927447059666	-3.03254679402805	114	10	0.0201612903225806	496	10287	6484,79623,50614,51301,9507,10164,4586,10071,6482,56999	ST3GAL4,GALNT14,GALNT9,GCNT4,ADAMTS4,CHST4,MUC5AC,MUC12,ST3GAL1,ADAMTS9
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.0482161951976543	-3.03206031440959	1	1	0.00201612903225806	496	10287	7296	TXNRD1
R-HSA-196807	Nicotinate metabolism	0.0488054585863168	-3.0199131161015	29	4	0.00806451612903226	496	10287	10135,952,54625,5743	NAMPT,CD38,PARP14,PTGS2
R-HSA-179812	GRB2 events in EGFR signaling	0.0494765442315935	-3.00625657561893	245	18	0.0362903225806452	496	10287	3561,1850,4233,6708,2247,1844,5699,2668,1848,2069,10125,26281,3559,5698,5721,1839,1847,1437	IL2RG,DUSP8,MET,SPTA1,FGF2,DUSP2,PSMB10,GDNF,DUSP6,EREG,RASGRP1,FGF20,IL2RA,PSMB9,PSME2,HBEGF,DUSP5,CSF2
R-HSA-5673001	RAF/MAP kinase cascade	0.0494765442315935	-3.00625657561893	245	18	0.0362903225806452	496	10287	4233,3561,1850,6708,1848,2668,1844,2247,5699,1839,1847,5698,5721,1437,3559,26281,2069,10125	MET,IL2RG,DUSP8,SPTA1,DUSP6,GDNF,DUSP2,FGF2,PSMB10,HBEGF,DUSP5,PSMB9,PSME2,CSF2,IL2RA,FGF20,EREG,RASGRP1
R-HSA-180336	SHC1 events in EGFR signaling	0.0494765442315935	-3.00625657561893	245	18	0.0362903225806452	496	10287	2247,1844,5699,2668,1848,2069,10125,26281,3559,1847,1839,5721,5698,1437,3561,1850,4233,6708	FGF2,DUSP2,PSMB10,GDNF,DUSP6,EREG,RASGRP1,FGF20,IL2RA,DUSP5,HBEGF,PSME2,PSMB9,CSF2,IL2RG,DUSP8,MET,SPTA1
R-HSA-112412	SOS-mediated signalling	0.0494765442315935	-3.00625657561893	245	18	0.0362903225806452	496	10287	6708,3561,1850,4233,10125,2069,26281,3559,1839,5698,5721,1847,1437,1844,2247,5699,2668,1848	SPTA1,IL2RG,DUSP8,MET,RASGRP1,EREG,FGF20,IL2RA,HBEGF,PSMB9,PSME2,DUSP5,CSF2,DUSP2,FGF2,PSMB10,GDNF,DUSP6
R-HSA-451927	Interleukin-2 signaling	0.0495122643015802	-3.00553487642755	262	19	0.0383064516129032	496	10287	1839,5698,5721,1847,1437,3559,26281,10125,2069,1848,8503,2668,1844,2247,5699,6708,4233,3561,1850	HBEGF,PSMB9,PSME2,DUSP5,CSF2,IL2RA,FGF20,RASGRP1,EREG,DUSP6,PIK3R3,GDNF,DUSP2,FGF2,PSMB10,SPTA1,MET,IL2RG,DUSP8
R-HSA-187687	Signalling to ERKs	0.0510864109899054	-2.97423674688551	263	19	0.0383064516129032	496	10287	1844,2247,5699,2668,1848,2069,10125,4803,26281,3559,1839,5721,1847,5698,1437,3561,1850,4233,6708	DUSP2,FGF2,PSMB10,GDNF,DUSP6,EREG,RASGRP1,NGF,FGF20,IL2RA,HBEGF,PSME2,DUSP5,PSMB9,CSF2,IL2RG,DUSP8,MET,SPTA1
R-HSA-197264	Nicotinamide salvaging	0.0530252739395156	-2.93698661231153	18	3	0.00604838709677419	496	10287	5743,54625,10135	PTGS2,PARP14,NAMPT
R-HSA-912631	Regulation of signaling by CBL	0.0530252739395156	-2.93698661231153	18	3	0.00604838709677419	496	10287	8503,4067,3055	PIK3R3,LYN,HCK
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.0535536689382544	-2.92707097018226	8	2	0.00403225806451613	496	10287	27289,4233	RND1,MET
R-HSA-381042	PERK regulates gene expression	0.054253298469505	-2.91409148712869	30	4	0.00806451612903226	496	10287	467,3484,3576,6347	ATF3,IGFBP1,CXCL8,CCL2
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.054396746135419	-2.9114509405963	101	9	0.0181451612903226	496	10287	4791,3553,3710,5721,5698,5699,4792,5971,4790	NFKB2,IL1B,ITPR3,PSME2,PSMB9,PSMB10,NFKBIA,RELB,NFKB1
R-HSA-5688426	Deubiquitination	0.0567609042041276	-2.8689074965119	301	21	0.0423387096774194	496	10287	90865,8900,5699,723790,64127,4792,1080,79931,8313,330,10318,84101,219333,5698,5721,8767,7128,8975,1540,23586,64135	IL33,CCNA1,PSMB10,HIST2H2AA4,NOD2,NFKBIA,CFTR,TNIP3,AXIN2,BIRC3,TNIP1,USP44,USP12,PSMB9,PSME2,RIPK2,TNFAIP3,USP13,CYLD,DDX58,IFIH1
R-HSA-1433557	Signaling by SCF-KIT	0.0584070549525604	-2.84031859246197	337	23	0.0463709677419355	496	10287	1848,8503,4318,4067,2668,1844,2247,5699,2886,5721,1847,5698,1839,1437,3559,26281,2069,10125,4233,3561,1850,941,6708	DUSP6,PIK3R3,MMP9,LYN,GDNF,DUSP2,FGF2,PSMB10,GRB7,PSME2,DUSP5,PSMB9,HBEGF,CSF2,IL2RA,FGF20,EREG,RASGRP1,MET,IL2RG,DUSP8,CD80,SPTA1
R-HSA-917937	Iron uptake and transport	0.0591702815670199	-2.82733586369374	44	5	0.0100806451612903	496	10287	3934,50617,3162,245973,2495	LCN2,ATP6V0A4,HMOX1,ATP6V1C2,FTH1
R-HSA-194138	Signaling by VEGF	0.0599721980011337	-2.81387419079531	338	23	0.0463709677419355	496	10287	26281,10125,2069,1437,1847,5698,1839,5721,857,3559,6461,5699,1844,2247,4688,1848,2668,3710,6708,8828,1850,3561,4233	FGF20,RASGRP1,EREG,CSF2,DUSP5,PSMB9,HBEGF,PSME2,CAV1,IL2RA,SHB,PSMB10,DUSP2,FGF2,NCF2,DUSP6,GDNF,ITPR3,SPTA1,NRP2,DUSP8,IL2RG,MET
R-HSA-114452	Activation of BH3-only proteins	0.0600161007243461	-2.81314240735246	31	4	0.00806451612903226	496	10287	27113,8626,637,5366	BBC3,TP63,BID,PMAIP1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.0607904264767579	-2.80032296167188	19	3	0.00604838709677419	496	10287	64127,3656,8767	NOD2,IRAK2,RIPK2
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.0607904264767579	-2.80032296167188	19	3	0.00604838709677419	496	10287	6534,11254,6580	SLC6A7,SLC6A14,SLC22A1
R-HSA-2586552	Signaling by Leptin	0.0635942692642892	-2.75523191860324	253	18	0.0362903225806452	496	10287	6708,4233,1850,3561,3559,1437,5721,5698,1839,1847,10125,2069,26281,2668,1848,5699,1844,2247	SPTA1,MET,DUSP8,IL2RG,IL2RA,CSF2,PSME2,PSMB9,HBEGF,DUSP5,RASGRP1,EREG,FGF20,GDNF,DUSP6,PSMB10,DUSP2,FGF2
R-HSA-166658	Complement cascade	0.0640530816291258	-2.74804313892987	45	5	0.0100806451612903	496	10287	719,1604,718,10584,629	C3AR1,CD55,C3,COLEC10,CFB
R-HSA-1296052	Ca2+ activated K+ channels	0.0667045885997327	-2.70748153382811	9	2	0.00403225806451613	496	10287	3783,3779	KCNN4,KCNMB1
R-HSA-2179392	EGFR Transactivation by Gastrin	0.0667045885997327	-2.70748153382811	9	2	0.00403225806451613	496	10287	1839,4314	HBEGF,MMP3
R-HSA-194002	Glucocorticoid biosynthesis	0.0667045885997327	-2.70748153382811	9	2	0.00403225806451613	496	10287	3290,1586	HSD11B1,CYP17A1
R-HSA-390696	Adrenoceptors	0.0667045885997327	-2.70748153382811	9	2	0.00403225806451613	496	10287	150,147	ADRA2A,ADRA1B
R-HSA-5683057	MAPK family signaling cascades	0.0679615417476191	-2.68881329633186	290	20	0.0403225806451613	496	10287	2668,1848,1844,2247,5699,3559,1847,5698,5721,1839,1437,2069,10125,26281,3569,4233,3725,3561,1850,6708	GDNF,DUSP6,DUSP2,FGF2,PSMB10,IL2RA,DUSP5,PSMB9,PSME2,HBEGF,CSF2,EREG,RASGRP1,FGF20,IL6,MET,JUN,IL2RG,DUSP8,SPTA1
R-HSA-8874081	MET activates PTK2 signaling	0.0690524338291893	-2.67288915240276	20	3	0.00604838709677419	496	10287	4233,3918,3914	MET,LAMC2,LAMB3
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.0690524338291893	-2.67288915240276	20	3	0.00604838709677419	496	10287	64127,3656,8767	NOD2,IRAK2,RIPK2
R-HSA-389356	CD28 co-stimulation	0.0724712440654268	-2.62456542938173	33	4	0.00806451612903226	496	10287	4067,941,8503,1326	LYN,CD80,PIK3R3,MAP3K8
R-HSA-1222556	ROS, RNS production in phagocytes	0.0724712440654268	-2.62456542938173	33	4	0.00806451612903226	496	10287	4843,245973,50617,4688	NOS2,ATP6V1C2,ATP6V0A4,NCF2
R-HSA-5357905	Regulation of TNFR1 signaling	0.0724712440654268	-2.62456542938173	33	4	0.00806451612903226	496	10287	7185,7128,330,1540	TRAF1,TNFAIP3,BIRC3,CYLD
R-HSA-5689880	Ub-specific processing proteases	0.0726865477868142	-2.62159894888448	223	16	0.032258064516129	496	10287	1540,8975,23586,64135,1080,4792,723790,90865,8900,5699,219333,5721,5698,330,84101,8313	CYLD,USP13,DDX58,IFIH1,CFTR,NFKBIA,HIST2H2AA4,IL33,CCNA1,PSMB10,USP12,PSME2,PSMB9,BIRC3,USP44,AXIN2
R-HSA-375165	NCAM signaling for neurite out-growth	0.0748646982503323	-2.59207281798453	276	19	0.0383064516129032	496	10287	2069,10125,26281,3559,5721,5698,1839,1847,1437,2247,1844,5699,2668,1848,375790,6708,3561,1850,4233	EREG,RASGRP1,FGF20,IL2RA,PSME2,PSMB9,HBEGF,DUSP5,CSF2,FGF2,DUSP2,PSMB10,GDNF,DUSP6,AGRN,SPTA1,IL2RG,DUSP8,MET
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0769474099050327	-2.56463307871751	330	22	0.0443548387096774	496	10287	10125,2069,26281,6461,3559,857,5698,5721,1847,1839,1437,2247,1844,5699,2668,1848,4688,3710,6708,3561,1850,4233	RASGRP1,EREG,FGF20,SHB,IL2RA,CAV1,PSMB9,PSME2,DUSP5,HBEGF,CSF2,FGF2,DUSP2,PSMB10,GDNF,DUSP6,NCF2,ITPR3,SPTA1,IL2RG,DUSP8,MET
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.0777916370837491	-2.55372134607232	21	3	0.00604838709677419	496	10287	1263,7832,10769	PLK3,BTG2,PLK2
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0791535279013871	-2.53636592129989	34	4	0.00806451612903226	496	10287	6461,4067,1943,4629	SHB,LYN,EFNA2,MYH11
R-HSA-211945	Phase 1 - Functionalization of compounds	0.0798546822458538	-2.5275467680208	109	9	0.0181451612903226	496	10287	1586,1551,1591,1581,54498,9420,1594,874,1577	CYP17A1,CYP3A7,CYP24A1,CYP7A1,SMOX,CYP7B1,CYP27B1,CBR3,CYP3A5
R-HSA-1250342	PI3K events in ERBB4 signaling	0.080788279271673	-2.51592338249599	10	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.080788279271673	-2.51592338249599	10	2	0.00403225806451613	496	10287	27113,8626	BBC3,TP63
R-HSA-425381	Bicarbonate transporters	0.080788279271673	-2.51592338249599	10	2	0.00403225806451613	496	10287	23382,8671	AHCYL2,SLC4A4
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.0857619406755988	-2.45617995276924	49	5	0.0100806451612903	496	10287	1263,7832,8900,10769,25946	PLK3,BTG2,CCNA1,PLK2,ZNF385A
R-HSA-2871837	FCERI mediated NF-kB activation	0.0858349793861491	-2.45532867041598	79	7	0.0141129032258065	496	10287	5699,10125,5698,5721,4792,4067,4790	PSMB10,RASGRP1,PSMB9,PSME2,NFKBIA,LYN,NFKB1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.086986900455229	-2.4419977411444	22	3	0.00604838709677419	496	10287	8503,941,1326	PIK3R3,CD80,MAP3K8
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.086986900455229	-2.4419977411444	22	3	0.00604838709677419	496	10287	5971,4790,4067	RELB,NFKB1,LYN
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.086986900455229	-2.4419977411444	22	3	0.00604838709677419	496	10287	5270,5197,3053	SERPINE2,PF4V1,SERPIND1
R-HSA-166663	Initial triggering of complement	0.086986900455229	-2.4419977411444	22	3	0.00604838709677419	496	10287	718,629,10584	C3,CFB,COLEC10
R-HSA-2172127	DAP12 interactions	0.0870133160052749	-2.44169411450777	371	24	0.0483870967741935	496	10287	5699,1844,2247,2668,8503,1848,10125,2069,26281,3559,1437,5698,5721,1847,1839,1850,3937,3561,54210,4233,6708,3710,342510,941	PSMB10,DUSP2,FGF2,GDNF,PIK3R3,DUSP6,RASGRP1,EREG,FGF20,IL2RA,CSF2,PSMB9,PSME2,DUSP5,HBEGF,DUSP8,LCP2,IL2RG,TREM1,MET,SPTA1,ITPR3,CD300E,CD80
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.0871551199141564	-2.44006576044389	229	16	0.032258064516129	496	10287	2247,5699,4067,8503,4792,2069,10125,26281,4794,1839,5721,5698,4790,4233,3710,941	FGF2,PSMB10,LYN,PIK3R3,NFKBIA,EREG,RASGRP1,FGF20,NFKBIE,HBEGF,PSME2,PSMB9,NFKB1,MET,ITPR3,CD80
R-HSA-76002	Platelet activation, signaling and aggregation	0.0880086763458011	-2.43031987452543	282	19	0.0383064516129032	496	10287	5004,150,4067,5552,8503,9162,10125,7273,2151,11343,5005,5341,3559,1437,5880,2207,3937,3561,3710	ORM1,ADRA2A,LYN,SRGN,PIK3R3,DGKI,RASGRP1,TTN,F2RL2,MGLL,ORM2,PLEK,IL2RA,CSF2,RAC2,FCER1G,LCP2,IL2RG,ITPR3
R-HSA-141334	PAOs oxidise polyamines to amines	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	54498	SMOX
R-HSA-6804754	Regulation of TP53 Expression	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	639	PRDM1
R-HSA-190872	Transport of connexons to the plasma membrane	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	2706	GJB2
R-HSA-5652227	Fructose biosynthesis	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	231	AKR1B1
R-HSA-205017	NFG and proNGF binds to p75NTR	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-187042	TRKA activation by NGF	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-111452	Activation and oligomerization of BAK protein	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	637	BID
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	366	AQP9
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.0941120504524042	-2.36326918052174	2	1	0.00201612903225806	496	10287	637	BID
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0943581751093857	-2.36065736429282	197	14	0.0282258064516129	496	10287	2069,10125,4794,26281,5721,941,1839,5698,5699,2247,4790,4233,8503,4792	EREG,RASGRP1,NFKBIE,FGF20,PSME2,CD80,HBEGF,PSMB9,PSMB10,FGF2,NFKB1,MET,PIK3R3,NFKBIA
R-HSA-6803157	Antimicrobial peptides	0.0956617348870697	-2.34693690492256	97	8	0.0161290322580645	496	10287	6280,6278,6279,5068,5266,7097,3934,114770	S100A9,S100A7,S100A8,REG3A,PI3,TLR2,LCN2,PGLYRP2
R-HSA-193048	Androgen biosynthesis	0.0956846223285609	-2.34669767965658	11	2	0.00403225806451613	496	10287	6716,1586	SRD5A2,CYP17A1
R-HSA-446107	Type I hemidesmosome assembly	0.0956846223285609	-2.34669767965658	11	2	0.00403225806451613	496	10287	3914,3918	LAMB3,LAMC2
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.0956846223285609	-2.34669767965658	11	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.106655408745258	-2.23815212043973	24	3	0.00604838709677419	496	10287	27289,4629,5880	RND1,MYH11,RAC2
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.106655408745258	-2.23815212043973	24	3	0.00604838709677419	496	10287	3779,4843,5152	KCNMB1,NOS2,PDE9A
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.108758037087637	-2.21862970748999	38	4	0.00806451612903226	496	10287	4688,7296,6648,7295	NCF2,TXNRD1,SOD2,TXN
R-HSA-1169091	Activation of NF-kappaB in B cells	0.108772495414074	-2.21849677602247	68	6	0.0120967741935484	496	10287	4794,5699,5721,4792,5698,4790	NFKBIE,PSMB10,PSME2,NFKBIA,PSMB9,NFKB1
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-8851680	Butyrophilin (BTN) family interactions	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	7498,11119	XDH,BTN3A1
R-HSA-73621	Pyrimidine catabolism	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	1890,51733	TYMP,UPB1
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-190373	FGFR1c ligand binding and activation	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-879518	Transport of organic anions	0.111282873646559	-2.19567990813317	12	2	0.00403225806451613	496	10287	28231,28232	SLCO4A1,SLCO3A1
R-HSA-1236975	Antigen processing-Cross presentation	0.113834428992333	-2.17301026357006	101	8	0.0161290322580645	496	10287	5698,1520,5721,6890,7097,6891,5699,4688	PSMB9,CTSS,PSME2,TAP1,TLR2,TAP2,PSMB10,NCF2
R-HSA-2187338	Visual phototransduction	0.113834428992333	-2.17301026357006	101	8	0.0161290322580645	496	10287	6385,2986,24,1645,5957,375790,4023,64220	SDC4,GUCY2F,ABCA4,AKR1C1,RCVRN,AGRN,LPL,STRA6
R-HSA-388841	Costimulation by the CD28 family	0.114585204341943	-2.16643659000037	69	6	0.0120967741935484	496	10287	29126,4067,8503,941,1326,23308	CD274,LYN,PIK3R3,CD80,MAP3K8,ICOSLG
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.116837501055857	-2.14697118943647	39	4	0.00806451612903226	496	10287	5270,2152,5197,3053	SERPINE2,F3,PF4V1,SERPIND1
R-HSA-388396	GPCR downstream signaling	0.119344849828541	-2.12573807896296	974	55	0.110887096774194	496	10287	5996,2642,26575,1236,147,5999,3561,6000,6288,3627,719,283365,9340,6352,3576,8111,150,2847,5880,7852,6373,10125,134864,6372,6364,4283,6752,5142,64108,1910,2918,53831,3710,6374,135,2914,8503,9628,9162,623,26230,5021,2919,11343,643,3559,6004,6363,1437,10887,2921,718,2151,57007,2920	RGS1,GCGR,RGS17,CCR7,ADRA1B,RGS4,IL2RG,RGS7,SAA1,CXCL10,C3AR1,OR6C6,GLP2R,CCL5,CXCL8,GPR68,ADRA2A,MCHR1,RAC2,CXCR4,CXCL11,RASGRP1,TAAR1,CXCL6,CCL20,CXCL9,SSTR2,PDE4B,RTP4,EDNRB,GRM8,GPR84,ITPR3,CXCL5,ADORA2A,GRM4,PIK3R3,RGS6,DGKI,BDKRB1,TIAM2,OXTR,CXCL1,MGLL,CXCR5,IL2RA,RGS16,CCL19,CSF2,PROKR1,CXCL3,C3,F2RL2,ACKR3,CXCL2
R-HSA-5675221	Negative regulation of MAPK pathway	0.125170039570646	-2.07808214950703	40	4	0.00806451612903226	496	10287	1847,1848,1844,1850	DUSP5,DUSP6,DUSP2,DUSP8
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.125906452957019	-2.07221608462244	87	7	0.0141129032258065	496	10287	4233,8503,941,1839,26281,2247,2069	MET,PIK3R3,CD80,HBEGF,FGF20,FGF2,EREG
R-HSA-351202	Metabolism of polyamines	0.125906452957019	-2.07221608462244	87	7	0.0141129032258065	496	10287	54498,5699,5721,5698,6303,6611,6534	SMOX,PSMB10,PSME2,PSMB9,SAT1,SMS,SLC6A7
R-HSA-190372	FGFR3c ligand binding and activation	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	5880,4688	RAC2,NCF2
R-HSA-190239	FGFR3 ligand binding and activation	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-75892	Platelet Adhesion to exposed collagen	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	2207,4067	FCER1G,LYN
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	1540,7128	CYLD,TNFAIP3
R-HSA-190375	FGFR2c ligand binding and activation	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	25946,8900	ZNF385A,CCNA1
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	4435,163732	CITED1,CITED4
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	64135,23586	IFIH1,DDX58
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.127481041784403	-2.05978761732642	13	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-186763	Downstream signal transduction	0.127488941686885	-2.05972565001265	352	22	0.0443548387096774	496	10287	3710,6708,941,3561,1850,4233,26281,10125,2069,5721,1839,5698,1847,1437,3559,2247,1844,5699,2886,8503,1848,2668	ITPR3,SPTA1,CD80,IL2RG,DUSP8,MET,FGF20,RASGRP1,EREG,PSME2,HBEGF,PSMB9,DUSP5,CSF2,IL2RA,FGF2,DUSP2,PSMB10,GRB7,PIK3R3,DUSP6,GDNF
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.13434343189305	-2.00735583314659	122	9	0.0181451612903226	496	10287	6513,441024,54625,10135,8876,8875,5743,952,4363	SLC2A1,MTHFD2L,PARP14,NAMPT,VNN1,VNN2,PTGS2,CD38,ABCC1
R-HSA-5653890	Lactose synthesis	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	6513	SLC2A1
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	1080	CFTR
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	150	ADRA2A
R-HSA-193681	Ceramide signalling	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-177539	Autointegration results in viral DNA circles	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	51458	RHCG
R-HSA-190827	Transport of connexins along the secretory pathway	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	2706	GJB2
R-HSA-8875791	MET activates STAT3	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	4233	MET
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	4121	MAN1A1
R-HSA-198745	Signalling to STAT3	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-190704	Oligomerization of connexins into connexons	0.137799014279621	-1.98195907369652	3	1	0.00201612903225806	496	10287	2706	GJB2
R-HSA-2424491	DAP12 signaling	0.138433791578265	-1.97736310679798	356	22	0.0443548387096774	496	10287	3559,1437,1847,5721,1839,5698,2069,10125,26281,2668,8503,1848,5699,2247,1844,941,3710,6708,4233,1850,3561,3937	IL2RA,CSF2,DUSP5,PSME2,HBEGF,PSMB9,EREG,RASGRP1,FGF20,GDNF,PIK3R3,DUSP6,PSMB10,FGF2,DUSP2,CD80,ITPR3,SPTA1,MET,DUSP8,IL2RG,LCP2
R-HSA-186797	Signaling by PDGF	0.14250772963038	-1.94835903772432	376	23	0.0463709677419355	496	10287	2069,10125,26281,3559,1437,5721,5698,1847,1839,2886,5699,1844,2247,2668,8503,1848,3710,6708,5327,941,1850,3561,4233	EREG,RASGRP1,FGF20,IL2RA,CSF2,PSME2,PSMB9,DUSP5,HBEGF,GRB7,PSMB10,DUSP2,FGF2,GDNF,PIK3R3,DUSP6,ITPR3,SPTA1,PLAT,CD80,DUSP8,IL2RG,MET
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.143011190661519	-1.94483239540984	90	7	0.0141129032258065	496	10287	8503,1839,941,4233,2069,2247,26281	PIK3R3,HBEGF,CD80,MET,EREG,FGF2,FGF20
R-HSA-1630316	Glycosaminoglycan metabolism	0.144119886961242	-1.93710977744031	124	9	0.0181451612903226	496	10287	3038,6482,50515,375790,9435,3036,960,6484,6385	HAS3,ST3GAL1,CHST11,AGRN,CHST2,HAS1,CD44,ST3GAL4,SDC4
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	11182,6513	SLC2A6,SLC2A1
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	490,6547	ATP2B1,SLC8A3
R-HSA-162594	Early Phase of HIV Life Cycle	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	3159,7852	HMGA1,CXCR4
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	25946,8626	ZNF385A,TP63
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	1645,1646	AKR1C1,AKR1C2
R-HSA-209543	p75NTR recruits signalling complexes	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	8767,4803	RIPK2,NGF
R-HSA-190322	FGFR4 ligand binding and activation	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.144185304135953	-1.93665597239029	14	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-382556	ABC-family proteins mediated transport	0.144311777792268	-1.93577919635102	107	8	0.0161290322580645	496	10287	26154,24,5698,5721,5699,8714,4363,1080	ABCA12,ABCA4,PSMB9,PSME2,PSMB10,ABCC3,ABCC1,CFTR
R-HSA-74752	Signaling by Insulin receptor	0.147072500355806	-1.91682961408704	322	20	0.0403225806451613	496	10287	6708,4233,3561,1850,5698,1839,5721,1847,1437,3559,26281,2069,10125,1848,50617,2668,2247,1844,5699,245973	SPTA1,MET,IL2RG,DUSP8,PSMB9,HBEGF,PSME2,DUSP5,CSF2,IL2RA,FGF20,EREG,RASGRP1,DUSP6,ATP6V0A4,GDNF,FGF2,DUSP2,PSMB10,ATP6V1C2
R-HSA-418346	Platelet homeostasis	0.148949222986974	-1.90414981643951	91	7	0.0141129032258065	496	10287	3710,3779,4843,6547,2268,5152,490	ITPR3,KCNMB1,NOS2,SLC8A3,FGR,PDE9A,ATP2B1
R-HSA-1266695	Interleukin-7 signaling	0.150433945635622	-1.89423119056884	28	3	0.00604838709677419	496	10287	8503,3575,3561	PIK3R3,IL7R,IL2RG
R-HSA-211976	Endogenous sterols	0.150433945635622	-1.89423119056884	28	3	0.00604838709677419	496	10287	1586,1581,9420	CYP17A1,CYP7A1,CYP7B1
R-HSA-2022854	Keratan sulfate biosynthesis	0.150433945635622	-1.89423119056884	28	3	0.00604838709677419	496	10287	9435,6484,6482	CHST2,ST3GAL4,ST3GAL1
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.151584400264826	-1.88661271169629	43	4	0.00806451612903226	496	10287	64321,83595,6658,51176	SOX17,SOX7,SOX3,LEF1
R-HSA-75893	TNF signaling	0.151584400264826	-1.88661271169629	43	4	0.00806451612903226	496	10287	7185,7128,1540,330	TRAF1,TNFAIP3,CYLD,BIRC3
R-HSA-2559583	Cellular Senescence	0.152021858587694	-1.88373096197704	196	13	0.0262096774193548	496	10287	1030,8091,3159,23135,3552,3576,3725,4790,723790,3569,8900,3008,7295	CDKN2B,HMGA2,HMGA1,KDM6B,IL1A,CXCL8,JUN,NFKB1,HIST2H2AA4,IL6,CCNA1,HIST1H1E,TXN
R-HSA-2142753	Arachidonic acid metabolism	0.154196884211322	-1.86952502420931	59	5	0.0100806451612903	496	10287	242,9536,4363,247,5743	ALOX12B,PTGES,ABCC1,ALOX15B,PTGS2
R-HSA-975634	Retinoid metabolism and transport	0.160825812134609	-1.82743341189456	44	4	0.00806451612903226	496	10287	375790,6385,1645,4023	AGRN,SDC4,AKR1C1,LPL
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.160825812134609	-1.82743341189456	44	4	0.00806451612903226	496	10287	5366,637,8626,27113	PMAIP1,BID,TP63,BBC3
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.160918707416408	-1.82685596439361	110	8	0.0161290322580645	496	10287	8900,3569,723790,4790,3725,3576,3552,1030	CCNA1,IL6,HIST2H2AA4,NFKB1,JUN,CXCL8,IL1A,CDKN2B
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.161309458883081	-1.82443065401371	15	2	0.00403225806451613	496	10287	9536,5743	PTGES,PTGS2
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.161309458883081	-1.82443065401371	15	2	0.00403225806451613	496	10287	27121,7474	DKK4,WNT5A
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.161309458883081	-1.82443065401371	15	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.161309458883081	-1.82443065401371	15	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-177929	Signaling by EGFR	0.161914760754076	-1.82068525040952	364	22	0.0443548387096774	496	10287	26281,2069,10125,5721,5698,1839,1847,1437,3559,2247,1844,5699,1848,8503,2668,10252,6708,3710,941,3561,1850,4233	FGF20,EREG,RASGRP1,PSME2,PSMB9,HBEGF,DUSP5,CSF2,IL2RA,FGF2,DUSP2,PSMB10,DUSP6,PIK3R3,GDNF,SPRY1,SPTA1,ITPR3,CD80,IL2RG,DUSP8,MET
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.162027554070264	-1.8199888713594	60	5	0.0100806451612903	496	10287	5721,5698,5971,5699,4791	PSME2,PSMB9,RELB,PSMB10,NFKB2
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.167438548920621	-1.78713886714675	94	7	0.0141129032258065	496	10287	2069,26281,2247,4233,8503,1839,941	EREG,FGF20,FGF2,MET,PIK3R3,HBEGF,CD80
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.170014752010965	-1.77187006916165	61	5	0.0100806451612903	496	10287	5698,5721,5971,4791,5699	PSMB9,PSME2,RELB,NFKB2,PSMB10
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.170014752010965	-1.77187006916165	61	5	0.0100806451612903	496	10287	595,5721,5698,5699,8900	CCND1,PSME2,PSMB9,PSMB10,CCNA1
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.170267054135285	-1.77038716783695	45	4	0.00806451612903226	496	10287	5366,8626,637,27113	PMAIP1,TP63,BID,BBC3
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.174149977421643	-1.74783841181904	30	3	0.00604838709677419	496	10287	595,3725,10046	CCND1,JUN,MAMLD1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.174149977421643	-1.74783841181904	30	3	0.00604838709677419	496	10287	3937,3710,4067	LCP2,ITPR3,LYN
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.174149977421643	-1.74783841181904	30	3	0.00604838709677419	496	10287	54567,92737,113878	DLL4,DNER,DTX2
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.174962540019281	-1.74318338500478	387	23	0.0463709677419355	496	10287	1847,5721,1839,5698,1437,3559,4803,26281,10125,2069,8503,1848,2668,1844,2247,5699,941,135,3710,6708,4233,3561,1850	DUSP5,PSME2,HBEGF,PSMB9,CSF2,IL2RA,NGF,FGF20,RASGRP1,EREG,PIK3R3,DUSP6,GDNF,DUSP2,FGF2,PSMB10,CD80,ADORA2A,ITPR3,SPTA1,MET,IL2RG,DUSP8
R-HSA-1280218	Adaptive Immune System	0.175190788566087	-1.74187967853963	810	45	0.0907258064516129	496	10287	127544,255488,1326,3710,4233,285852,92369,57823,8767,3937,6890,1520,1839,5721,221687,4794,718,3383,4792,8503,55008,4067,29126,6891,2247,55521,941,342510,117157,4790,54210,23308,7498,10517,5698,11119,23327,84676,26281,3386,10125,2069,4688,5699,7097	RNF19B,RNF144B,MAP3K8,ITPR3,MET,TREML4,SPSB4,SLAMF7,RIPK2,LCP2,TAP1,CTSS,HBEGF,PSME2,RNF182,NFKBIE,C3,ICAM1,NFKBIA,PIK3R3,HERC6,LYN,CD274,TAP2,FGF2,TRIM36,CD80,CD300E,SH2D1B,NFKB1,TREM1,ICOSLG,XDH,FBXW10,PSMB9,BTN3A1,NEDD4L,TRIM63,FGF20,ICAM4,RASGRP1,EREG,NCF2,PSMB10,TLR2
R-HSA-112399	IRS-mediated signalling	0.177227969116809	-1.73031841400682	294	18	0.0362903225806452	496	10287	5699,2247,1844,2668,1848,2069,10125,26281,3559,1437,1839,5698,5721,1847,1850,3561,4233,6708	PSMB10,FGF2,DUSP2,GDNF,DUSP6,EREG,RASGRP1,FGF20,IL2RA,CSF2,HBEGF,PSMB9,PSME2,DUSP5,DUSP8,IL2RG,MET,SPTA1
R-HSA-1963642	PI3K events in ERBB2 signaling	0.178774410597097	-1.72163054395091	16	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.178774410597097	-1.72163054395091	16	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.178774410597097	-1.72163054395091	16	2	0.00403225806451613	496	10287	1326,4790	MAP3K8,NFKB1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.178774410597097	-1.72163054395091	16	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.178774410597097	-1.72163054395091	16	2	0.00403225806451613	496	10287	64135,23586	IFIH1,DDX58
R-HSA-190242	FGFR1 ligand binding and activation	0.178774410597097	-1.72163054395091	16	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-427975	Proton/oligopeptide cotransporters	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	51296	SLC15A3
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	637	BID
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	6506	SLC1A2
R-HSA-209905	Catecholamine biosynthesis	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	1644	DDC
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	25946	ZNF385A
R-HSA-140179	Amine Oxidase reactions	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	54498	SMOX
R-HSA-167060	NGF processing	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	7296	TXNRD1
R-HSA-2473224	Antagonism of Activin by Follistatin	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	3624	INHBA
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-417973	Adenosine P1 receptors	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	135	ADORA2A
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	6506	SLC1A2
R-HSA-173107	Binding and entry of HIV virion	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	7852	CXCR4
R-HSA-209563	Axonal growth stimulation	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	25946	ZNF385A
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.179383192509486	-1.71823102098446	4	1	0.00201612903225806	496	10287	8828	NRP2
R-HSA-2129379	Molecules associated with elastic fibres	0.186378607069914	-1.67997515225533	31	3	0.00604838709677419	496	10287	650,27302,10516	BMP2,BMP10,FBLN5
R-HSA-5654687	Downstream signaling of activated FGFR1	0.186378607069914	-1.67997515225533	31	3	0.00604838709677419	496	10287	26281,2247,23767	FGF20,FGF2,FLRT3
R-HSA-5339562	Uptake and actions of bacterial toxins	0.186378607069914	-1.67997515225533	31	3	0.00604838709677419	496	10287	1839,6616,7296	HBEGF,SNAP25,TXNRD1
R-HSA-8875878	MET promotes cell motility	0.186378607069914	-1.67997515225533	31	3	0.00604838709677419	496	10287	3918,4233,3914	LAMC2,MET,LAMB3
R-HSA-418360	Platelet calcium homeostasis	0.186378607069914	-1.67997515225533	31	3	0.00604838709677419	496	10287	490,6547,3710	ATP2B1,SLC8A3,ITPR3
R-HSA-15869	Metabolism of nucleotides	0.186883466694741	-1.67727002913579	97	7	0.0141129032258065	496	10287	51733,272,1890,7295,7498,57089,7296	UPB1,AMPD3,TYMP,TXN,XDH,ENTPD7,TXNRD1
R-HSA-74751	Insulin receptor signalling cascade	0.188228599127619	-1.67009810201759	297	18	0.0362903225806452	496	10287	6708,3561,1850,4233,10125,2069,26281,3559,1847,5721,5698,1839,1437,2247,1844,5699,2668,1848	SPTA1,IL2RG,DUSP8,MET,RASGRP1,EREG,FGF20,IL2RA,DUSP5,PSME2,PSMB9,HBEGF,CSF2,FGF2,DUSP2,PSMB10,GDNF,DUSP6
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.189703360148944	-1.66229368923576	47	4	0.00806451612903226	496	10287	10046,3725,595,6484	MAMLD1,JUN,CCND1,ST3GAL4
R-HSA-2428924	IGF1R signaling cascade	0.191969813624841	-1.65041714001878	298	18	0.0362903225806452	496	10287	1848,2668,2247,1844,5699,1839,1847,5698,5721,1437,3559,26281,10125,2069,4233,3561,1850,6708	DUSP6,GDNF,FGF2,DUSP2,PSMB10,HBEGF,DUSP5,PSMB9,PSME2,CSF2,IL2RA,FGF20,RASGRP1,EREG,MET,IL2RG,DUSP8,SPTA1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.191969813624841	-1.65041714001878	298	18	0.0362903225806452	496	10287	4233,3561,1850,6708,2668,1848,1844,2247,5699,3559,1847,1839,5721,5698,1437,2069,10125,26281	MET,IL2RG,DUSP8,SPTA1,GDNF,DUSP6,DUSP2,FGF2,PSMB10,IL2RA,DUSP5,HBEGF,PSME2,PSMB9,CSF2,EREG,RASGRP1,FGF20
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.195747507143055	-1.63092967909369	299	18	0.0362903225806452	496	10287	6708,4233,3561,1850,3559,1847,5698,1839,5721,1437,10125,2069,26281,2668,1848,2247,1844,5699	SPTA1,MET,IL2RG,DUSP8,IL2RA,DUSP5,PSMB9,HBEGF,PSME2,CSF2,RASGRP1,EREG,FGF20,GDNF,DUSP6,FGF2,DUSP2,PSMB10
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.196507687637666	-1.6270537256001	17	2	0.00403225806451613	496	10287	4586,10071	MUC5AC,MUC12
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.196507687637666	-1.6270537256001	17	2	0.00403225806451613	496	10287	10071,4586	MUC12,MUC5AC
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.196507687637666	-1.6270537256001	17	2	0.00403225806451613	496	10287	8876,8875	VNN1,VNN2
R-HSA-2033519	Activated point mutants of FGFR2	0.196507687637666	-1.6270537256001	17	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-192456	Digestion of dietary lipid	0.196507687637666	-1.6270537256001	17	2	0.00403225806451613	496	10287	119548,9388	PNLIPRP3,LIPG
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.196507687637666	-1.6270537256001	17	2	0.00403225806451613	496	10287	4586,10071	MUC5AC,MUC12
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.199675308558163	-1.61106268887795	48	4	0.00806451612903226	496	10287	4318,2048,1943,4067	MMP9,EPHB2,EFNA2,LYN
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.199675308558163	-1.61106268887795	48	4	0.00806451612903226	496	10287	1437,8503,3559,3561	CSF2,PIK3R3,IL2RA,IL2RG
R-HSA-75109	Triglyceride Biosynthesis	0.202921696461439	-1.59493510607101	82	6	0.0120967741935484	496	10287	51703,2182,80168,2181,79993,2710	ACSL5,ACSL4,MOGAT2,ACSL3,ELOVL7,GK
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.203397852243177	-1.59259135469984	65	5	0.0100806451612903	496	10287	25946,5698,5721,5699,8900	ZNF385A,PSMB9,PSME2,PSMB10,CCNA1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.203397852243177	-1.59259135469984	65	5	0.0100806451612903	496	10287	25946,5721,5698,5699,8900	ZNF385A,PSME2,PSMB9,PSMB10,CCNA1
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.211457326165654	-1.55373206839189	33	3	0.00604838709677419	496	10287	6482,6484,9435	ST3GAL1,ST3GAL4,CHST2
R-HSA-5654710	PI-3K cascade:FGFR3	0.214442989347669	-1.53971135986783	18	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-210993	Tie2 Signaling	0.214442989347669	-1.53971135986783	18	2	0.00403225806451613	496	10287	2888,2886	GRB14,GRB7
R-HSA-418457	cGMP effects	0.214442989347669	-1.53971135986783	18	2	0.00403225806451613	496	10287	5152,3779	PDE9A,KCNMB1
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.214442989347669	-1.53971135986783	18	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.214442989347669	-1.53971135986783	18	2	0.00403225806451613	496	10287	6580,6616	SLC22A1,SNAP25
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.214442989347669	-1.53971135986783	18	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-166520	Signalling by NGF	0.218016521030231	-1.52318443452221	477	27	0.0544354838709677	496	10287	5699,2247,1844,26230,8503,4792,1848,2668,4803,26281,2069,10125,1437,1839,5698,1847,5721,3559,1850,3561,8767,4233,4790,135,3710,6708,941	PSMB10,FGF2,DUSP2,TIAM2,PIK3R3,NFKBIA,DUSP6,GDNF,NGF,FGF20,EREG,RASGRP1,CSF2,HBEGF,PSMB9,DUSP5,PSME2,IL2RA,DUSP8,IL2RG,RIPK2,MET,NFKB1,ADORA2A,ITPR3,SPTA1,CD80
R-HSA-426048	Arachidonate production from DAG	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	11343	MGLL
R-HSA-1169092	Activation of RAS in B cells	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	10125	RASGRP1
R-HSA-2161517	Abacavir transmembrane transport	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	6580	SLC22A1
R-HSA-209931	Serotonin and melatonin biosynthesis	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	1644	DDC
R-HSA-8865999	MET activates PTPN11	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	4233	MET
R-HSA-3000471	Scavenging by Class B Receptors	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	6288	SAA1
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	2886	GRB7
R-HSA-112303	Electric Transmission Across Gap Junctions	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	56666	PANX2
R-HSA-187024	NGF-independant TRKA activation	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	135	ADORA2A
R-HSA-8875513	MET interacts with TNS proteins	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	4233	MET
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	64849	SLC13A3
R-HSA-68911	G2 Phase	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-1614517	Sulfide oxidation to sulfate	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	58472	SQOR
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	2152	F3
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-112307	Transmission across Electrical Synapses	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	56666	PANX2
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	4121	MAN1A1
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	5366	PMAIP1
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.218965603918061	-1.51884062123569	5	1	0.00201612903225806	496	10287	857	CAV1
R-HSA-73887	Death Receptor Signalling	0.220068606477542	-1.51381593361895	50	4	0.00806451612903226	496	10287	1540,330,7185,7128	CYLD,BIRC3,TRAF1,TNFAIP3
R-HSA-69615	G1/S DNA Damage Checkpoints	0.220854817549768	-1.51024972750413	67	5	0.0100806451612903	496	10287	5699,8900,25946,5721,5698	PSMB10,CCNA1,ZNF385A,PSME2,PSMB9
R-HSA-5357801	Programmed Cell Death	0.223999070307137	-1.49611337755028	175	11	0.0221774193548387	496	10287	5699,3008,8626,637,660,5317,27113,5366,5721,5698,330	PSMB10,HIST1H1E,TP63,BID,BMX,PKP1,BBC3,PMAIP1,PSME2,PSMB9,BIRC3
R-HSA-1236974	ER-Phagosome pathway	0.226145023747885	-1.48657878751049	85	6	0.0120967741935484	496	10287	5699,6891,6890,7097,5698,5721	PSMB10,TAP2,TAP1,TLR2,PSMB9,PSME2
R-HSA-3781865	Diseases of glycosylation	0.226145023747885	-1.48657878751049	85	6	0.0120967741935484	496	10287	56999,10071,4586,375790,9507,6385	ADAMTS9,MUC12,MUC5AC,AGRN,ADAMTS4,SDC4
R-HSA-373755	Semaphorin interactions	0.229750239946893	-1.47076247336432	68	5	0.0100806451612903	496	10287	5880,4233,4629,80031,27289	RAC2,MET,MYH11,SEMA6D,RND1
R-HSA-397795	G-protein beta:gamma signalling	0.230466682456246	-1.46764897165139	51	4	0.00806451612903226	496	10287	3561,1437,8503,3559	IL2RG,CSF2,PIK3R3,IL2RA
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.232519761448911	-1.45878006208745	19	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.232519761448911	-1.45878006208745	19	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.232519761448911	-1.45878006208745	19	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-933541	TRAF6 mediated IRF7 activation	0.237210618492483	-1.43880684687199	35	3	0.00604838709677419	496	10287	64135,23586,3659	IFIH1,DDX58,IRF1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.240983610998703	-1.42302635195863	52	4	0.00806451612903226	496	10287	595,5721,5698,5699	CCND1,PSME2,PSMB9,PSMB10
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.240983610998703	-1.42302635195863	52	4	0.00806451612903226	496	10287	5699,5698,5721,595	PSMB10,PSMB9,PSME2,CCND1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.248667696316458	-1.39163782677225	124	8	0.0161290322580645	496	10287	54210,57823,117157,3383,285852,342510,3386,718	TREM1,SLAMF7,SH2D1B,ICAM1,TREML4,CD300E,ICAM4,C3
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.250284679201478	-1.3851562921602	36	3	0.00604838709677419	496	10287	6446,639,8900	SGK1,PRDM1,CCNA1
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.250682797853636	-1.38356689263148	20	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-3000170	Syndecan interactions	0.250682797853636	-1.38356689263148	20	2	0.00403225806451613	496	10287	6385,2247	SDC4,FGF2
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.250682797853636	-1.38356689263148	20	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.250682797853636	-1.38356689263148	20	2	0.00403225806451613	496	10287	11343,857	MGLL,CAV1
R-HSA-190241	FGFR2 ligand binding and activation	0.250682797853636	-1.38356689263148	20	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-5654720	PI-3K cascade:FGFR4	0.250682797853636	-1.38356689263148	20	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-8851907	MET activates PI3K/AKT signaling	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	4233	MET
R-HSA-205025	NADE modulates death signalling	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-5676934	Protein repair	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	7295	TXN
R-HSA-6806942	MET Receptor Activation	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	4233	MET
R-HSA-189483	Heme degradation	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	3162	HMOX1
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	27121	DKK4
R-HSA-193144	Estrogen biosynthesis	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	441282	AKR1B15
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	242	ALOX12B
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	1839	HBEGF
R-HSA-388479	Vasopressin-like receptors	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	5021	OXTR
R-HSA-3000484	Scavenging by Class F Receptors	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	8578	SCARF1
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	595	CCND1
R-HSA-190370	FGFR1b ligand binding and activation	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	2247	FGF2
R-HSA-5690714	CD22 mediated BCR regulation	0.256642423647797	-1.36007151058379	6	1	0.00201612903225806	496	10287	4067	LYN
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.257019122053128	-1.35860479197884	71	5	0.0100806451612903	496	10287	5699,8900,5721,5698,595	PSMB10,CCNA1,PSME2,PSMB9,CCND1
R-HSA-201681	TCF dependent signaling in response to WNT	0.258806159897451	-1.35167591487107	238	14	0.0282258064516129	496	10287	83595,5721,5698,6658,51176,857,27121,284654,8313,64321,7474,723790,5699,84870	SOX7,PSME2,PSMB9,SOX3,LEF1,CAV1,DKK4,RSPO1,AXIN2,SOX17,WNT5A,HIST2H2AA4,PSMB10,RSPO3
R-HSA-6794362	Protein-protein interactions at synapses	0.266279243365485	-1.32320973375328	72	5	0.0100806451612903	496	10287	9456,57497,9378,9228,9369	HOMER1,LRFN2,NRXN1,DLGAP2,NRXN3
R-HSA-69202	Cyclin E associated events during G1/S transition	0.266279243365485	-1.32320973375328	72	5	0.0100806451612903	496	10287	8900,5699,595,5698,5721	CCNA1,PSMB10,CCND1,PSMB9,PSME2
R-HSA-5654689	PI-3K cascade:FGFR1	0.268881867407078	-1.31348315045746	21	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-2024096	HS-GAG degradation	0.268881867407078	-1.31348315045746	21	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.268881867407078	-1.31348315045746	21	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.273133518690537	-1.29779452390503	55	4	0.00806451612903226	496	10287	2182,51703,79993,2181	ACSL4,ACSL5,ELOVL7,ACSL3
R-HSA-198203	PI3K/AKT activation	0.276222786094227	-1.28654754287889	128	8	0.0161290322580645	496	10287	8503,4233,2247,941,1839,4803,26281,2069	PIK3R3,MET,FGF2,CD80,HBEGF,NGF,FGF20,EREG
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.283250467482743	-1.26142372865087	92	6	0.0120967741935484	496	10287	5329,27076,8875,5277,8876,154064	PLAUR,LYPD3,VNN2,PIGA,VNN1,RAET1L
R-HSA-373080	Class B/2 (Secretin family receptors)	0.283250467482743	-1.26142372865087	92	6	0.0120967741935484	496	10287	90226,9340,1604,2642,11211,7474	UCN2,GLP2R,CD55,GCGR,FZD10,WNT5A
R-HSA-4641257	Degradation of AXIN	0.284012583008528	-1.25873673543437	56	4	0.00806451612903226	496	10287	5699,8313,5721,5698	PSMB10,AXIN2,PSME2,PSMB9
R-HSA-202131	Metabolism of nitric oxide	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	857,2643	CAV1,GCH1
R-HSA-5655332	Signaling by FGFR3 in disease	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-203765	eNOS activation and regulation	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	857,2643	CAV1,GCH1
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	3053,5270	SERPIND1,SERPINE2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	84870,284654	RSPO3,RSPO1
R-HSA-389513	CTLA4 inhibitory signaling	0.287071364098526	-1.24802443873658	22	2	0.00403225806451613	496	10287	941,4067	CD80,LYN
R-HSA-190371	FGFR3b ligand binding and activation	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	26281	FGF20
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	64078	SLC28A3
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	5818	NECTIN1
R-HSA-447043	Neurofascin interactions	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	286	ANK1
R-HSA-162791	Attachment of GPI anchor to uPAR	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	5329	PLAUR
R-HSA-5652084	Fructose metabolism	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	231	AKR1B1
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-164843	2-LTR circle formation	0.292505214999881	-1.22927278340974	7	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-157118	Signaling by NOTCH	0.295427779373462	-1.21933087345033	112	7	0.0141129032258065	496	10287	54567,10046,92737,113878,3725,6484,595	DLL4,MAMLD1,DNER,DTX2,JUN,ST3GAL4,CCND1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.297413813766139	-1.2126307975945	131	8	0.0161290322580645	496	10287	4067,4233,8503,2247,1839,941,2069,26281	LYN,MET,PIK3R3,FGF2,HBEGF,CD80,EREG,FGF20
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.30341446303382	-1.19265554334949	40	3	0.00604838709677419	496	10287	28231,64078,28232	SLCO4A1,SLC28A3,SLCO3A1
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.305209979319928	-1.18675528246574	23	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.305209979319928	-1.18675528246574	23	2	0.00403225806451613	496	10287	6648,3725	SOD2,JUN
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.305209979319928	-1.18675528246574	23	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-8863678	Neurodegenerative Diseases	0.305209979319928	-1.18675528246574	23	2	0.00403225806451613	496	10287	6648,3725	SOD2,JUN
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.305209979319928	-1.18675528246574	23	2	0.00403225806451613	496	10287	64220,24	STRA6,ABCA4
R-HSA-5654695	PI-3K cascade:FGFR2	0.305209979319928	-1.18675528246574	23	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.305949158670153	-1.18433633897064	58	4	0.00806451612903226	496	10287	9369,9228,9378,9456	NRXN3,DLGAP2,NRXN1,HOMER1
R-HSA-2682334	EPH-Ephrin signaling	0.308656585769091	-1.17552599303279	95	6	0.0120967741935484	496	10287	4629,4318,2048,6461,1943,4067	MYH11,MMP9,EPHB2,SHB,EFNA2,LYN
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.316985687718342	-1.14889865527761	59	4	0.00806451612903226	496	10287	9507,4586,10071,56999	ADAMTS4,MUC5AC,MUC12,ADAMTS9
R-HSA-4086400	PCP/CE pathway	0.317213661136902	-1.14817972225192	96	6	0.0120967741935484	496	10287	23002,5699,7474,5721,5698,5880	DAAM1,PSMB10,WNT5A,PSME2,PSMB9,RAC2
R-HSA-109581	Apoptosis	0.317226330853824	-1.14813978240865	172	10	0.0201612903225806	496	10287	5699,3008,637,8626,5317,660,27113,5721,5698,5366	PSMB10,HIST1H1E,BID,TP63,PKP1,BMX,BBC3,PSME2,PSMB9,PMAIP1
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.323260394825132	-1.12929710461555	24	2	0.00403225806451613	496	10287	6506,6616	SLC1A2,SNAP25
R-HSA-201451	Signaling by BMP	0.323260394825132	-1.12929710461555	24	2	0.00403225806451613	496	10287	658,650	BMPR1B,BMP2
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	57089	ENTPD7
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	9945	GFPT2
R-HSA-68952	DNA replication initiation	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-448424	Interleukin-17 signaling	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	27189	IL17C
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	6513	SLC2A1
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	4688	NCF2
R-HSA-174430	Telomere C-strand synthesis initiation	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-164944	Nef and signal transduction	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	3055	HCK
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	6288	SAA1
R-HSA-5576890	Phase 3 - rapid repolarisation	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	23630	KCNE5
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.326641150133426	-1.11889311087297	8	1	0.00201612903225806	496	10287	11343	MGLL
R-HSA-1566948	Elastic fibre formation	0.330213624652869	-1.10801548652764	42	3	0.00604838709677419	496	10287	650,27302,10516	BMP2,BMP10,FBLN5
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.332766352693064	-1.10031467883311	79	5	0.0100806451612903	496	10287	8091,723790,3159,8900,3008	HMGA2,HIST2H2AA4,HMGA1,CCNA1,HIST1H1E
R-HSA-202424	Downstream TCR signaling	0.334431409070605	-1.09532347553588	98	6	0.0120967741935484	496	10287	5699,8767,5698,4792,5721,4790	PSMB10,RIPK2,PSMB9,NFKBIA,PSME2,NFKB1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.340686873756583	-1.07679148233483	813	42	0.0846774193548387	496	10287	441282,660,6716,9536,857,9388,84879,3290,1581,8714,7296,51365,1586,1646,2181,242,247,4023,2710,25816,80736,9108,130367,1645,29923,80168,11343,3638,26230,5743,9420,8503,51703,2182,231,27242,79993,9023,85441,50486,4363,119548	AKR1B15,BMX,SRD5A2,PTGES,CAV1,LIPG,MFSD2A,HSD11B1,CYP7A1,ABCC3,TXNRD1,PLA1A,CYP17A1,AKR1C2,ACSL3,ALOX12B,ALOX15B,LPL,GK,TNFAIP8,SLC44A4,MTMR7,SGPP2,AKR1C1,HILPDA,MOGAT2,MGLL,INSIG1,TIAM2,PTGS2,CYP7B1,PIK3R3,ACSL5,ACSL4,AKR1B1,TNFRSF21,ELOVL7,CH25H,HELZ2,G0S2,ABCC1,PNLIPRP3
R-HSA-1251985	Nuclear signaling by ERBB4	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-425410	Metal ion SLC transporters	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	84102,64116	SLC41A2,SLC39A8
R-HSA-211981	Xenobiotics	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	1577,1551	CYP3A5,CYP3A7
R-HSA-5654708	Downstream signaling of activated FGFR3	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	7295,7296	TXN,TXNRD1
R-HSA-3000157	Laminin interactions	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	3918,3914	LAMC2,LAMB3
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	6891,6890	TAP2,TAP1
R-HSA-1614635	Sulfur amino acid metabolism	0.341188995319456	-1.07531871675856	25	2	0.00403225806451613	496	10287	2730,58472	GCLM,SQOR
R-HSA-422356	Regulation of insulin secretion	0.342420652681551	-1.0717153191225	80	5	0.0100806451612903	496	10287	3710,4082,6616,6513,150	ITPR3,MARCKS,SNAP25,SLC2A1,ADRA2A
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.343610816478862	-1.06824560951053	43	3	0.00604838709677419	496	10287	8578,2495,6288	SCARF1,FTH1,SAA1
R-HSA-375280	Amine ligand-binding receptors	0.343610816478862	-1.06824560951053	43	3	0.00604838709677419	496	10287	134864,150,147	TAAR1,ADRA2A,ADRA1B
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.350247544072914	-1.04911510571562	62	4	0.00806451612903226	496	10287	5699,5721,5698,1080	PSMB10,PSME2,PSMB9,CFTR
R-HSA-202403	TCR signaling	0.350272779519242	-1.04904305799483	119	7	0.0141129032258065	496	10287	5698,5721,4792,4790,5699,8767,3937	PSMB9,PSME2,NFKBIA,NFKB1,PSMB10,RIPK2,LCP2
R-HSA-1187000	Fertilization	0.358965599294481	-1.0245287187775	26	2	0.00403225806451613	496	10287	79820,7784	CATSPERB,ZP3
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.358965599294481	-1.0245287187775	26	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-1474165	Reproduction	0.358965599294481	-1.0245287187775	26	2	0.00403225806451613	496	10287	7784,79820	ZP3,CATSPERB
R-HSA-73848	Pyrimidine metabolism	0.358965599294481	-1.0245287187775	26	2	0.00403225806451613	496	10287	51733,1890	UPB1,TYMP
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.358965599294481	-1.0245287187775	26	2	0.00403225806451613	496	10287	6385,375790	SDC4,AGRN
R-HSA-112411	MAPK1 (ERK2) activation	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	3569	IL6
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	9353	SLIT2
R-HSA-1300642	Sperm Motility And Taxes	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	79820	CATSPERB
R-HSA-2474795	Diseases associated with visual transduction	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	64220	STRA6
R-HSA-162592	Integration of provirus	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-2453864	Retinoid cycle disease events	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	64220	STRA6
R-HSA-428543	Inactivation of Cdc42 and Rac	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	9353	SLIT2
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	81894	SLC25A28
R-HSA-447041	CHL1 interactions	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	286	ANK1
R-HSA-1614558	Degradation of cysteine and homocysteine	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	58472	SQOR
R-HSA-193697	p75NTR regulates axonogenesis	0.359133220342381	-1.02406187202504	9	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-69239	Synthesis of DNA	0.36044616576437	-1.02041266554596	101	6	0.0120967741935484	496	10287	5698,5721,64785,8900,23649,5699	PSMB9,PSME2,GINS3,CCNA1,POLA2,PSMB10
R-HSA-77387	Insulin receptor recycling	0.37656320719737	-0.976669364830316	27	2	0.00403225806451613	496	10287	50617,245973	ATP6V0A4,ATP6V1C2
R-HSA-5654716	Downstream signaling of activated FGFR4	0.37656320719737	-0.976669364830316	27	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-2672351	Stimuli-sensing channels	0.386576527745116	-0.9504254286266	104	6	0.0120967741935484	496	10287	6338,8989,6446,23327,266675,338440	SCNN1B,TRPA1,SGK1,NEDD4L,BEST4,ANO9
R-HSA-74259	Purine catabolism	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	7498	XDH
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	64116	SLC39A8
R-HSA-8875656	MET receptor recycling	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	4233	MET
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	117283	IP6K3
R-HSA-110056	MAPK3 (ERK1) activation	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	3569	IL6
R-HSA-168799	Neurotoxicity of clostridium toxins	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	3725	JUN
R-HSA-196108	Pregnenolone biosynthesis	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	231	AKR1B1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	9108	MTMR7
R-HSA-1300644	Interaction With The Zona Pellucida	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	7784	ZP3
R-HSA-418886	Netrin mediated repulsion signals	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	137970	UNC5D
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	3656	IRAK2
R-HSA-190377	FGFR2b ligand binding and activation	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	2247	FGF2
R-HSA-2161522	Abacavir transport and metabolism	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	6580	SLC22A1
R-HSA-193692	Regulated proteolysis of p75NTR	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	4790	NFKB1
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	6580	SLC22A1
R-HSA-427601	Multifunctional anion exchangers	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	115019	SLC26A9
R-HSA-399997	Acetylcholine regulates insulin secretion	0.390060436018278	-0.941453587714717	10	1	0.00201612903225806	496	10287	4082	MARCKS
R-HSA-1483191	Synthesis of PC	0.393957765780607	-0.931511568880068	28	2	0.00403225806451613	496	10287	80736,84879	SLC44A4,MFSD2A
R-HSA-8948216	Collagen chain trimerization	0.396828617170388	-0.924250786286883	47	3	0.00604838709677419	496	10287	1305,169044,1294	COL13A1,COL22A1,COL7A1
R-HSA-1257604	PIP3 activates AKT signaling	0.398090680499607	-0.921075459198119	125	7	0.0141129032258065	496	10287	2247,26281,2069,1839,8503,941,4233	FGF2,FGF20,EREG,HBEGF,PIK3R3,CD80,MET
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.400535159098586	-0.914953728315415	86	5	0.0100806451612903	496	10287	3710,3055,2268,644150,4067	ITPR3,HCK,FGR,WIPF3,LYN
R-HSA-4608870	Asymmetric localization of PCP proteins	0.40563371357648	-0.902304709901866	67	4	0.00806451612903226	496	10287	5721,5698,7474,5699	PSME2,PSMB9,WNT5A,PSMB10
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.409972171081027	-0.891665996999552	48	3	0.00604838709677419	496	10287	56938,85441,10135	ARNTL2,HELZ2,NAMPT
R-HSA-418597	G alpha (z) signalling events	0.409972171081027	-0.891665996999552	48	3	0.00604838709677419	496	10287	150,26575,5999	ADRA2A,RGS17,RGS4
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.411127947720647	-0.888850804609542	29	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.416626430686385	-0.875565308369406	68	4	0.00806451612903226	496	10287	4790,4792,6288,4791	NFKB1,NFKBIA,SAA1,NFKB2
R-HSA-1980150	Signaling by NOTCH4	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	259307	IL4I1
R-HSA-73614	Pyrimidine salvage reactions	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	1890	TYMP
R-HSA-549127	Organic cation transport	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	6580	SLC22A1
R-HSA-8851805	MET activates RAS signaling	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	4233	MET
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	5317	PKP1
R-HSA-1980148	Signaling by NOTCH3	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-1059683	Interleukin-6 signaling	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	3569	IL6
R-HSA-71288	Creatine metabolism	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	6534	SLC6A7
R-HSA-5661231	Metallothioneins bind metals	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	4504	MT3
R-HSA-8875555	MET activates RAP1 and RAC1	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	4233	MET
R-HSA-5660526	Response to metal ions	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	4504	MT3
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	7097	TLR2
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.419498017380626	-0.868696479234731	11	1	0.00201612903225806	496	10287	7097	TLR2
R-HSA-180292	GAB1 signalosome	0.42203150937556	-0.862675300966819	128	7	0.0141129032258065	496	10287	2069,26281,2247,4233,8503,941,1839	EREG,FGF20,FGF2,MET,PIK3R3,CD80,HBEGF
R-HSA-5619084	ABC transporter disorders	0.427572825898004	-0.849630652135956	69	4	0.00806451612903226	496	10287	5699,1080,5721,5698	PSMB10,CFTR,PSME2,PSMB9
R-HSA-420092	Glucagon-type ligand receptors	0.428054945602862	-0.848503714063256	30	2	0.00403225806451613	496	10287	2642,9340	GCGR,GLP2R
R-HSA-917977	Transferrin endocytosis and recycling	0.428054945602862	-0.848503714063256	30	2	0.00403225806451613	496	10287	50617,245973	ATP6V0A4,ATP6V1C2
R-HSA-8863795	Downregulation of ERBB2 signaling	0.428054945602862	-0.848503714063256	30	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-445095	Interaction between L1 and Ankyrins	0.428054945602862	-0.848503714063256	30	2	0.00403225806451613	496	10287	286,6708	ANK1,SPTA1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.428054945602862	-0.848503714063256	30	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-5683826	Surfactant metabolism	0.428054945602862	-0.848503714063256	30	2	0.00403225806451613	496	10287	135,150	ADORA2A,ADRA2A
R-HSA-3858494	Beta-catenin independent WNT signaling	0.429517409653278	-0.845093003680203	149	8	0.0161290322580645	496	10287	5699,23002,7474,3710,5698,5721,5880,51176	PSMB10,DAAM1,WNT5A,ITPR3,PSMB9,PSME2,RAC2,LEF1
R-HSA-69306	DNA Replication	0.430064937667068	-0.843819063866182	109	6	0.0120967741935484	496	10287	64785,5699,23649,8900,5698,5721	GINS3,PSMB10,POLA2,CCNA1,PSMB9,PSME2
R-HSA-5654736	Signaling by FGFR1	0.43598159586734	-0.830155247837467	50	3	0.00604838709677419	496	10287	26281,23767,2247	FGF20,FLRT3,FGF2
R-HSA-69242	S Phase	0.43794466681454	-0.825662708059837	130	7	0.0141129032258065	496	10287	23649,8900,5699,64785,5721,5698,595	POLA2,CCNA1,PSMB10,GINS3,PSME2,PSMB9,CCND1
R-HSA-2022928	HS-GAG biosynthesis	0.444722279298019	-0.810305283107164	31	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.444722279298019	-0.810305283107164	31	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.444722279298019	-0.810305283107164	31	2	0.00403225806451613	496	10287	3725,1848	JUN,DUSP6
R-HSA-1839124	FGFR1 mutant receptor activation	0.444722279298019	-0.810305283107164	31	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-418990	Adherens junctions interactions	0.444722279298019	-0.810305283107164	31	2	0.00403225806451613	496	10287	1000,5818	CDH2,NECTIN1
R-HSA-163685	Integration of energy metabolism	0.447343499672386	-0.804428523836507	111	6	0.0120967741935484	496	10287	150,6616,6513,3710,4082,2642	ADRA2A,SNAP25,SLC2A1,ITPR3,MARCKS,GCGR
R-HSA-4641265	Repression of WNT target genes	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	51176	LEF1
R-HSA-203615	eNOS activation	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	857	CAV1
R-HSA-844456	The NLRP3 inflammasome	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	7295	TXN
R-HSA-1236977	Endosomal/Vacuolar pathway	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	1520	CTSS
R-HSA-1475029	Reversible hydration of carbon dioxide	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	771	CA12
R-HSA-389359	CD28 dependent Vav1 pathway	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	941	CD80
R-HSA-2160916	Hyaluronan uptake and degradation	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	960	CD44
R-HSA-209822	Glycoprotein hormones	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	3624	INHBA
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	8626	TP63
R-HSA-176974	Unwinding of DNA	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	64785	GINS3
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	2643	GCH1
R-HSA-210990	PECAM1 interactions	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	4067	LYN
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.44751757590868	-0.804039466264914	12	1	0.00201612903225806	496	10287	8626	TP63
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.448826277959871	-0.801119374883739	51	3	0.00604838709677419	496	10287	50515,375790,6385	CHST11,AGRN,SDC4
R-HSA-1227986	Signaling by ERBB2	0.448826277959871	-0.801119374883739	51	3	0.00604838709677419	496	10287	2069,2886,1839	EREG,GRB7,HBEGF
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.448826277959871	-0.801119374883739	51	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.448826277959871	-0.801119374883739	51	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-112310	Neurotransmitter Release Cycle	0.448826277959871	-0.801119374883739	51	3	0.00604838709677419	496	10287	6580,6506,6616	SLC22A1,SLC1A2,SNAP25
R-HSA-1266738	Developmental Biology	0.452964430232169	-0.791941677040784	1075	53	0.106854838709677	496	10287	5317,55203,27289,214,2048,1000,3855,3561,4023,1850,8828,2312,3725,4790,26281,2069,10125,5698,1847,5880,4629,6092,5266,1844,5699,2886,1848,375790,3868,2668,723790,4211,6708,1943,80031,4233,85441,688,3854,3849,9119,1839,5721,137970,1437,6461,3559,2247,9353,286,8503,4318,4067	PKP1,LGI2,RND1,ALCAM,EPHB2,CDH2,KRT7,IL2RG,LPL,DUSP8,NRP2,FLG,JUN,NFKB1,FGF20,EREG,RASGRP1,PSMB9,DUSP5,RAC2,MYH11,ROBO2,PI3,DUSP2,PSMB10,GRB7,DUSP6,AGRN,KRT16,GDNF,HIST2H2AA4,MEIS1,SPTA1,EFNA2,SEMA6D,MET,HELZ2,KLF5,KRT6B,KRT2,KRT75,HBEGF,PSME2,UNC5D,CSF2,SHB,IL2RA,FGF2,SLIT2,ANK1,PIK3R3,MMP9,LYN
R-HSA-195721	Signaling by Wnt	0.454664806114642	-0.788194821378434	336	17	0.0342741935483871	496	10287	5699,84870,23002,723790,8313,64321,5880,5721,5698,284654,51176,857,27121,7474,3710,6658,83595	PSMB10,RSPO3,DAAM1,HIST2H2AA4,AXIN2,SOX17,RAC2,PSME2,PSMB9,RSPO1,LEF1,CAV1,DKK4,WNT5A,ITPR3,SOX3,SOX7
R-HSA-68949	Orc1 removal from chromatin	0.460064221086433	-0.776389188186251	72	4	0.00806451612903226	496	10287	5699,8900,5698,5721	PSMB10,CCNA1,PSMB9,PSME2
R-HSA-69052	Switching of origins to a post-replicative state	0.460064221086433	-0.776389188186251	72	4	0.00806451612903226	496	10287	5698,5721,5699,8900	PSMB9,PSME2,PSMB10,CCNA1
R-HSA-69190	DNA strand elongation	0.461115616069152	-0.774106473352815	32	2	0.00403225806451613	496	10287	64785,23649	GINS3,POLA2
R-HSA-376176	Signaling by Robo receptor	0.461115616069152	-0.774106473352815	32	2	0.00403225806451613	496	10287	6092,9353	ROBO2,SLIT2
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.461551339199715	-0.773161987023342	52	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.461551339199715	-0.773161987023342	52	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-1980143	Signaling by NOTCH1	0.470757057500361	-0.753413119522499	73	4	0.00806451612903226	496	10287	113878,92737,54567,10046	DTX2,DNER,DLL4,MAMLD1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.470757057500361	-0.753413119522499	73	4	0.00806451612903226	496	10287	8900,5699,5698,5721	CCNA1,PSMB10,PSMB9,PSME2
R-HSA-180534	Vpu mediated degradation of CD4	0.474147943841109	-0.746235888177444	53	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-75153	Apoptotic execution  phase	0.474147943841109	-0.746235888177444	53	3	0.00604838709677419	496	10287	3008,5317,660	HIST1H1E,PKP1,BMX
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.474147943841109	-0.746235888177444	53	3	0.00604838709677419	496	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-350054	Notch-HLH transcription pathway	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	10046	MAMLD1
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	51700	CYB5R2
R-HSA-202670	ERKs are inactivated	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	1848	DUSP6
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	7474	WNT5A
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	2247	FGF2
R-HSA-74217	Purine salvage	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	272	AMPD3
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	6288	SAA1
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	2247	FGF2
R-HSA-425561	Sodium/Calcium exchangers	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	6547	SLC8A3
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	51700	CYB5R2
R-HSA-432047	Passive transport by Aquaporins	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	366	AQP9
R-HSA-211227	Activation of DNA fragmentation factor	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	3008	HIST1H1E
R-HSA-140342	Apoptosis induced DNA fragmentation	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	3008	HIST1H1E
R-HSA-1502540	Signaling by Activin	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	3624	INHBA
R-HSA-977441	GABA A receptor activation	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	55879	GABRQ
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.474187287070921	-0.746152914923783	13	1	0.00201612903225806	496	10287	10046	MAMLD1
R-HSA-1839126	FGFR2 mutant receptor activation	0.477222602519684	-0.739772225002262	33	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-4085001	Sialic acid metabolism	0.477222602519684	-0.739772225002262	33	2	0.00403225806451613	496	10287	6484,6482	ST3GAL4,ST3GAL1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.477222602519684	-0.739772225002262	33	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-1980145	Signaling by NOTCH2	0.477222602519684	-0.739772225002262	33	2	0.00403225806451613	496	10287	10046,54567	MAMLD1,DLL4
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.481371018954897	-0.731116957034682	74	4	0.00806451612903226	496	10287	8900,5699,5721,5698	CCNA1,PSMB10,PSME2,PSMB9
R-HSA-69300	Removal of licensing factors from origins	0.481371018954897	-0.731116957034682	74	4	0.00806451612903226	496	10287	5721,5698,5699,8900	PSME2,PSMB9,PSMB10,CCNA1
R-HSA-73923	Lipid digestion, mobilization, and transport	0.481536005960708	-0.730774271805151	115	6	0.0120967741935484	496	10287	119548,857,9388,11343,29923,4023	PNLIPRP3,CAV1,LIPG,MGLL,HILPDA,LPL
R-HSA-169911	Regulation of Apoptosis	0.486607923201087	-0.72029656598458	54	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.486607923201087	-0.72029656598458	54	3	0.00604838709677419	496	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-69610	p53-Independent DNA Damage Response	0.486607923201087	-0.72029656598458	54	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.486607923201087	-0.72029656598458	54	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-73847	Purine metabolism	0.49303270769193	-0.707179762937428	34	2	0.00403225806451613	496	10287	7498,272	XDH,AMPD3
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.49303270769193	-0.707179762937428	34	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-113510	E2F mediated regulation of DNA replication	0.49303270769193	-0.707179762937428	34	2	0.00403225806451613	496	10287	8900,23649	CCNA1,POLA2
R-HSA-5694530	Cargo concentration in the ER	0.49303270769193	-0.707179762937428	34	2	0.00403225806451613	496	10287	374,1294	AREG,COL7A1
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.498923754233416	-0.695301992032712	55	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-5675482	Regulation of necroptotic cell death	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	330	BIRC3
R-HSA-177504	Retrograde neurotrophin signalling	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-877312	Regulation of IFNG signaling	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	3460	IFNGR2
R-HSA-69109	Leading Strand Synthesis	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	8626	TP63
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	1520	CTSS
R-HSA-428540	Activation of Rac	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	9353	SLIT2
R-HSA-69091	Polymerase switching	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-69166	Removal of the Flap Intermediate	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-209952	Peptide hormone biosynthesis	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	3624	INHBA
R-HSA-174403	Glutathione synthesis and recycling	0.499572054996737	-0.69400343704945	14	1	0.00201612903225806	496	10287	2730	GCLM
R-HSA-5619115	Disorders of transmembrane transporters	0.502340349756219	-0.688477401457956	76	4	0.00806451612903226	496	10287	5698,1080,5721,5699	PSMB9,CFTR,PSME2,PSMB10
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.502340349756219	-0.688477401457956	76	4	0.00806451612903226	496	10287	8900,5699,5721,5698	CCNA1,PSMB10,PSME2,PSMB9
R-HSA-193704	p75 NTR receptor-mediated signalling	0.504796977113868	-0.683598956057794	97	5	0.0100806451612903	496	10287	4803,8767,26230,4792,4790	NGF,RIPK2,TIAM2,NFKBIA,NFKB1
R-HSA-211859	Biological oxidations	0.507362659599632	-0.678529226169352	222	11	0.0221774193548387	496	10287	1577,874,1594,54498,9420,2730,1591,1581,1551,1586,27233	CYP3A5,CBR3,CYP27B1,SMOX,CYP7B1,GCLM,CYP24A1,CYP7A1,CYP3A7,CYP17A1,SULT1C4
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.508537076742084	-0.676217152204548	35	2	0.00403225806451613	496	10287	2986,5957	GUCY2F,RCVRN
R-HSA-6804757	Regulation of TP53 Degradation	0.508537076742084	-0.676217152204548	35	2	0.00403225806451613	496	10287	6446,8900	SGK1,CCNA1
R-HSA-5578775	Ion homeostasis	0.511088537503901	-0.671212440569743	56	3	0.00604838709677419	496	10287	6547,3710,490	SLC8A3,ITPR3,ATP2B1
R-HSA-69541	Stabilization of p53	0.511088537503901	-0.671212440569743	56	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.511088537503901	-0.671212440569743	56	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	0.511088537503901	-0.671212440569743	56	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.512685498797017	-0.668092684585037	77	4	0.00806451612903226	496	10287	8900,5699,5721,5698	CCNA1,PSMB10,PSME2,PSMB9
R-HSA-69304	Regulation of DNA replication	0.512685498797017	-0.668092684585037	77	4	0.00806451612903226	496	10287	5698,5721,8900,5699	PSMB9,PSME2,CCNA1,PSMB10
R-HSA-69206	G1/S Transition	0.515063878370451	-0.663464350339409	119	6	0.0120967741935484	496	10287	595,5721,5698,5699,8900,23649	CCND1,PSME2,PSMB9,PSMB10,CCNA1,POLA2
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.523095974840762	-0.647990323453067	57	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-3000178	ECM proteoglycans	0.523095974840762	-0.647990323453067	57	3	0.00604838709677419	496	10287	3687,63923,375790	ITGAX,TNN,AGRN
R-HSA-167021	PLC-gamma1 signalling	0.523728394248071	-0.646782060629001	36	2	0.00403225806451613	496	10287	4803,3710	NGF,ITPR3
R-HSA-2514856	The phototransduction cascade	0.523728394248071	-0.646782060629001	36	2	0.00403225806451613	496	10287	2986,5957	GUCY2F,RCVRN
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	7474	WNT5A
R-HSA-5682910	LGI-ADAM interactions	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	55203	LGI2
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	637	BID
R-HSA-205043	NRIF signals cell death from the nucleus	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	4803	NGF
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-69183	Processive synthesis on the lagging strand	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-975577	N-Glycan antennae elongation	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	6484	ST3GAL4
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	4233	MET
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.523733669013909	-0.646771989112287	15	1	0.00201612903225806	496	10287	27289	RND1
R-HSA-1483255	PI Metabolism	0.533073455012546	-0.629096050029357	79	4	0.00806451612903226	496	10287	25816,660,9108,8503	TNFAIP8,BMX,MTMR7,PIK3R3
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.534940346636273	-0.62560003991734	58	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-419037	NCAM1 interactions	0.538600756958556	-0.618780693186844	37	2	0.00403225806451613	496	10287	375790,2668	AGRN,GDNF
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.538600756958556	-0.618780693186844	37	2	0.00403225806451613	496	10287	9507,56999	ADAMTS4,ADAMTS9
R-HSA-453279	Mitotic G1-G1/S phases	0.538786341709483	-0.618436184229957	143	7	0.0141129032258065	496	10287	8900,23649,5699,595,5721,5698,1030	CCNA1,POLA2,PSMB10,CCND1,PSME2,PSMB9,CDKN2B
R-HSA-194840	Rho GTPase cycle	0.538786341709483	-0.618436184229957	143	7	0.0141129032258065	496	10287	171177,9938,5880,116984,26230,83478,343578	RHOV,ARHGAP25,RAC2,ARAP2,TIAM2,ARHGAP24,ARHGAP40
R-HSA-373760	L1CAM interactions	0.540998957009551	-0.614337928031136	101	5	0.0100806451612903	496	10287	286,2048,214,8828,6708	ANK1,EPHB2,ALCAM,NRP2,SPTA1
R-HSA-4641258	Degradation of DVL	0.546616489072046	-0.604007839327648	59	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-549132	Organic cation/anion/zwitterion transport	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	6580	SLC22A1
R-HSA-159418	Recycling of bile acids and salts	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	8714	ABCC3
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	330	BIRC3
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	135	ADORA2A
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	5277	PIGA
R-HSA-392517	Rap1 signalling	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	10125	RASGRP1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	3656	IRAK2
R-HSA-5218859	Regulated Necrosis	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	330	BIRC3
R-HSA-1433559	Regulation of KIT signaling	0.546730952899443	-0.603798456978686	16	1	0.00201612903225806	496	10287	4067	LYN
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.553030597160728	-0.592341949585846	81	4	0.00806451612903226	496	10287	5721,5698,5699,8900	PSME2,PSMB9,PSMB10,CCNA1
R-HSA-5655302	Signaling by FGFR1 in disease	0.553149555106288	-0.592126870792803	38	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.553149555106288	-0.592126870792803	38	2	0.00403225806451613	496	10287	150,10125	ADRA2A,RASGRP1
R-HSA-1989781	PPARA activates gene expression	0.555752478483113	-0.587432266439069	124	6	0.0120967741935484	496	10287	7296,27242,1581,26230,50486,85441	TXNRD1,TNFRSF21,CYP7A1,TIAM2,G0S2,HELZ2
R-HSA-983712	Ion channel transport	0.556350073710518	-0.586357553888964	209	10	0.0201612903225806	496	10287	6338,8989,23327,490,338440,55879,245973,50617,266675,6446	SCNN1B,TRPA1,NEDD4L,ATP2B1,ANO9,GABRQ,ATP6V1C2,ATP6V0A4,BEST4,SGK1
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.558119771339447	-0.583181695656045	60	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.558119771339447	-0.583181695656045	60	3	0.00604838709677419	496	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.56283828185067	-0.574762935709286	82	4	0.00806451612903226	496	10287	7296,7295,54541,8626	TXNRD1,TXN,DDIT4,TP63
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.565922568827344	-0.569298014329473	253	12	0.0241935483870968	496	10287	2182,2181,80168,85441,50486,51703,1581,26230,27242,79993,2710,7296	ACSL4,ACSL3,MOGAT2,HELZ2,G0S2,ACSL5,CYP7A1,TIAM2,TNFRSF21,ELOVL7,GK,TXNRD1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.567371361785276	-0.566741230589537	39	2	0.00403225806451613	496	10287	4067,3710	LYN,ITPR3
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.567371361785276	-0.566741230589537	39	2	0.00403225806451613	496	10287	2918,2914	GRM8,GRM4
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.567371361785276	-0.566741230589537	39	2	0.00403225806451613	496	10287	56999,9507	ADAMTS9,ADAMTS4
R-HSA-69231	Cyclin D associated events in G1	0.567371361785276	-0.566741230589537	39	2	0.00403225806451613	496	10287	1030,595	CDKN2B,CCND1
R-HSA-69236	G1 Phase	0.567371361785276	-0.566741230589537	39	2	0.00403225806451613	496	10287	595,1030	CCND1,CDKN2B
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.567371361785276	-0.566741230589537	39	2	0.00403225806451613	496	10287	660,5317	BMX,PKP1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	4629	MYH11
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	3656	IRAK2
R-HSA-622312	Inflammasomes	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	7295	TXN
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	80852	GRIP2
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-5625900	RHO GTPases activate CIT	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	4629	MYH11
R-HSA-189445	Metabolism of porphyrins	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	3162	HMOX1
R-HSA-435354	Zinc transporters	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	64116	SLC39A8
R-HSA-432142	Platelet sensitization by LDL	0.568619906992851	-0.564543069838431	17	1	0.00201612903225806	496	10287	2268	FGR
R-HSA-71387	Metabolism of carbohydrates	0.569257690738251	-0.563422063829594	296	14	0.0282258064516129	496	10287	3038,6482,50515,375790,9435,3036,669,6513,3099,6484,960,231,6385,1118	HAS3,ST3GAL1,CHST11,AGRN,CHST2,HAS1,BPGM,SLC2A1,HK2,ST3GAL4,CD44,AKR1B1,SDC4,CHIT1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.569446072889026	-0.563091192608278	61	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-4086398	Ca2+ pathway	0.569446072889026	-0.563091192608278	61	3	0.00604838709677419	496	10287	3710,7474,51176	ITPR3,WNT5A,LEF1
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	0.569446072889026	-0.563091192608278	61	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.569446072889026	-0.563091192608278	61	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.569446072889026	-0.563091192608278	61	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.57252760938356	-0.557694318719093	83	4	0.00806451612903226	496	10287	51176,5698,5721,5699	LEF1,PSMB9,PSME2,PSMB10
R-HSA-71291	Metabolism of amino acids and derivatives	0.576439763989396	-0.550884430439935	361	17	0.0342741935483871	496	10287	259307,5699,1644,7296,54498,2730,5698,5721,58472,6534,6303,6611,6999,3620,8140,8564,8942	IL4I1,PSMB10,DDC,TXNRD1,SMOX,GCLM,PSMB9,PSME2,SQOR,SLC6A7,SAT1,SMS,TDO2,IDO1,SLC7A5,KMO,KYNU
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.579394272094781	-0.545772079621225	127	6	0.0120967741935484	496	10287	85441,50486,7296,26230,1581,27242	HELZ2,G0S2,TXNRD1,TIAM2,CYP7A1,TNFRSF21
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.581263830139923	-0.542550528574525	40	2	0.00403225806451613	496	10287	4435,163732	CITED1,CITED4
R-HSA-5654741	Signaling by FGFR3	0.581263830139923	-0.542550528574525	40	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-196757	Metabolism of folate and pterines	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	441024	MTHFD2L
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	6484	ST3GAL4
R-HSA-209776	Amine-derived hormones	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	1644	DDC
R-HSA-1369062	ABC transporters in lipid homeostasis	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	26154	ABCA12
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	330	BIRC3
R-HSA-69205	G1/S-Specific Transcription	0.589453843322341	-0.528558860081457	18	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.591553667479532	-0.525002868522236	63	3	0.00604838709677419	496	10287	6482,9945,6484	ST3GAL1,GFPT2,ST3GAL4
R-HSA-5654743	Signaling by FGFR4	0.59482559743989	-0.519487029949082	41	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-68874	M/G1 Transition	0.600856742383922	-0.509398738278248	86	4	0.00806451612903226	496	10287	5699,23649,5721,5698	PSMB10,POLA2,PSME2,PSMB9
R-HSA-69002	DNA Replication Pre-Initiation	0.600856742383922	-0.509398738278248	86	4	0.00806451612903226	496	10287	23649,5699,5721,5698	POLA2,PSMB10,PSME2,PSMB9
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.602329068626623	-0.506951357393062	64	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-373752	Netrin-1 signaling	0.608056196084848	-0.497487973516021	42	2	0.00403225806451613	496	10287	137970,9353	UNC5D,SLIT2
R-HSA-3928662	EPHB-mediated forward signaling	0.608056196084848	-0.497487973516021	42	2	0.00403225806451613	496	10287	2048,4067	EPHB2,LYN
R-HSA-156584	Cytosolic sulfonation of small molecules	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	27233	SULT1C4
R-HSA-3928664	Ephrin signaling	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	2048	EPHB2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	2247	FGF2
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	25946	ZNF385A
R-HSA-416700	Other semaphorin interactions	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	80031	SEMA6D
R-HSA-190861	Gap junction assembly	0.609283514525906	-0.495471578509433	19	1	0.00201612903225806	496	10287	2706	GJB2
R-HSA-1430728	Metabolism	0.60994423278595	-0.494387747656372	2158	102	0.205645161290323	496	10287	1594,857,84879,3290,660,6716,51365,1646,952,57089,8714,7296,150,259307,960,10135,242,81894,2643,2181,4082,6513,9435,6611,247,7498,3162,80736,6580,5721,3638,54625,6385,1645,874,51703,26230,2730,5743,1644,2182,8140,441024,85441,50486,272,4363,119548,3620,79993,9023,6534,6484,9536,9388,5698,441282,3036,1586,50515,375790,1890,1581,1591,5699,8942,3099,51733,2642,9108,6303,4023,2710,25816,11343,58472,8876,1118,130367,80168,29923,669,27233,8503,3038,7295,771,54498,6482,9420,51700,117283,8875,8564,231,3710,1577,6616,4504,1551,27242,6999	CYP27B1,CAV1,MFSD2A,HSD11B1,BMX,SRD5A2,PLA1A,AKR1C2,CD38,ENTPD7,ABCC3,TXNRD1,ADRA2A,IL4I1,CD44,NAMPT,ALOX12B,SLC25A28,GCH1,ACSL3,MARCKS,SLC2A1,CHST2,SMS,ALOX15B,XDH,HMOX1,SLC44A4,SLC22A1,PSME2,INSIG1,PARP14,SDC4,AKR1C1,CBR3,ACSL5,TIAM2,GCLM,PTGS2,DDC,ACSL4,SLC7A5,MTHFD2L,HELZ2,G0S2,AMPD3,ABCC1,PNLIPRP3,IDO1,ELOVL7,CH25H,SLC6A7,ST3GAL4,PTGES,LIPG,PSMB9,AKR1B15,HAS1,CYP17A1,CHST11,AGRN,TYMP,CYP7A1,CYP24A1,PSMB10,KYNU,HK2,UPB1,GCGR,MTMR7,SAT1,LPL,GK,TNFAIP8,MGLL,SQOR,VNN1,CHIT1,SGPP2,MOGAT2,HILPDA,BPGM,SULT1C4,PIK3R3,HAS3,TXN,CA12,SMOX,ST3GAL1,CYP7B1,CYB5R2,IP6K3,VNN2,KMO,AKR1B1,ITPR3,CYP3A5,SNAP25,MT3,CYP3A7,TNFRSF21,TDO2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.610045174197813	-0.494222268494806	87	4	0.00806451612903226	496	10287	5698,5721,8900,5699	PSMB9,PSME2,CCNA1,PSMB10
R-HSA-453276	Regulation of mitotic cell cycle	0.610045174197813	-0.494222268494806	87	4	0.00806451612903226	496	10287	8900,5699,5698,5721	CCNA1,PSMB10,PSMB9,PSME2
R-HSA-416482	G alpha (12/13) signalling events	0.619102728760434	-0.479484060841992	88	4	0.00806451612903226	496	10287	26230,5880,8503,147	TIAM2,RAC2,PIK3R3,ADRA1B
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.619102728760434	-0.479484060841992	88	4	0.00806451612903226	496	10287	688,85441,4790,4023	KLF5,HELZ2,NFKB1,LPL
R-HSA-446728	Cell junction organization	0.619102728760434	-0.479484060841992	88	4	0.00806451612903226	496	10287	3918,3914,1000,5818	LAMC2,LAMB3,CDH2,NECTIN1
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.620955970696882	-0.476495100211371	43	2	0.00403225806451613	496	10287	9628,6000	RGS6,RGS7
R-HSA-1236394	Signaling by ERBB4	0.620955970696882	-0.476495100211371	43	2	0.00403225806451613	496	10287	2069,1839	EREG,HBEGF
R-HSA-5655253	Signaling by FGFR2 in disease	0.620955970696882	-0.476495100211371	43	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.628157236469732	-0.464964767308755	20	1	0.00201612903225806	496	10287	4233	MET
R-HSA-69186	Lagging Strand Synthesis	0.628157236469732	-0.464964767308755	20	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.631207630058015	-0.460120421345437	373	17	0.0342741935483871	496	10287	23327,84676,221687,10517,5721,1520,5698,7097,6891,55521,5699,55008,4688,255488,127544,6890,92369	NEDD4L,TRIM63,RNF182,FBXW10,PSME2,CTSS,PSMB9,TLR2,TAP2,TRIM36,PSMB10,HERC6,NCF2,RNF144B,RNF19B,TAP1,SPSB4
R-HSA-8848021	Signaling by PTK6	0.633515191837708	-0.456471298707044	67	3	0.00604838709677419	496	10287	1839,595,2069	HBEGF,CCND1,EREG
R-HSA-5358346	Hedgehog ligand biogenesis	0.633515191837708	-0.456471298707044	67	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.633515191837708	-0.456471298707044	67	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-1296072	Voltage gated Potassium channels	0.633526001259441	-0.456454236244053	44	2	0.00403225806451613	496	10287	3788,131096	KCNS2,KCNH8
R-HSA-5687128	MAPK6/MAPK4 signaling	0.63681821308546	-0.451271043910178	90	4	0.00806451612903226	496	10287	3725,5698,5721,5699	JUN,PSMB9,PSME2,PSMB10
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.643525442370323	-0.440793715244521	68	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	50515	CHST11
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	54567	DLL4
R-HSA-3000480	Scavenging by Class A Receptors	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	2495	FTH1
R-HSA-8849932	SALM protein interactions at the synapses	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	57497	LRFN2
R-HSA-2028269	Signaling by Hippo	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	23286	WWC1
R-HSA-6807004	Negative regulation of MET activity	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	4233	MET
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	4363	ABCC1
R-HSA-5423646	Aflatoxin activation and detoxification	0.646121004918511	-0.436768478625292	21	1	0.00201612903225806	496	10287	1577	CYP3A5
R-HSA-6806834	Signaling by MET	0.653341470375021	-0.425655360847598	69	3	0.00604838709677419	496	10287	3914,3918,4233	LAMB3,LAMC2,MET
R-HSA-68867	Assembly of the pre-replicative complex	0.653341470375021	-0.425655360847598	69	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-381119	Unfolded Protein Response (UPR)	0.653991324026494	-0.424661193627468	92	4	0.00806451612903226	496	10287	467,3484,3576,6347	ATF3,IGFBP1,CXCL8,CCL2
R-HSA-70153	Glucose transport	0.657684403217977	-0.419030093084073	46	2	0.00403225806451613	496	10287	3099,6513	HK2,SLC2A1
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.657684403217977	-0.419030093084073	46	2	0.00403225806451613	496	10287	23327,1030	NEDD4L,CDKN2B
R-HSA-5658442	Regulation of RAS by GAPs	0.662962771101646	-0.411036442557413	70	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.662962771101646	-0.411036442557413	70	3	0.00604838709677419	496	10287	169044,1305,1294	COL22A1,COL13A1,COL7A1
R-HSA-198753	ERK/MAPK targets	0.663218606859904	-0.410650619372617	22	1	0.00201612903225806	496	10287	1848	DUSP6
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.663218606859904	-0.410650619372617	22	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-1482801	Acyl chain remodelling of PS	0.663218606859904	-0.410650619372617	22	1	0.00201612903225806	496	10287	51365	PLA1A
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.663218606859904	-0.410650619372617	22	1	0.00201612903225806	496	10287	4363	ABCC1
R-HSA-400253	Circadian Clock	0.672389140901064	-0.396918027338549	71	3	0.00604838709677419	496	10287	56938,10135,85441	ARNTL2,NAMPT,HELZ2
R-HSA-6809371	Formation of the cornified envelope	0.672389140901064	-0.396918027338549	71	3	0.00604838709677419	496	10287	5266,5317,2312	PI3,PKP1,FLG
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.679491726305246	-0.386410221616288	23	1	0.00201612903225806	496	10287	2847	MCHR1
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.679491726305246	-0.386410221616288	23	1	0.00201612903225806	496	10287	6616	SNAP25
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.679491726305246	-0.386410221616288	23	1	0.00201612903225806	496	10287	23327	NEDD4L
R-HSA-5627123	RHO GTPases activate PAKs	0.679491726305246	-0.386410221616288	23	1	0.00201612903225806	496	10287	4629	MYH11
R-HSA-389948	PD-1 signaling	0.679491726305246	-0.386410221616288	23	1	0.00201612903225806	496	10287	29126	CD274
R-HSA-5365859	RA biosynthesis pathway	0.679491726305246	-0.386410221616288	23	1	0.00201612903225806	496	10287	195814	SDR16C5
R-HSA-948021	Transport to the Golgi and subsequent modification	0.682999501094752	-0.381261149873177	164	7	0.0141129032258065	496	10287	4121,6708,1294,374,286,1604,6484	MAN1A1,SPTA1,COL7A1,AREG,ANK1,CD55,ST3GAL4
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.690657670648236	-0.370110989478911	73	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.694980045060989	-0.363872145972008	24	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.694980045060989	-0.363872145972008	24	1	0.00201612903225806	496	10287	330	BIRC3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.702157730558528	-0.353597212789449	50	2	0.00403225806451613	496	10287	8503,660	PIK3R3,BMX
R-HSA-982772	Growth hormone receptor signaling	0.709721338797163	-0.342882866554809	25	1	0.00201612903225806	496	10287	4067	LYN
R-HSA-162588	Budding and maturation of HIV virion	0.709721338797163	-0.342882866554809	25	1	0.00201612903225806	496	10287	23327	NEDD4L
R-HSA-1538133	G0 and Early G1	0.709721338797163	-0.342882866554809	25	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.709721338797163	-0.342882866554809	25	1	0.00201612903225806	496	10287	1848	DUSP6
R-HSA-3295583	TRP channels	0.709721338797163	-0.342882866554809	25	1	0.00201612903225806	496	10287	8989	TRPA1
R-HSA-182971	EGFR downregulation	0.709721338797163	-0.342882866554809	25	1	0.00201612903225806	496	10287	10252	SPRY1
R-HSA-390466	Chaperonin-mediated protein folding	0.709727088265408	-0.342874765565529	99	4	0.00806451612903226	496	10287	10517,9628,6000,10471	FBXW10,RGS6,RGS7,PFDN6
R-HSA-383280	Nuclear Receptor transcription pathway	0.712497789857189	-0.338978468798965	51	2	0.00403225806451613	496	10287	8013,4929	NR4A3,NR4A2
R-HSA-418555	G alpha (s) signalling events	0.712514260627135	-0.33895535212435	146	6	0.0120967741935484	496	10287	9340,134864,53831,135,2642,5142	GLP2R,TAAR1,GPR84,ADORA2A,GCGR,PDE4B
R-HSA-112316	Neuronal System	0.71496327117733	-0.335524106590316	349	15	0.030241935483871	496	10287	131096,9228,57497,9378,9369,3788,3779,80852,9456,56666,6616,6506,6580,55879,3783	KCNH8,DLGAP2,LRFN2,NRXN1,NRXN3,KCNS2,KCNMB1,GRIP2,HOMER1,PANX2,SNAP25,SLC1A2,SLC22A1,GABRQ,KCNN4
R-HSA-1296071	Potassium Channels	0.717129854439397	-0.332498346775854	100	4	0.00806451612903226	496	10287	3788,3779,131096,3783	KCNS2,KCNMB1,KCNH8,KCNN4
R-HSA-445717	Aquaporin-mediated transport	0.722535647875905	-0.324988520592079	52	2	0.00403225806451613	496	10287	366,4645	AQP9,MYO5B
R-HSA-975298	Ligand-gated ion channel transport	0.723751568371183	-0.323307083090465	26	1	0.00201612903225806	496	10287	55879	GABRQ
R-HSA-2029485	Role of phospholipids in phagocytosis	0.723751568371183	-0.323307083090465	26	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.723751568371183	-0.323307083090465	26	1	0.00201612903225806	496	10287	6484	ST3GAL4
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.723751568371183	-0.323307083090465	26	1	0.00201612903225806	496	10287	7474	WNT5A
R-HSA-912694	Regulation of IFNA signaling	0.723751568371183	-0.323307083090465	26	1	0.00201612903225806	496	10287	3455	IFNAR2
R-HSA-2262749	Cellular response to hypoxia	0.724875899551918	-0.321754811811075	77	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.724875899551918	-0.321754811811075	77	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.732953682595494	-0.310672767911228	78	3	0.00604838709677419	496	10287	6484,9945,6482	ST3GAL4,GFPT2,ST3GAL1
R-HSA-2559580	Oxidative Stress Induced Senescence	0.733231596147303	-0.310293670454491	126	5	0.0100806451612903	496	10287	7295,1030,3725,723790,23135	TXN,CDKN2B,JUN,HIST2H2AA4,KDM6B
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.737104966888169	-0.305024972391243	27	1	0.00201612903225806	496	10287	23327	NEDD4L
R-HSA-180024	DARPP-32 events	0.737104966888169	-0.305024972391243	27	1	0.00201612903225806	496	10287	5142	PDE4B
R-HSA-6807878	COPI-mediated anterograde transport	0.74084369159935	-0.29996561844855	79	3	0.00604838709677419	496	10287	286,1604,6708	ANK1,CD55,SPTA1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.741725127502815	-0.298776552557022	54	2	0.00403225806451613	496	10287	375790,6385	AGRN,SDC4
R-HSA-189200	Hexose transport	0.741725127502815	-0.298776552557022	54	2	0.00403225806451613	496	10287	6513,3099	SLC2A1,HK2
R-HSA-190828	Gap junction trafficking	0.749814122483377	-0.287929939857199	28	1	0.00201612903225806	496	10287	2706	GJB2
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.749814122483377	-0.287929939857199	28	1	0.00201612903225806	496	10287	10125	RASGRP1
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.749814122483377	-0.287929939857199	28	1	0.00201612903225806	496	10287	150	ADRA2A
R-HSA-5576893	Phase 2 - plateau phase	0.749814122483377	-0.287929939857199	28	1	0.00201612903225806	496	10287	23630	KCNE5
R-HSA-174800	Chylomicron-mediated lipid transport	0.749814122483377	-0.287929939857199	28	1	0.00201612903225806	496	10287	4023	LPL
R-HSA-1368082	RORA activates gene expression	0.749814122483377	-0.287929939857199	28	1	0.00201612903225806	496	10287	85441	HELZ2
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.750887443476829	-0.28649951398065	55	2	0.00403225806451613	496	10287	3638,85441	INSIG1,HELZ2
R-HSA-391251	Protein folding	0.75205924506762	-0.284940174800941	105	4	0.00806451612903226	496	10287	9628,10517,10471,6000	RGS6,FBXW10,PFDN6,RGS7
R-HSA-5689603	UCH proteinases	0.75205924506762	-0.284940174800941	105	4	0.00806451612903226	496	10287	723790,5721,5698,5699	HIST2H2AA4,PSME2,PSMB9,PSMB10
R-HSA-525793	Myogenesis	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	1000	CDH2
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	54514	DDX4
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	10471	PFDN6
R-HSA-375170	CDO in myogenesis	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	1000	CDH2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	3055	HCK
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	85441	HELZ2
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.761910057289393	-0.271926765315466	29	1	0.00201612903225806	496	10287	857	CAV1
R-HSA-2262752	Cellular responses to stress	0.762711286523437	-0.270875711804958	451	19	0.0383064516129032	496	10287	6648,3576,23135,3159,1030,3008,3569,4790,3725,3552,8091,5721,5698,7295,5699,7296,8900,723790,4688	SOD2,CXCL8,KDM6B,HMGA1,CDKN2B,HIST1H1E,IL6,NFKB1,JUN,IL1A,HMGA2,PSME2,PSMB9,TXN,PSMB10,TXNRD1,CCNA1,HIST2H2AA4,NCF2
R-HSA-114608	Platelet degranulation	0.769424607161474	-0.262112306901549	132	5	0.0100806451612903	496	10287	5004,7273,5005,5552,5341	ORM1,TTN,ORM2,SRGN,PLEK
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.769760510905769	-0.261675837310353	156	6	0.0120967741935484	496	10287	23764,10938,3659,55619,9732,4602	MAFF,EHD1,IRF1,DOCK10,DOCK4,MYB
R-HSA-157858	Gap junction trafficking and regulation	0.773422302524504	-0.256930063239324	30	1	0.00201612903225806	496	10287	2706	GJB2
R-HSA-199977	ER to Golgi Anterograde Transport	0.775078367111095	-0.254791135887931	133	5	0.0100806451612903	496	10287	1604,286,1294,374,6708	CD55,ANK1,COL7A1,AREG,SPTA1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.776712130113348	-0.252685486177074	58	2	0.00403225806451613	496	10287	10046,54567	MAMLD1,DLL4
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.776712130113348	-0.252685486177074	58	2	0.00403225806451613	496	10287	10046,54567	MAMLD1,DLL4
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.776712130113348	-0.252685486177074	58	2	0.00403225806451613	496	10287	10046,54567	MAMLD1,DLL4
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.776712130113348	-0.252685486177074	58	2	0.00403225806451613	496	10287	54567,10046	DLL4,MAMLD1
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.776712130113348	-0.252685486177074	58	2	0.00403225806451613	496	10287	10046,54567	MAMLD1,DLL4
R-HSA-162909	Host Interactions of HIV factors	0.780625570882364	-0.247659666788084	134	5	0.0100806451612903	496	10287	3055,5699,3159,5698,5721	HCK,PSMB10,HMGA1,PSMB9,PSME2
R-HSA-3700989	Transcriptional Regulation by TP53	0.782363476286067	-0.245435842989614	367	15	0.030241935483871	496	10287	5366,10769,27113,1263,7832,3725,6446,8626,25946,637,8900,639,7296,54541,7295	PMAIP1,PLK2,BBC3,PLK3,BTG2,JUN,SGK1,TP63,ZNF385A,BID,CCNA1,PRDM1,TXNRD1,DDIT4,TXN
R-HSA-180786	Extension of Telomeres	0.784378969968512	-0.242862995360359	31	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-1483257	Phospholipid metabolism	0.78742511323836	-0.238987007104593	207	8	0.0161290322580645	496	10287	660,84879,11343,25816,80736,8503,51365,9108	BMX,MFSD2A,MGLL,TNFAIP8,SLC44A4,PIK3R3,PLA1A,MTMR7
R-HSA-5632684	Hedgehog 'on' state	0.790980865855826	-0.234481501322705	86	3	0.00604838709677419	496	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-597592	Post-translational protein modification	0.792119969199952	-0.233042422376516	1034	45	0.0907258064516129	496	10287	5721,374,84101,10318,8876,79623,51301,4792,154064,286,6482,8900,8875,64135,23586,6708,10164,56999,8767,5698,1294,50614,219333,6484,330,8313,79931,1080,64127,1604,723790,90865,5699,27076,10071,4586,5329,9945,4121,9507,1540,124872,5277,8975,7128	PSME2,AREG,USP44,TNIP1,VNN1,GALNT14,GCNT4,NFKBIA,RAET1L,ANK1,ST3GAL1,CCNA1,VNN2,IFIH1,DDX58,SPTA1,CHST4,ADAMTS9,RIPK2,PSMB9,COL7A1,GALNT9,USP12,ST3GAL4,BIRC3,AXIN2,TNIP3,CFTR,NOD2,CD55,HIST2H2AA4,IL33,PSMB10,LYPD3,MUC12,MUC5AC,PLAUR,GFPT2,MAN1A1,ADAMTS4,CYLD,B4GALNT2,PIGA,USP13,TNFAIP3
R-HSA-193648	NRAGE signals death through JNK	0.792601726528827	-0.23243441991777	60	2	0.00403225806451613	496	10287	4803,26230	NGF,TIAM2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	2151	F2RL2
R-HSA-68962	Activation of the pre-replicative complex	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	23649	POLA2
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	857	CAV1
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	80852	GRIP2
R-HSA-2559585	Oncogene Induced Senescence	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	1030	CDKN2B
R-HSA-70171	Glycolysis	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	3099	HK2
R-HSA-399719	Trafficking of AMPA receptors	0.794806820098842	-0.229656187441892	32	1	0.00201612903225806	496	10287	80852	GRIP2
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.796635332281712	-0.227358255362168	137	5	0.0100806451612903	496	10287	5004,7273,5552,5005,5341	ORM1,TTN,SRGN,ORM2,PLEK
R-HSA-5633007	Regulation of TP53 Activity	0.799797199923702	-0.223397083546162	162	6	0.0120967741935484	496	10287	1263,639,8900,8626,25946,6446	PLK3,PRDM1,CCNA1,TP63,ZNF385A,SGK1
R-HSA-421270	Cell-cell junction organization	0.800166324967351	-0.222935666714522	61	2	0.00403225806451613	496	10287	5818,1000	NECTIN1,CDH2
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.804731326908699	-0.217246812665222	33	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.804731326908699	-0.217246812665222	33	1	0.00201612903225806	496	10287	2642	GCGR
R-HSA-202433	Generation of second messenger molecules	0.804731326908699	-0.217246812665222	33	1	0.00201612903225806	496	10287	3937	LCP2
R-HSA-190236	Signaling by FGFR	0.80986661719131	-0.210885715009453	89	3	0.00604838709677419	496	10287	23767,2247,26281	FLRT3,FGF2,FGF20
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.814176739593142	-0.205577811740476	34	1	0.00201612903225806	496	10287	1030	CDKN2B
R-HSA-5656169	Termination of translesion DNA synthesis	0.814176739593142	-0.205577811740476	34	1	0.00201612903225806	496	10287	9636	ISG15
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.814176739593142	-0.205577811740476	34	1	0.00201612903225806	496	10287	23327	NEDD4L
R-HSA-1489509	DAG and IP3 signaling	0.814176739593142	-0.205577811740476	34	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.814176739593142	-0.205577811740476	34	1	0.00201612903225806	496	10287	10471	PFDN6
R-HSA-390522	Striated Muscle Contraction	0.814176739593142	-0.205577811740476	34	1	0.00201612903225806	496	10287	7273	TTN
R-HSA-1226099	Signaling by FGFR in disease	0.814565208571845	-0.205100794510697	63	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-6805567	Keratinization	0.816570709754058	-0.202641769275272	214	8	0.0161290322580645	496	10287	3849,9119,5317,5266,2312,3855,3854,3868	KRT2,KRT75,PKP1,PI3,FLG,KRT7,KRT6B,KRT16
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.821641552114489	-0.196451047018491	91	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.821641552114489	-0.196451047018491	91	3	0.00604838709677419	496	10287	8313,723790,51176	AXIN2,HIST2H2AA4,LEF1
R-HSA-4791275	Signaling by WNT in cancer	0.823166141455688	-0.194597225706999	35	1	0.00201612903225806	496	10287	27121	DKK4
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.825491068901119	-0.191776834697902	311	12	0.0241935483870968	496	10287	92369,5699,55521,55008,255488,5721,10517,5698,127544,23327,84676,221687	SPSB4,PSMB10,TRIM36,HERC6,RNF144B,PSME2,FBXW10,PSMB9,RNF19B,NEDD4L,TRIM63,RNF182
R-HSA-445355	Smooth Muscle Contraction	0.831721505666939	-0.184257622960805	36	1	0.00201612903225806	496	10287	4629	MYH11
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.831721505666939	-0.184257622960805	36	1	0.00201612903225806	496	10287	644150	WIPF3
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.831721505666939	-0.184257622960805	36	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.831721505666939	-0.184257622960805	36	1	0.00201612903225806	496	10287	3159	HMGA1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.831721505666939	-0.184257622960805	36	1	0.00201612903225806	496	10287	2247	FGF2
R-HSA-5689901	Metalloprotease DUBs	0.847612780955604	-0.165331373707338	38	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-156590	Glutathione conjugation	0.847612780955604	-0.165331373707338	38	1	0.00201612903225806	496	10287	2730	GCLM
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.852350480061731	-0.159757475163997	69	2	0.00403225806451613	496	10287	374,1294	AREG,COL7A1
R-HSA-5663202	Diseases of signal transduction	0.860033886719214	-0.150783487348991	370	14	0.0282258064516129	496	10287	2069,26281,27121,1839,5721,941,5698,64220,2247,54567,10046,5699,8503,4233	EREG,FGF20,DKK4,HBEGF,PSME2,CD80,PSMB9,STRA6,FGF2,DLL4,MAMLD1,PSMB10,PIK3R3,MET
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.8620061121752	-0.148492917653095	40	1	0.00201612903225806	496	10287	10517	FBXW10
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.8620061121752	-0.148492917653095	40	1	0.00201612903225806	496	10287	9636	ISG15
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.868685625030789	-0.14077398553271	41	1	0.00201612903225806	496	10287	9636	ISG15
R-HSA-5610787	Hedgehog 'off' state	0.871581931544496	-0.137445406341672	101	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-3214841	PKMTs methylate histone lysines	0.873498566503324	-0.135248790504594	73	2	0.00403225806451613	496	10287	4790,4791	NFKB1,NFKB2
R-HSA-1461957	Beta defensins	0.875042440381755	-0.133482890507335	42	1	0.00201612903225806	496	10287	7097	TLR2
R-HSA-168253	Host Interactions with Influenza Factors	0.875042440381755	-0.133482890507335	42	1	0.00201612903225806	496	10287	9636	ISG15
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.875042440381755	-0.133482890507335	42	1	0.00201612903225806	496	10287	85441	HELZ2
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.875042440381755	-0.133482890507335	42	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-1483206	Glycerophospholipid biosynthesis	0.87522432220306	-0.133275057249174	129	4	0.00806451612903226	496	10287	80736,84879,51365,11343	SLC44A4,MFSD2A,PLA1A,MGLL
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.881092118229559	-0.126593097525063	43	1	0.00201612903225806	496	10287	4645	MYO5B
R-HSA-5362517	Signaling by Retinoic Acid	0.881092118229559	-0.126593097525063	43	1	0.00201612903225806	496	10287	195814	SDR16C5
R-HSA-5654738	Signaling by FGFR2	0.882994333482524	-0.124436495745853	75	2	0.00403225806451613	496	10287	2247,26281	FGF2,FGF20
R-HSA-446203	Asparagine N-linked glycosylation	0.884703437864729	-0.122502788590175	284	10	0.0201612903225806	496	10287	6482,286,1604,124872,4121,6708,374,1294,6484,9945	ST3GAL1,ANK1,CD55,B4GALNT2,MAN1A1,SPTA1,AREG,COL7A1,ST3GAL4,GFPT2
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.88684946978917	-0.120080018189242	44	1	0.00201612903225806	496	10287	130367	SGPP2
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.887491241391193	-0.119356626536257	76	2	0.00403225806451613	496	10287	23586,9636	DDX58,ISG15
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.887491241391193	-0.119356626536257	76	2	0.00403225806451613	496	10287	26230,4803	TIAM2,NGF
R-HSA-1169408	ISG15 antiviral mechanism	0.887491241391193	-0.119356626536257	76	2	0.00403225806451613	496	10287	9636,23586	ISG15,DDX58
R-HSA-1500931	Cell-Cell communication	0.889562730782958	-0.117025250717101	133	4	0.00806451612903226	496	10287	3914,5818,1000,3918	LAMB3,NECTIN1,CDH2,LAMC2
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.891827650493645	-0.1144823820063	77	2	0.00403225806451613	496	10287	23327,1030	NEDD4L,CDKN2B
R-HSA-6811438	Intra-Golgi traffic	0.892328593379384	-0.113920836008719	45	1	0.00201612903225806	496	10287	4121	MAN1A1
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.892328593379384	-0.113920836008719	45	1	0.00201612903225806	496	10287	85441	HELZ2
R-HSA-109704	PI3K Cascade	0.900038800314507	-0.105317405126535	79	2	0.00403225806451613	496	10287	26281,2247	FGF20,FGF2
R-HSA-3214858	RMTs methylate histone arginines	0.900038800314507	-0.105317405126535	79	2	0.00403225806451613	496	10287	723790,595	HIST2H2AA4,CCND1
R-HSA-112043	PLC beta mediated events	0.902505189480605	-0.102580838674619	47	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-1483249	Inositol phosphate metabolism	0.902505189480605	-0.102580838674619	47	1	0.00201612903225806	496	10287	117283	IP6K3
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.907227594369499	-0.097361929397277	48	1	0.00201612903225806	496	10287	10046	MAMLD1
R-HSA-112040	G-protein mediated events	0.907227594369499	-0.097361929397277	48	1	0.00201612903225806	496	10287	3710	ITPR3
R-HSA-70326	Glucose metabolism	0.907666367889767	-0.096878404146831	81	2	0.00403225806451613	496	10287	669,3099	BPGM,HK2
R-HSA-1643685	Disease	0.909051323147827	-0.0953537252898056	859	34	0.0685483870967742	496	10287	6648,6616,3055,64220,56999,10046,4233,4791,1839,5721,6385,2247,8503,4792,3159,941,4790,9507,3725,2069,7852,26281,23327,27121,5698,10071,7097,4586,7296,5699,54567,9636,1080,375790	SOD2,SNAP25,HCK,STRA6,ADAMTS9,MAMLD1,MET,NFKB2,HBEGF,PSME2,SDC4,FGF2,PIK3R3,NFKBIA,HMGA1,CD80,NFKB1,ADAMTS4,JUN,EREG,CXCR4,FGF20,NEDD4L,DKK4,PSMB9,MUC12,TLR2,MUC5AC,TXNRD1,PSMB10,DLL4,ISG15,CFTR,AGRN
R-HSA-157579	Telomere Maintenance	0.911272892170368	-0.0929128742515027	82	2	0.00403225806451613	496	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-73893	DNA Damage Bypass	0.915998512274566	-0.0877405384637301	50	1	0.00201612903225806	496	10287	9636	ISG15
R-HSA-5576891	Cardiac conduction	0.916664079226519	-0.0870141996555932	142	4	0.00806451612903226	496	10287	3710,6547,23630,490	ITPR3,SLC8A3,KCNE5,ATP2B1
R-HSA-171306	Packaging Of Telomere Ends	0.920068526731882	-0.0833071261348311	51	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-1461973	Defensins	0.920068526731882	-0.0833071261348311	51	1	0.00201612903225806	496	10287	7097	TLR2
R-HSA-111885	Opioid Signalling	0.921316403297493	-0.0819517585131119	85	2	0.00403225806451613	496	10287	5142,3710	PDE4B,ITPR3
R-HSA-3214842	HDMs demethylate histones	0.923941720427239	-0.0791062824603398	52	1	0.00201612903225806	496	10287	23135	KDM6B
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.927627593093975	-0.075124927283834	53	1	0.00201612903225806	496	10287	2847	MCHR1
R-HSA-1592230	Mitochondrial biogenesis	0.931135186784277	-0.0713508062482916	54	1	0.00201612903225806	496	10287	85441	HELZ2
R-HSA-397014	Muscle contraction	0.933166642989307	-0.0691714842344299	204	6	0.0120967741935484	496	10287	6547,7273,3710,23630,4629,490	SLC8A3,TTN,ITPR3,KCNE5,MYH11,ATP2B1
R-HSA-977443	GABA receptor activation	0.937649548381438	-0.0643790155857241	56	1	0.00201612903225806	496	10287	55879	GABRQ
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.940672305105372	-0.06116044116753	57	1	0.00201612903225806	496	10287	2495	FTH1
R-HSA-162906	HIV Infection	0.942211551819107	-0.0595254523168197	236	7	0.0141129032258065	496	10287	5699,7852,3055,5698,5721,23327,3159	PSMB10,CXCR4,HCK,PSMB9,PSME2,NEDD4L,HMGA1
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.943118081489362	-0.0585637852172294	93	2	0.00403225806451613	496	10287	8900,1263	CCNA1,PLK3
R-HSA-5625740	RHO GTPases activate PKNs	0.943118081489362	-0.0585637852172294	93	2	0.00403225806451613	496	10287	723790,4629	HIST2H2AA4,MYH11
R-HSA-936837	Ion transport by P-type ATPases	0.943548799407414	-0.0581071938285783	58	1	0.00201612903225806	496	10287	490	ATP2B1
R-HSA-5619507	Activation of HOX genes during differentiation	0.94648995138405	-0.0549949249933948	126	3	0.00604838709677419	496	10287	4211,3725,723790	MEIS1,JUN,HIST2H2AA4
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.94648995138405	-0.0549949249933948	126	3	0.00604838709677419	496	10287	4211,723790,3725	MEIS1,HIST2H2AA4,JUN
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.951369657842506	-0.0498525876067668	61	1	0.00201612903225806	496	10287	644150	WIPF3
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.955562822424371	-0.0454547692429599	99	2	0.00403225806451613	496	10287	7474,1080	WNT5A,CFTR
R-HSA-194315	Signaling by Rho GTPases	0.955587225024945	-0.0454292321579912	427	14	0.0282258064516129	496	10287	116984,4688,9938,1080,723790,171177,644150,343578,26230,23002,5880,4629,91010,83478	ARAP2,NCF2,ARHGAP25,CFTR,HIST2H2AA4,RHOV,WIPF3,ARHGAP40,TIAM2,DAAM1,RAC2,MYH11,FMNL3,ARHGAP24
R-HSA-73728	RNA Polymerase I Promoter Opening	0.955972982750209	-0.045025627051616	63	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-977225	Amyloid fiber formation	0.959098951922043	-0.0417610270211751	101	2	0.00403225806451613	496	10287	6288,723790	SAA1,HIST2H2AA4
R-HSA-5334118	DNA methylation	0.960141354160312	-0.0406747614425852	65	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.96391579426146	-0.0367513385380386	67	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-2467813	Separation of Sister Chromatids	0.964751031131581	-0.0358852097579516	168	4	0.00806451612903226	496	10287	9700,5698,5721,5699	ESPL1,PSMB9,PSME2,PSMB10
R-HSA-5358351	Signaling by Hedgehog	0.965623222214254	-0.0349815599703389	138	3	0.00604838709677419	496	10287	5699,5698,5721	PSMB10,PSMB9,PSME2
R-HSA-5663205	Infectious disease	0.966200005153105	-0.0343844215284573	388	12	0.0241935483870968	496	10287	4233,3055,9636,7296,5699,3159,23327,1839,5721,5698,7852,6616	MET,HCK,ISG15,TXNRD1,PSMB10,HMGA1,NEDD4L,HBEGF,PSME2,PSMB9,CXCR4,SNAP25
R-HSA-156580	Phase II conjugation	0.966798816404608	-0.0337648543937241	106	2	0.00403225806451613	496	10287	2730,27233	GCLM,SULT1C4
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	0.96733346343171	-0.0332119997143477	69	1	0.00201612903225806	496	10287	3725	JUN
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.96733346343171	-0.0332119997143477	69	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-69620	Cell Cycle Checkpoints	0.968627504382537	-0.031875153398682	201	5	0.0100806451612903	496	10287	5699,8900,5698,5721,25946	PSMB10,CCNA1,PSMB9,PSME2,ZNF385A
R-HSA-73886	Chromosome Maintenance	0.970728445213841	-0.0297085148776651	109	2	0.00403225806451613	496	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-774815	Nucleosome assembly	0.971863780710172	-0.0285396276449802	72	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.971863780710172	-0.0285396276449802	72	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.973229964241322	-0.0271348791495872	73	1	0.00201612903225806	496	10287	2495	FTH1
R-HSA-421837	Clathrin derived vesicle budding	0.973229964241322	-0.0271348791495872	73	1	0.00201612903225806	496	10287	2495	FTH1
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.973229964241322	-0.0271348791495872	73	1	0.00201612903225806	496	10287	5452	POU2F2
R-HSA-2299718	Condensation of Prophase Chromosomes	0.97452993856898	-0.0258000385269762	74	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-174824	Lipoprotein metabolism	0.97452993856898	-0.0258000385269762	74	1	0.00201612903225806	496	10287	4023	LPL
R-HSA-212300	PRC2 methylates histones and DNA	0.97452993856898	-0.0258000385269762	74	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-195258	RHO GTPase Effectors	0.975553028263641	-0.0247507603106858	294	8	0.0161290322580645	496	10287	23002,723790,644150,1080,4688,91010,5880,4629	DAAM1,HIST2H2AA4,WIPF3,CFTR,NCF2,FMNL3,RAC2,MYH11
R-HSA-68882	Mitotic Anaphase	0.975945714634562	-0.0243483143673819	179	4	0.00806451612903226	496	10287	9700,5698,5721,5699	ESPL1,PSMB9,PSME2,PSMB10
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.976777966116297	-0.0234959136510577	180	4	0.00806451612903226	496	10287	5699,9700,5698,5721	PSMB10,ESPL1,PSMB9,PSME2
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.976943915081757	-0.0233260338258322	76	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-69275	G2/M Transition	0.978361992284921	-0.0218755421698219	182	4	0.00806451612903226	496	10287	5699,8900,5698,5721	PSMB10,CCNA1,PSMB9,PSME2
R-HSA-5663220	RHO GTPases Activate Formins	0.979138843268286	-0.0210818249871369	117	2	0.00403225806451613	496	10287	23002,91010	DAAM1,FMNL3
R-HSA-162587	HIV Life Cycle	0.979787535980493	-0.0204195308419464	152	3	0.00604838709677419	496	10287	7852,23327,3159	CXCR4,NEDD4L,HMGA1
R-HSA-453274	Mitotic G2-G2/M phases	0.9798439821858	-0.0203619218427035	184	4	0.00806451612903226	496	10287	5699,8900,5721,5698	PSMB10,CCNA1,PSME2,PSMB9
R-HSA-1221632	Meiotic synapsis	0.980143503035858	-0.0200562863683473	79	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-112315	Transmission across Chemical Synapses	0.981474732056934	-0.018699009807978	217	5	0.0100806451612903	496	10287	55879,6580,6506,6616,80852	GABRQ,SLC22A1,SLC1A2,SNAP25,GRIP2
R-HSA-912446	Meiotic recombination	0.987319497015255	-0.0127615867472449	88	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.987936178015752	-0.0121371804708033	89	1	0.00201612903225806	496	10287	23258	DENND5A
R-HSA-428157	Sphingolipid metabolism	0.988522925981257	-0.0115434439431358	90	1	0.00201612903225806	496	10287	130367	SGPP2
R-HSA-392499	Metabolism of proteins	0.988621303208864	-0.011443929475516	1619	61	0.122983870967742	496	10287	135,6708,64135,5069,23586,56999,8767,10164,4312,51301,5721,374,10318,84101,79623,8876,6347,6482,8900,8875,7295,10471,286,467,4792,154064,9628,4121,3576,3624,9945,7128,6000,8975,6288,1540,9507,124872,5277,8313,79931,3484,60676,5698,10517,1294,219333,50614,6484,330,5699,90865,150,10071,4586,27076,5329,1080,64127,723790,1604	ADORA2A,SPTA1,IFIH1,PAPPA,DDX58,ADAMTS9,RIPK2,CHST4,MMP1,GCNT4,PSME2,AREG,TNIP1,USP44,GALNT14,VNN1,CCL2,ST3GAL1,CCNA1,VNN2,TXN,PFDN6,ANK1,ATF3,NFKBIA,RAET1L,RGS6,MAN1A1,CXCL8,INHBA,GFPT2,TNFAIP3,RGS7,USP13,SAA1,CYLD,ADAMTS4,B4GALNT2,PIGA,AXIN2,TNIP3,IGFBP1,PAPPA2,PSMB9,FBXW10,COL7A1,USP12,GALNT9,ST3GAL4,BIRC3,PSMB10,IL33,ADRA2A,MUC12,MUC5AC,LYPD3,PLAUR,CFTR,NOD2,HIST2H2AA4,CD55
R-HSA-2980736	Peptide hormone metabolism	0.989081191035341	-0.0109788566588462	91	1	0.00201612903225806	496	10287	3624	INHBA
R-HSA-73777	RNA Polymerase I Chain Elongation	0.989081191035341	-0.0109788566588462	91	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-69481	G2/M Checkpoints	0.989587702647101	-0.010466884570499	169	3	0.00604838709677419	496	10287	5721,5698,5699	PSME2,PSMB9,PSMB10
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.990117725699569	-0.00993142807526219	93	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-3214815	HDACs deacetylate histones	0.990598558351039	-0.0094459141581129	94	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-8856828	Clathrin-mediated endocytosis	0.991193761091281	-0.00884524298555959	137	2	0.00403225806451613	496	10287	7474,1080	WNT5A,CFTR
R-HSA-211000	Gene Silencing by RNA	0.991193761091281	-0.00884524298555959	137	2	0.00403225806451613	496	10287	54514,723790	DDX4,HIST2H2AA4
R-HSA-5693607	Processing of DNA double-strand break ends	0.992299430206986	-0.00773037227657137	98	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-2132295	MHC class II antigen presentation	0.994000234226836	-0.00601783668491028	103	1	0.00201612903225806	496	10287	1520	CTSS
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.994063523259734	-0.0059541676675752	146	2	0.00403225806451613	496	10287	80852,55879	GRIP2,GABRQ
R-HSA-5578749	Transcriptional regulation by small RNAs	0.99483494484575	-0.00517844016104833	106	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-427413	NoRC negatively regulates rRNA expression	0.995086577031492	-0.00492553351692467	107	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.995325973687004	-0.00468498373082154	108	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.99577040675743	-0.0042385632740603	110	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.99577040675743	-0.0042385632740603	110	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-73864	RNA Polymerase I Transcription	0.99617265767831	-0.003834685338461	112	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-2408522	Selenoamino acid metabolism	0.997559475513939	-0.00244350742021499	121	1	0.00201612903225806	496	10287	7296	TXNRD1
R-HSA-1500620	Meiosis	0.997559475513939	-0.00244350742021499	121	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-4839726	Chromatin organization	0.997944575686264	-0.00205753959732422	279	5	0.0100806451612903	496	10287	23135,723790,595,4790,4791	KDM6B,HIST2H2AA4,CCND1,NFKB1,NFKB2
R-HSA-3247509	Chromatin modifying enzymes	0.997944575686264	-0.00205753959732422	279	5	0.0100806451612903	496	10287	4790,595,723790,23135,4791	NFKB1,CCND1,HIST2H2AA4,KDM6B,NFKB2
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.998592648387625	-0.00140834286178871	132	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-212436	Generic Transcription Pathway	0.99881506014712	-0.0011856424491849	865	25	0.0504032258064516	496	10287	6446,10308,4929,8626,25946,637,639,8900,7296,54541,7295,4435,23327,1263,27113,3725,85441,163732,10046,90874,5366,1030,8013,10769,7832	SGK1,ZNF267,NR4A2,TP63,ZNF385A,BID,PRDM1,CCNA1,TXNRD1,DDIT4,TXN,CITED1,NEDD4L,PLK3,BBC3,JUN,HELZ2,CITED4,MAMLD1,ZNF697,PMAIP1,CDKN2B,NR4A3,PLK2,BTG2
R-HSA-5693538	Homology Directed Repair	0.998957963111459	-0.00104258018643704	138	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-162599	Late Phase of HIV Life Cycle	0.99900888934189	-0.000991602133042332	139	1	0.00201612903225806	496	10287	23327	NEDD4L
R-HSA-68875	Mitotic Prophase	0.999103410478379	-0.000896991698415835	141	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-3214847	HATs acetylate histones	0.999188933682176	-0.000811395410065957	143	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-68886	M Phase	0.999313730883469	-0.000686504706972669	308	5	0.0100806451612903	496	10287	723790,5721,5698,9700,5699	HIST2H2AA4,PSME2,PSMB9,ESPL1,PSMB10
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.99939966776006	-0.000600512511490918	149	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-212165	Epigenetic regulation of gene expression	0.999456975854409	-0.000543171636598789	151	1	0.00201612903225806	496	10287	723790	HIST2H2AA4
R-HSA-168254	Influenza Infection	0.999598164177787	-0.000401916579861645	157	1	0.00201612903225806	496	10287	9636	ISG15
R-HSA-5693532	DNA Double-Strand Break Repair	0.999756823712358	-0.000243205859790077	167	1	0.00201612903225806	496	10287	8900	CCNA1
R-HSA-69278	Cell Cycle, Mitotic	0.999851322523202	-0.000148688530389652	514	10	0.0201612903225806	496	10287	595,5698,5721,1030,64785,23649,723790,9700,5699,8900	CCND1,PSMB9,PSME2,CDKN2B,GINS3,POLA2,HIST2H2AA4,ESPL1,PSMB10,CCNA1
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.999866992445251	-0.000133016401037723	179	1	0.00201612903225806	496	10287	4121	MAN1A1
R-HSA-5617833	Cilium Assembly	0.999930875177621	-6.91272116097245e-05	192	1	0.00201612903225806	496	10287	2847	MCHR1
R-HSA-5653656	Vesicle-mediated transport	0.999965272782674	-3.47278203295025e-05	650	13	0.0262096774193548	496	10287	2495,6288,23258,7474,1604,286,1080,6708,4121,2706,8578,374,1294	FTH1,SAA1,DENND5A,WNT5A,CD55,ANK1,CFTR,SPTA1,MAN1A1,GJB2,SCARF1,AREG,COL7A1
R-HSA-199991	Membrane Trafficking	0.999984344146677	-1.5655975876628e-05	610	11	0.0221774193548387	496	10287	23258,7474,1604,286,1080,2495,1294,374,6708,2706,4121	DENND5A,WNT5A,CD55,ANK1,CFTR,FTH1,COL7A1,AREG,SPTA1,GJB2,MAN1A1
R-HSA-1640170	Cell Cycle	0.999989451054809	-1.05490008319204e-05	621	11	0.0221774193548387	496	10287	23649,64785,1030,5698,5721,595,8900,5699,9700,723790,25946	POLA2,GINS3,CDKN2B,PSMB9,PSME2,CCND1,CCNA1,PSMB10,ESPL1,HIST2H2AA4,ZNF385A
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.999995705595004	-4.29441421655329e-06	247	1	0.00201612903225806	496	10287	9589	WTAP
R-HSA-73894	DNA Repair	0.999997743612981	-2.25638956469856e-06	316	2	0.00403225806451613	496	10287	9636,8900	ISG15,CCNA1
R-HSA-1852241	Organelle biogenesis and maintenance	0.999999288727248	-7.11273005004653e-07	340	2	0.00403225806451613	496	10287	85441,2847	HELZ2,MCHR1
R-HSA-381753	Olfactory Signaling Pathway	0.999999940272416	-5.97275859298261e-08	391	2	0.00403225806451613	496	10287	283365,64108	OR6C6,RTP4
R-HSA-74160	Gene Expression	0.999999999901093	-9.89067743229589e-11	1821	32	0.0645161290322581	496	10287	4435,5721,1263,6446,8626,637,8900,639,54541,7295,1030,5366,8013,10769,85441,10046,5698,23327,9589,27113,5452,10308,4929,723790,25946,7296,5699,7832,3725,163732,54514,90874	CITED1,PSME2,PLK3,SGK1,TP63,BID,CCNA1,PRDM1,DDIT4,TXN,CDKN2B,PMAIP1,NR4A3,PLK2,HELZ2,MAMLD1,PSMB9,NEDD4L,WTAP,BBC3,POU2F2,ZNF267,NR4A2,HIST2H2AA4,ZNF385A,TXNRD1,PSMB10,BTG2,JUN,CITED4,DDX4,ZNF697
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-977347	Serine biosynthesis	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-1483115	Hydrolysis of LPC	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-444821	Relaxin receptors	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-72731	Recycling of eIF2:GDP	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-196783	Coenzyme A biosynthesis	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-73942	DNA Damage Reversal	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-70921	Histidine catabolism	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-1483148	Synthesis of PG	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-804914	Transport of fatty acids	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-5632681	Ligand-receptor interactions	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-73928	Depyrimidination	0.999999999953621	-4.63786578556598e-11	8	0	0	496	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-1663150	The activation of arylsulfatases	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-2168880	Scavenging of heme from plasma	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-2408517	SeMet incorporation into proteins	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-175474	Assembly Of The HIV Virion	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-375281	Hormone ligand-binding receptors	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-5210891	Uptake and function of anthrax toxins	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-171007	p38MAPK events	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.99999999996418	-3.58204383428223e-11	13	0	0	496	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-1170546	Prolactin receptor signaling	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-110312	Translesion synthesis by REV1	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-163615	PKA activation	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.99999999996969	-3.03094788226583e-11	16	0	0	496	10287
R-HSA-8876725	Protein methylation	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-5576886	Phase 4 - resting membrane potential	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.999999999972367	-2.76329373522245e-11	19	0	0	496	10287
R-HSA-163282	Mitochondrial transcription initiation	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-191650	Regulation of gap junction activity	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-77108	Utilization of Ketone Bodies	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-844455	The NLRP1 inflammasome	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-844615	The AIM2 inflammasome	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-977442	GABA A (rho) receptor activation	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1296067	Potassium transport channels	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-217271	FMO oxidises nucleophiles	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-265473	Trafficking of dietary sterols	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-6806664	Metabolism of vitamin K	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-8849472	PTK6 Down-Regulation	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-73927	Depurination	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-111458	Formation of apoptosome	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-110331	Cleavage of the damaged purine	0.999999999973315	-2.66853432526106e-11	3	0	0	496	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-71384	Ethanol oxidation	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-390666	Serotonin receptors	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-8866427	VLDLR internalisation and degradation	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-5689877	Josephin domain DUBs	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-211958	Miscellaneous substrates	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-166786	Creation of C4 and C2 activators	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-5578768	Physiological factors	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-2022857	Keratan sulfate degradation	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-3371511	HSF1 activation	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-1296346	Tandem pore domain potassium channels	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-71064	Lysine catabolism	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-417957	P2Y receptors	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-211979	Eicosanoids	0.999999999973485	-2.65153026076788e-11	12	0	0	496	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-429593	Inositol transporters	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-199920	CREB phosphorylation	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-171319	Telomere Extension By Telomerase	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-111471	Apoptotic factor-mediated response	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-75158	TRAIL  signaling	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-433692	Proton-coupled monocarboxylate transport	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-6814848	Glycerophospholipid catabolism	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-5619102	SLC transporter disorders	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3656225	Defective CHST6 causes MCDC1	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-174362	Transport and synthesis of PAPS	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.999999999973809	-2.61913660948414e-11	7	0	0	496	10287
R-HSA-1483213	Synthesis of PE	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-2024101	CS/DS degradation	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999974628	-2.53722368227766e-11	14	0	0	496	10287
R-HSA-380287	Centrosome maturation	0.999999999975135	-2.48654401566262e-11	82	0	0	496	10287
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.999999999975135	-2.48654401566262e-11	82	0	0	496	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999975135	-2.48654401566262e-11	82	0	0	496	10287
R-HSA-727802	Transport of nucleotide sugars	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-70635	Urea cycle	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-190873	Gap junction degradation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-201688	WNT mediated activation of DVL	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-3215018	Processing and activation of SUMO	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-209968	Thyroxine biosynthesis	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-3229121	Glycogen storage diseases	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-428643	Organic anion transporters	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-74749	Signal attenuation	0.999999999976187	-2.38126513820676e-11	10	0	0	496	10287
R-HSA-168268	Virus Assembly and Release	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-192905	vRNP Assembly	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-165160	PDE3B signalling	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-156582	Acetylation	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-380612	Metabolism of serotonin	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-844623	The IPAF inflammasome	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-75102	C6 deamination of adenosine	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-8849175	Threonine catabolism	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-70688	Proline catabolism	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-888568	GABA synthesis	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-75896	Plasmalogen biosynthesis	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-198765	Signalling to ERK5	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-111995	phospho-PLA2 pathway	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-1483101	Synthesis of PS	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-71737	Pyrophosphate hydrolysis	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-1483152	Hydrolysis of LPE	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-8942233	Intestinal infectious diseases	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-351143	Agmatine biosynthesis	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-916853	Degradation of GABA	0.999999999976239	-2.37613964962358e-11	2	0	0	496	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-211999	CYP2E1 reactions	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-69416	Dimerization of procaspase-8	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-376172	DSCAM interactions	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-5218900	CASP8 activity is inhibited	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-3371378	Regulation by c-FLIP	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-196780	Biotin transport and metabolism	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-75072	mRNA Editing	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-189451	Heme biosynthesis	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-5655291	Signaling by FGFR4 in disease	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999979165	-2.08353466182342e-11	11	0	0	496	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-165158	Activation of AKT2	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-1296061	HCN channels	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-6783984	Glycine degradation	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-888593	Reuptake of GABA	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-390650	Histamine receptors	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-399710	Activation of AMPA receptors	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-8848584	Wax biosynthesis	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-8935690	Miscellaneous digestion events	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-428776	Class II GLUTs	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-1296053	Classical Kir channels	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-8849474	PTK6 Activates STAT3	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-442745	Activation of CaMK IV	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999980083	-1.99166671746421e-11	4	0	0	496	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-373753	Nephrin interactions	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999982496	-1.75039051429188e-11	22	0	0	496	10287
R-HSA-6784531	tRNA processing in the nucleus	0.999999999982708	-1.72916189845887e-11	60	0	0	496	10287
R-HSA-156581	Methylation	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-3371568	Attenuation phase	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-211935	Fatty acids	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-3322077	Glycogen synthesis	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-5358508	Mismatch Repair	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999983171	-1.68293622593739e-11	15	0	0	496	10287
R-HSA-1482839	Acyl chain remodelling of PE	0.999999999983596	-1.64041029157345e-11	29	0	0	496	10287
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.999999999983596	-1.64041029157345e-11	29	0	0	496	10287
R-HSA-390918	Peroxisomal lipid metabolism	0.999999999983596	-1.64041029157345e-11	29	0	0	496	10287
R-HSA-72086	mRNA Capping	0.999999999983596	-1.64041029157345e-11	29	0	0	496	10287
R-HSA-202040	G-protein activation	0.999999999983596	-1.64041029157345e-11	29	0	0	496	10287
R-HSA-444257	RSK activation	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-111957	Cam-PDE 1 activation	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-428808	Na+-dependent glucose transporters	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-6798163	Choline catabolism	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999983764	-1.6235969314108e-11	6	0	0	496	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-5673000	RAF activation	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-429947	Deadenylation of mRNA	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-1296041	Activation of G protein gated Potassium channels	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-1296059	G protein gated Potassium channels	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999983768	-1.6231818548802e-11	25	0	0	496	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999983972	-1.60278408095471e-11	26	0	0	496	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.999999999983972	-1.60278408095471e-11	26	0	0	496	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-163316	Mitochondrial transcription termination	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-8853333	Signaling by FGFR2 fusions	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2408552	Methylation of MeSeH for excretion	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-389542	NADPH regeneration	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-164525	Plus-strand DNA synthesis	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-169131	Inhibition of PKR	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-162585	Uncoating of the HIV Virion	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1483076	Synthesis of CL	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-3248023	Regulation by TREX1	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1300645	Acrosome Reaction	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-6809583	Retinoid metabolism disease events	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-164516	Minus-strand DNA synthesis	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-140180	COX reactions	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999984099	-1.59004823196973e-11	1	0	0	496	10287
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.999999999984344	-1.56564038826027e-11	78	0	0	496	10287
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.999999999984365	-1.56346271075893e-11	41	0	0	496	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.999999999984365	-1.56346271075893e-11	41	0	0	496	10287
R-HSA-5620924	Intraflagellar transport	0.999999999984365	-1.56346271075893e-11	41	0	0	496	10287
R-HSA-5696400	Dual Incision in GG-NER	0.999999999984365	-1.56346271075893e-11	41	0	0	496	10287
R-HSA-74158	RNA Polymerase III Transcription	0.999999999984365	-1.56346271075893e-11	41	0	0	496	10287
R-HSA-1660662	Glycosphingolipid metabolism	0.999999999984472	-1.55278962390991e-11	46	0	0	496	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	0.999999999984472	-1.55278962390991e-11	46	0	0	496	10287
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-1482925	Acyl chain remodelling of PG	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-5635838	Activation of SMO	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.999999999984792	-1.52080646224644e-11	18	0	0	496	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.999999999985407	-1.45929359328668e-11	191	0	0	496	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.99999999998721	-1.27897978721055e-11	30	0	0	496	10287
R-HSA-420029	Tight junction interactions	0.99999999998721	-1.27897978721055e-11	30	0	0	496	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.99999999998721	-1.27897978721055e-11	30	0	0	496	10287
R-HSA-111996	Ca-dependent events	0.99999999998721	-1.27897978721055e-11	30	0	0	496	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999988069	-1.19314966273213e-11	24	0	0	496	10287
R-HSA-156588	Glucuronidation	0.999999999988069	-1.19314966273213e-11	24	0	0	496	10287
R-HSA-191273	Cholesterol biosynthesis	0.999999999988069	-1.19314966273213e-11	24	0	0	496	10287
R-HSA-171052	LDL-mediated lipid transport	0.999999999988069	-1.19314966273213e-11	24	0	0	496	10287
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999988069	-1.19314966273213e-11	24	0	0	496	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999988435	-1.15650371471944e-11	34	0	0	496	10287
R-HSA-1483166	Synthesis of PA	0.999999999988435	-1.15650371471944e-11	34	0	0	496	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999988435	-1.15650371471944e-11	34	0	0	496	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999988435	-1.15650371471944e-11	34	0	0	496	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-70350	Fructose catabolism	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-561048	Organic anion transport	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-70370	Galactose catabolism	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8852405	Signaling by MST1	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-5662702	Melanin biosynthesis	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8866423	VLDL biosynthesis	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-71032	Propionyl-CoA catabolism	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-167826	The fatty acid cycling model	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-114516	Disinhibition of SNARE formation	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8866376	Reelin signalling pathway	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-75157	FasL/ CD95L signaling	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-1483226	Synthesis of PI	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-444209	Free fatty acid receptors	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-157881	Cyclin B2 mediated events	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-111463	SMAC binds to IAPs	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-6785470	tRNA processing in the mitochondrion	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-390651	Dopamine receptors	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-167827	The proton buffering model	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8849473	PTK6 Expression	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-2161541	Abacavir metabolism	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-446205	Synthesis of GDP-mannose	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-71262	Carnitine synthesis	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-74713	IRS activation	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-391906	Leukotriene receptors	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999988771	-1.12289533294072e-11	5	0	0	496	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-1296065	Inwardly rectifying K+ channels	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.999999999989158	-1.08419717541143e-11	31	0	0	496	10287
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-196025	Formation of annular gap junctions	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-166665	Terminal pathway of complement	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-75094	Formation of the Editosome	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-1462054	Alpha-defensins	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-425986	Sodium/Proton exchangers	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-391908	Prostanoid ligand receptors	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-419771	Opsins	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-159424	Conjugation of carboxylic acids	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-156587	Amino Acid conjugation	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-74182	Ketone body metabolism	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999990144	-9.85595668734956e-12	9	0	0	496	10287
R-HSA-156842	Eukaryotic Translation Elongation	0.999999999990363	-9.63666075968341e-12	96	0	0	496	10287
R-HSA-72764	Eukaryotic Translation Termination	0.999999999990363	-9.63666075968341e-12	96	0	0	496	10287
R-HSA-69618	Mitotic Spindle Checkpoint	0.99999999999119	-8.81004978349502e-12	21	0	0	496	10287
R-HSA-500657	Presynaptic function of Kainate receptors	0.99999999999119	-8.81004978349502e-12	21	0	0	496	10287
R-HSA-445144	Signal transduction by L1	0.99999999999119	-8.81004978349502e-12	21	0	0	496	10287
R-HSA-1181150	Signaling by NODAL	0.99999999999119	-8.81004978349502e-12	21	0	0	496	10287
R-HSA-210745	Regulation of gene expression in beta cells	0.99999999999119	-8.81004978349502e-12	21	0	0	496	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.99999999999119	-8.81004978349502e-12	21	0	0	496	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999991521	-8.47937074285924e-12	45	0	0	496	10287
R-HSA-379724	tRNA Aminoacylation	0.999999999991521	-8.47937074285924e-12	45	0	0	496	10287
R-HSA-8854214	TBC/RABGAPs	0.999999999991521	-8.47937074285924e-12	45	0	0	496	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-1643713	Signaling by EGFR in Cancer	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-194223	HDL-mediated lipid transport	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-418217	G beta:gamma signalling through PLC beta	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999992556	-7.44384742361965e-12	20	0	0	496	10287
R-HSA-5389840	Mitochondrial translation elongation	0.999999999993149	-6.85137786743233e-12	88	0	0	496	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999993149	-6.85137786743233e-12	88	0	0	496	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.999999999993238	-6.76253400088619e-12	43	0	0	496	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.999999999993238	-6.76253400088619e-12	43	0	0	496	10287
R-HSA-168325	Viral Messenger RNA Synthesis	0.999999999993238	-6.76253400088619e-12	43	0	0	496	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-437239	Recycling pathway of L1	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-111933	Calmodulin induced events	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-70268	Pyruvate metabolism	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-264876	Insulin processing	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-111997	CaM pathway	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-6803529	FGFR2 alternative splicing	0.999999999994214	-5.78586087820997e-12	28	0	0	496	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999994322	-5.67813969303663e-12	50	0	0	496	10287
R-HSA-6802949	Signaling by RAS mutants	0.999999999994322	-5.67813969303663e-12	50	0	0	496	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999994322	-5.67813969303663e-12	50	0	0	496	10287
R-HSA-167169	HIV Transcription Elongation	0.999999999994322	-5.67813969303663e-12	50	0	0	496	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.999999999994368	-5.63230979866652e-12	69	0	0	496	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-165159	mTOR signalling	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-6783310	Fanconi Anemia Pathway	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-5674135	MAP2K and MAPK activation	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.999999999994758	-5.2424225286307e-12	39	0	0	496	10287
R-HSA-5576892	Phase 0 - rapid depolarisation	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-167161	HIV Transcription Initiation	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	0.99999999999478	-5.2200105379708e-12	47	0	0	496	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-1482788	Acyl chain remodelling of PC	0.999999999995196	-4.80412857107865e-12	27	0	0	496	10287
R-HSA-5668914	Diseases of metabolism	0.999999999995204	-4.7959588254031e-12	44	0	0	496	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.999999999995204	-4.7959588254031e-12	44	0	0	496	10287
R-HSA-70263	Gluconeogenesis	0.999999999995446	-4.55399255649923e-12	32	0	0	496	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	0.999999999995446	-4.55399255649923e-12	32	0	0	496	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.999999999995446	-4.55399255649923e-12	32	0	0	496	10287
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.999999999995446	-4.55399255649923e-12	32	0	0	496	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.999999999995628	-4.37188918059643e-12	137	0	0	496	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.999999999995752	-4.24827215435677e-12	72	0	0	496	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.999999999995752	-4.24827215435677e-12	72	0	0	496	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.999999999996248	-3.75209160068903e-12	100	0	0	496	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.999999999996659	-3.34122032174426e-12	52	0	0	496	10287
R-HSA-2980766	Nuclear Envelope Breakdown	0.999999999996659	-3.34122032174426e-12	52	0	0	496	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	0.999999999996744	-3.25635042145973e-12	61	0	0	496	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.999999999996744	-3.25635042145973e-12	61	0	0	496	10287
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.999999999996815	-3.18504355185458e-12	104	0	0	496	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.999999999996913	-3.08723279013706e-12	70	0	0	496	10287
R-HSA-1632852	Macroautophagy	0.999999999997139	-2.86060064553703e-12	67	0	0	496	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.999999999997546	-2.45377085136371e-12	40	0	0	496	10287
R-HSA-167290	Pausing and recovery of HIV elongation	0.999999999997546	-2.45377085136371e-12	40	0	0	496	10287
R-HSA-167287	HIV elongation arrest and recovery	0.999999999997546	-2.45377085136371e-12	40	0	0	496	10287
R-HSA-109703	PKB-mediated events	0.999999999997546	-2.45377085136371e-12	40	0	0	496	10287
R-HSA-991365	Activation of GABAB receptors	0.999999999997546	-2.45377085136371e-12	40	0	0	496	10287
R-HSA-977444	GABA B receptor activation	0.999999999997546	-2.45377085136371e-12	40	0	0	496	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	0.999999999997636	-2.36443828553767e-12	42	0	0	496	10287
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.999999999997636	-2.36443828553767e-12	42	0	0	496	10287
R-HSA-983189	Kinesins	0.999999999997636	-2.36443828553767e-12	42	0	0	496	10287
R-HSA-167172	Transcription of the HIV genome	0.999999999997681	-2.31915860669352e-12	77	0	0	496	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-3371571	HSF1-dependent transactivation	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-5205647	Mitophagy	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-8855121	VLDL interactions	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-428930	Thromboxane signalling through TP receptor	0.999999999997682	-2.31759117052546e-12	23	0	0	496	10287
R-HSA-3371556	Cellular response to heat stress	0.999999999997862	-2.13784378519399e-12	89	0	0	496	10287
R-HSA-164378	PKA activation in glucagon signalling	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-140534	Ligand-dependent caspase activation	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-5656121	Translesion synthesis by POLI	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-156711	Polo-like kinase mediated events	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-3232118	SUMOylation of transcription factors	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-5655862	Translesion synthesis by POLK	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-1482922	Acyl chain remodelling of PI	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	0.99999999999848	-1.51974015240568e-12	17	0	0	496	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.999999999998733	-1.26670620937211e-12	87	0	0	496	10287
R-HSA-5419276	Mitochondrial translation termination	0.999999999998733	-1.26670620937211e-12	87	0	0	496	10287
R-HSA-5368286	Mitochondrial translation initiation	0.999999999998733	-1.26670620937211e-12	87	0	0	496	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.999999999998764	-1.23613651592112e-12	63	0	0	496	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.999999999999116	-8.84048529726942e-13	99	0	0	496	10287
R-HSA-168255	Influenza Life Cycle	0.99999999999912	-8.80135467463426e-13	146	0	0	496	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.999999999999385	-6.15321168511064e-13	48	0	0	496	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	0.999999999999385	-6.15321168511064e-13	48	0	0	496	10287
R-HSA-2990846	SUMOylation	0.999999999999832	-1.67641529741982e-13	110	0	0	496	10287
R-HSA-8856688	Golgi-to-ER retrograde transport	0.999999999999832	-1.67641529741982e-13	110	0	0	496	10287
R-HSA-8873719	RAB geranylgeranylation	0.999999999999933	-6.7062945826007e-14	64	0	0	496	10287
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	1.00000000000008	8.30870997244958e-14	158	0	0	496	10287
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000000171	1.70805771298154e-12	105	0	0	496	10287
R-HSA-72312	rRNA processing	1.00000000000171	1.71377368102021e-12	201	0	0	496	10287
R-HSA-176187	Activation of ATR in response to replication stress	1.00000000000175	1.74624404898945e-12	37	0	0	496	10287
R-HSA-73933	Resolution of Abasic Sites (AP sites)	1.00000000000175	1.74624404898945e-12	37	0	0	496	10287
R-HSA-73884	Base Excision Repair	1.00000000000175	1.74624404898945e-12	37	0	0	496	10287
R-HSA-438064	Post NMDA receptor activation events	1.00000000000175	1.74624404898945e-12	37	0	0	496	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.00000000000185	1.85301865787374e-12	71	0	0	496	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	1.00000000000185	1.85301865787374e-12	71	0	0	496	10287
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000000206	2.06301708079098e-12	56	0	0	496	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	1.00000000000247	2.47262769223418e-12	90	0	0	496	10287
R-HSA-72172	mRNA Splicing	1.00000000000252	2.52288809395835e-12	195	0	0	496	10287
R-HSA-73857	RNA Polymerase II Transcription	1.00000000000293	2.93078570348662e-12	159	0	0	496	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	1.0000000000033	3.29720559132654e-12	85	0	0	496	10287
R-HSA-5696398	Nucleotide Excision Repair	1.00000000000355	3.5538774265601e-12	112	0	0	496	10287
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	1.00000000000374	3.74036637930199e-12	103	0	0	496	10287
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1.00000000000392	3.9199322388062e-12	113	0	0	496	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000000416	4.15751967392664e-12	53	0	0	496	10287
R-HSA-194441	Metabolism of non-coding RNA	1.00000000000416	4.15751967392664e-12	53	0	0	496	10287
R-HSA-191859	snRNP Assembly	1.00000000000416	4.15751967392664e-12	53	0	0	496	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000000416	4.15751967392664e-12	53	0	0	496	10287
R-HSA-6799198	Complex I biogenesis	1.00000000000448	4.48240165968851e-12	51	0	0	496	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000000465	4.65454132766385e-12	54	0	0	496	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	1.00000000000491	4.90695470260822e-12	35	0	0	496	10287
R-HSA-113418	Formation of the Early Elongation Complex	1.00000000000491	4.90695470260822e-12	35	0	0	496	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	1.00000000000491	4.90695470260822e-12	35	0	0	496	10287
R-HSA-5693537	Resolution of D-Loop Structures	1.00000000000491	4.90695470260822e-12	35	0	0	496	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	1.00000000000491	4.90695470260822e-12	35	0	0	496	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	1.00000000000491	4.90695470260822e-12	35	0	0	496	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	1.00000000000491	4.90905510276123e-12	57	0	0	496	10287
R-HSA-5368287	Mitochondrial translation	1.00000000000505	5.05102325581391e-12	94	0	0	496	10287
R-HSA-611105	Respiratory electron transport	1.00000000000579	5.79369954996338e-12	92	0	0	496	10287
R-HSA-156902	Peptide chain elongation	1.00000000000579	5.79369954996338e-12	92	0	0	496	10287
R-HSA-192823	Viral mRNA Translation	1.00000000000579	5.79369954996338e-12	92	0	0	496	10287
R-HSA-8854518	AURKA Activation by TPX2	1.00000000000616	6.15978503338167e-12	75	0	0	496	10287
R-HSA-6802957	Oncogenic MAPK signaling	1.00000000000616	6.15978503338167e-12	75	0	0	496	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000000616	6.15978503338167e-12	75	0	0	496	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000000616	6.15978503338167e-12	75	0	0	496	10287
R-HSA-72766	Translation	1.00000000000757	7.56977226932769e-12	162	0	0	496	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.00000000000866	8.65782147203182e-12	115	0	0	496	10287
R-HSA-8852135	Protein ubiquitination	1.00000000000872	8.71955398126861e-12	62	0	0	496	10287
R-HSA-1268020	Mitochondrial protein import	1.00000000000872	8.71955398126861e-12	62	0	0	496	10287
R-HSA-72187	mRNA 3'-end processing	1.00000000000872	8.71955398126861e-12	62	0	0	496	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1.00000000000872	8.71955398126861e-12	62	0	0	496	10287
R-HSA-72649	Translation initiation complex formation	1.00000000000872	8.71955398126861e-12	62	0	0	496	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000000872	8.71955398126861e-12	62	0	0	496	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.0000000000089	8.90274707091259e-12	36	0	0	496	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.0000000000089	8.90274707091259e-12	36	0	0	496	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	1.0000000000089	8.90274707091259e-12	36	0	0	496	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	1.0000000000089	8.90274707091259e-12	36	0	0	496	10287
R-HSA-72306	tRNA processing	1.0000000000094	9.39937432677487e-12	109	0	0	496	10287
R-HSA-381070	IRE1alpha activates chaperones	1.0000000000095	9.5022087522978e-12	58	0	0	496	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000000979	9.78954658116945e-12	120	0	0	496	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000000979	9.78954658116945e-12	120	0	0	496	10287
R-HSA-69473	G2/M DNA damage checkpoint	1.00000000001004	1.00378487700725e-11	95	0	0	496	10287
R-HSA-2408557	Selenocysteine synthesis	1.00000000001004	1.00378487700725e-11	95	0	0	496	10287
R-HSA-180746	Nuclear import of Rev protein	1.00000000001046	1.04576187798761e-11	33	0	0	496	10287
R-HSA-392518	Signal amplification	1.00000000001046	1.04576187798761e-11	33	0	0	496	10287
R-HSA-186712	Regulation of beta-cell development	1.00000000001046	1.04576187798761e-11	33	0	0	496	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000001139	1.13905766237613e-11	65	0	0	496	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000001139	1.13905766237613e-11	65	0	0	496	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000001139	1.13905766237613e-11	65	0	0	496	10287
R-HSA-6782135	Dual incision in TC-NER	1.00000000001262	1.26245264728759e-11	66	0	0	496	10287
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000001262	1.26247237862745e-11	49	0	0	496	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1.00000000001262	1.26247237862745e-11	49	0	0	496	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.0000000000127	1.27020338917429e-11	79	0	0	496	10287
R-HSA-5693606	DNA Double Strand Break Response	1.00000000001298	1.29773307681133e-11	76	0	0	496	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000001346	1.34622958787295e-11	117	0	0	496	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000001346	1.34622958787295e-11	117	0	0	496	10287
R-HSA-68877	Mitotic Prometaphase	1.00000000001361	1.36093510009086e-11	111	0	0	496	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000001853	1.85314091384135e-11	125	0	0	496	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000001853	1.85314091384135e-11	125	0	0	496	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.0000000000186	1.85984319376687e-11	179	0	0	496	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000001895	1.89515808610389e-11	38	0	0	496	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000001895	1.89515808610389e-11	38	0	0	496	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000001895	1.89515808610389e-11	38	0	0	496	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.0000000000205	2.04953558960821e-11	187	0	0	496	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000002136	2.13564487436116e-11	68	0	0	496	10287
